As presented at #ctad2026: OpenScientist, an open-source AI co-scientist, reproduced expert findings and generated testable hypotheses across expert-evaluated biomedical studies, including air-gapped runs on open-weight models.
dlvr.it/TWM9kb
Nature Medicine
Nature Medicine is a monthly peer-reviewed medical journal published by Nature Portfolio covering all aspects of medicine. It was established in 1995. The journal seeks to publish research papers that "demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results". Nature Medicine also publishes reviews, perspectives and other content commissioned from leading scientists in their fields. As with other Nature journals, there is no external editorial board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. The editor-in-chief is João Monteiro. More on Wikipedia
-
Nature Medicine
@NatureMedicine
-
Nature Medicine
@NatureMedicine
New Perspective: A group of policymakers and researchers discuss the impacts of #climatechange on #malaria in the Asia Pacific; they identify gaps in national adaptation strategies and propose five priority actions for the region.
dlvr.it/TWCW4K -
Nature Medicine
@NatureMedicine
A 5-year analysis of the phase 2 PHERGain trial supports the clinical utility of a PET-guided adaptive strategy for treatment de-escalation in HER2+ early breast cancer, and provides ctDNA insights to inform future treatment de-escalation approaches. dlvr.it/TW8d7w
-
Nature Medicine
@NatureMedicine
In ALS, persistent T cell responses relate to disease outcome differently in blood than in CSF, with both intrathecal antigen presentation and cytomegalovirus-specific immunity linked to worse clinical outcomes. dlvr.it/TW72Zk
-
Nature Medicine
@NatureMedicine
A multimodal vision language foundation model, EVLF-FM, integrates extensive clinical data and training techniques, achieving superior diagnostic accuracy and explainability across diverse imaging modalities. dlvr.it/TW6x3W
-
Nature Medicine
@NatureMedicine
A high-resolution snRNA-seq atlas including data from 189 colorectal cancers from patients aged 20-90+ years uncovers age-associated features of colorectal cancer. dlvr.it/TW6sdj
-
Nature Medicine
@NatureMedicine
Metabolic heterogeneity of obesity: Sam Klein & colleagues examine the differences between metabolically healthy and metabolically unhealthy obesity, as well as variations in response to weight loss and clinical implications.
dlvr.it/TW65gK -
Nature Medicine
@NatureMedicine
At #esmo26: in the phase 2 MDT-BRIDGE trial, neoadjuvant durvalumab + chemotherapy in patients with resectable NSCLC, followed by multidisciplinary reassessment, enabled surgery in the majority of patients, leading to encouraging response rates dlvr.it/TW3jXV
-
Nature Medicine
@NatureMedicine
At #esmo26: In an analysis of the phase 3 RELATIVITY-047 trial comparing relatlimab + nivolumab vs nivolumab alone in patients with melanoma, high baseline levels of LAG3hi CD8+ T cells were associated with improved response in the combination arm dlvr.it/TW34gN
-
Nature Medicine
@NatureMedicine
At #esmo26: In a phase 2a trial, treatment of patients with immune checkpoint-inhibitor-naive bladder cancer with the GDF15-neutralizing antibody visugromab + nivolumab produced encouraging response with no new safety signals @AndreaNecchi dlvr.it/TW32cC
-
Nature Medicine
@NatureMedicine
CAR-T therapies are generating excitement beyond cancer, with trials in autoimmune disease. But recent results have complicated that picture.
In our latest news story, Marianne Guenot asks what the latest developments mean for the field. Read more: dlvr.it/TW2LG7 -
Nature Medicine
@NatureMedicine
A high-profile chronotherapy trial was retracted. What does the fallout mean for a field built around the idea that when we treat disease can matter?
Natalie Healey investigates what comes next for chronotherapy in NatureMedicine.
Read more: dlvr.it/TW2KzW -
Nature Medicine
@NatureMedicine
News & Views: New studies of trends in the global burden of #measles and #pertussis offer a reminder of how much vaccination has achieved, and a warning of the need for more resilient and sustainable vaccination programs.
dlvr.it/TW2FXZ -
Nature Medicine
@NatureMedicine
Now #esmo26: In a phase 2 trial evaluating an off-the-shelf peptide vaccine in patients with mKRAS PDAC, the 1ry endpoint of DFS was not met but prespecified analyses showed that significant DFS was seen in the vaccine arm in patients with ctDNA- disease. dlvr.it/TW27M9
-
Nature Medicine
@NatureMedicine
As presented at #esmo26: In a phase 1/2 trial in patients with solid tumors, a first-in-class bispecific antibody targeting the Vβ6/Vβ10 T cell subsets was well tolerated and showed preliminary efficacy signals in immunologically hot and cold tumors dlvr.it/TW276w
-
Nature Medicine
@NatureMedicine
News & Views: A small study shows that patients with #epilepsy can help fine-tune their own seizure detectors by chatting with an #ai agent. However, the more difficult challenge ahead is to build AI that responds appropriately.
dlvr.it/TW1gBk -
Nature Medicine
@NatureMedicine
The liver can warn us of metabolic dysfunction long before serious disease develops. So why do we wait until people are “sick enough” to act?
Jeffrey V. Lazarus argues for earlier action in a new World View.
Read the article: dlvr.it/TW1b9r -
Nature Medicine
@NatureMedicine
News & Views: A secondary analysis of trial data shows that both host antibodies and infused antibodies against #hiv help to delay viral rebound after interruption of therapy, which could inform approaches to durable, ART-free HIV control.
dlvr.it/TW1SnF -
Nature Medicine
@NatureMedicine
News & Views: A new study tackles issues around operational and decisional trust of #agenticai, using locally deployed, on-premise agents and referral of uncertain cases — but what happens after referral remains untested.
dlvr.it/TW0rMM -
Nature Medicine
@NatureMedicine
Happening today, free to join...
Nature Reviews Nephrology
@NatRevNeph
Join @NatureMedicine, @NatRevNeph and our speakers @valerie_luyckx, Ole Norheim, Laura Sola & Yot Teerawattananon for a webinar on financing kidney replacement therapy. Watch live today, Wed Oct 21st, at 14.30 (BST) or on demand afterwards. cassyni.com/events/5PxZX3djbrqDttHngZJmbK
-
Nature Medicine
@NatureMedicine
In a randomised phase 2 trial, patients with metastatic hormone sensitive prostate cancer treated with PARP inhibitor talazoparib combined with androgen receptor inhibitor enzalutamide had an improved PSA response vs enzalutamide alone. dlvr.it/TVz69C @quimmateo @VHIO
-
Nature Medicine
@NatureMedicine
A phase 1 trial shows that treatment of patients with high-grade serous ovarian cancer with personalized neoantigen vaccines combined with PD-1 blockade was feasible and led to tumor-specific immune responses in many patients.
@DFCI_NeoVax -
Nature Medicine
@NatureMedicine
A small epilepsy monitoring study shows that a moderated LLM-based chat interface lets patients converse with their EEG monitoring in real time using a smartphone, and patient feedback cut seizure-detector false alarms by about 80% without clinician input dlvr.it/TVxZyG
-
Nature Medicine
@NatureMedicine
Utilizing longitudinal data from 52,236 patients with cancer, this study created a multimodal atlas of cancer cachexia, demonstrating that weight-loss episodes are linked to systemic serologic signatures and specific tumor genotypes. dlvr.it/TVxNP3
-
Nature Medicine
@NatureMedicine
A phase 1 trial shows that treatment of patients with high-grade serous ovarian cancer with personalized neoantigen vaccines combined with PD-1 blockade was feasible and led to tumor-specific immune responses in many patients. dlvr.it/TVwzPY
@DFCI_NeoVax -
Nature Medicine
@NatureMedicine
📢Upcoming webinar: Join @NatureMedicine and Nature Reviews Nephrology @NatRevNeph for a discussion on approaches to financing #dialysis, a leading cause of catastrophic health expenditure worldwide. Wednesday, October 21st
With @valerie_luyckx, Ole Norheim, Laura Sola & Yot Teerawattananon
cassyni.com/events/5PxZX3djbrqDttHngZJmbK -
Nature Medicine
@NatureMedicine
A cross sectional analysis on lab data from 2 independent cohorts reveals that the final menstrual period marks an abrupt, multisystem physiological shift, occurring 10 years before menopause onset. @glen_pridham @UriAlonWeizmann dlvr.it/TVwm7K
-
Nature Medicine
@NatureMedicine
New study out now describes a new device that links scalp and intracranial EEG to a secure, large language model-based #ai that communicates bidirectionally with a person with #epilepsy through a smartphone app. This improves #seizure detection.
dlvr.it/TVwjb5 -
Nature Medicine
@NatureMedicine
An analysis of code availability in the open access published literature shows that code sharing in clinical prediction models remains limited, and reveals significant variability in practices and documentation quality. dlvr.it/TVwgyv
-
Nature Medicine
@NatureMedicine
Applied to samples from more than 600 patients and controls, urinary cell-free RNA profiling with uRARE-seq demonstrated high sensitivity in detecting bladder cancer, and correlated with treatment response dlvr.it/TVrSmM
-
Nature Medicine
@NatureMedicine
Global age and sex-specific reference curves for 11 pain sites, from 6.1 million people in 118 countries, found higher late-life pain in the lowest HDI countries, and provide a tool for benchmarking pain assessments in other cohorts. dlvr.it/TVr74Q
-
Nature Medicine
@NatureMedicine
A pragmatic cluster-randomised trial done in Yobe State, Northern Nigeria found that distributing small-quantity lipid-based nutrient supplements alongside routine immunization services substantially increased measles vaccination uptake in children -
dlvr.it/TVqdmY -
Nature Medicine
@NatureMedicine
MedGemma, a collection of medical vision–language foundation models based on Gemma 3, demonstrates advanced medical understanding and reasoning on images and text across multiple medical imaging domains dlvr.it/TVqK1F
-
Nature Medicine
@NatureMedicine
News & Views: Inhibition of the Werner syndrome helicase enzyme exploits a new synthetic lethal vulnerability in cancers with microsatellite instability, offering a new way to target these tumors. @JiaJennyLiu discusses the data.
dlvr.it/TVkV7r -
Nature Medicine
@NatureMedicine
#reproducibility key to trustworthy science, but reproducible research practices are inconsistently used. Judy Zhong & colleagues review the current landscape and highlight persistent barriers and responses.
dlvr.it/TVjVXn -
Nature Medicine
@NatureMedicine
Redesigning cardiovascular medicine around sex differences:
Hester den Ruijter & colleagues connect evidence across mechanistic and clinical domains, focusing on female-predominant cardiovascular conditions.
dlvr.it/TVjPST -
Nature Medicine
@NatureMedicine
New studies provide evidence on performance, safety & implementation of the #galleri multi-cancer early detection test, underscoring the next challenge: demonstrating population-level benefit.
Catherine Marinac & colleagues @DanaFarber discuss the data:
idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
Integrating numerous multimodal, patient-level biomarkers enhances the prediction of #cancer #immunotherapy response, but generalizability is still a challenge.
News & Views from Raquel Perez-Lopez, Mireia Crispin-Ortuzar @CRUKCamCentre @VHIO
idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
Trials of selective #krasg12d inhibitors show promise in advanced cancers with G12D mutations, signaling a major shift in the treatment landscape — with potential applications across tumor types and disease stages
News & Views from Jennifer Knox et al.
idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
⚡ Our September issue is live! Featuring new research on #epigenetic clocks, #measles transmission, #preeclampsia, #ai for retinal disease diagnosis, #ipscs for heart failure and much more including Reviews, News and Opinion.
Read it here: idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
New article today: EBV reactivation priming of the peripheral immune system in multiple sclerosis relapse idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… Read more via link:
-
Nature Medicine
@NatureMedicine
An in-depth phenomic analysis of health and disease patterns from 1.9 million participants of the Our Future Health cohort reports the prevalence of health conditions and medication-use patterns compared to national UK estimates and the UK Biobank.
idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
A 15-year cohort study shows that Alzheimer’s #dementia risk is jointly shaped by #alzheimers pathology and #cognitiveresilience, with high #resilience linked to lower risk even under greater pathology.
idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
New article today: Rethinking the global health system for a new international order idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat…
-
Nature Medicine
@NatureMedicine
New article today: Prospective evidence for conversational medical AI is hard, but non-negotiable idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat…
-
Nature Medicine
@NatureMedicine
New article today: A global digital navigator of human health for precision medicine idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat…
-
Nature Medicine
@NatureMedicine
News & Views: An early assessment of the UK’s 'Our Future Health' project shows how national-scale cohorts might reshape population medicine by accelerating discovery and clinical recruitment – provided that biases are carefully measured and managed.
idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
As policymakers debate whether AI "superintelligence" should be banned, what would medical superintelligence actually look like? In Nature Medicine, Ethan Goh and colleagues propose a framework to test it. idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat…
-
Nature Medicine
@NatureMedicine
What happens when an AI agent is deployed in routine clinical care? In a new Comment, Tien Yin Wong and colleagues share early lessons from the real-world deployment of an AI-native model in a large public hospital in Beijing, China.
idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
The Value Cube: translating clinical benefit into realizable value in global oncology idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat…
-
Nature Medicine
@NatureMedicine
As clinical trial activity grows across Africa, strengthening ethics review and regulatory oversight is becoming increasingly important. A new Nature Medicine Correspondence shares lessons from the TRACE initiative. Read more: idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat…
-
Nature Medicine
@NatureMedicine
Obesity medicines are reshaping healthcare faster than many systems are prepared for. In a new Nature Medicine World View, Naveed Sattar @UofGlasgow argues that health systems must adapt to a new era of obesity treatment. Read more: idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat…
-
Nature Medicine
@NatureMedicine
Japan has introduced a legally binding ban on heritable human genome editing. In a new Nature Medicine Correspondence, Tsutomu Sawai examines what the legislation achieves, and where its limits remain. Read more: www.nature.com/articles/s41591-026-04641-x
-
Nature Medicine
@NatureMedicine
A new class of medicines is coming of age. The approval of the first PROTAC for breast cancer demonstrated that drugs can be designed to bring proteins together, opening new opportunities to target disease. Read more: www.nature.com/articles/d41591-026-00045-z
-
Nature Medicine
@NatureMedicine
After years of asking whether AI can match clinicians, one of the first randomized trials of AI in medicine suggests a different question: can human–AI systems improve patient outcomes? Read Comment by Kristina Lång @Lundsuni www.nature.com/articles/s41591-026-04633-x
-
Nature Medicine
@NatureMedicine
Presented at #esccongress: Combining direct oral anticoagulants with powerful P2Y12 inhibitors in atrial fibrillation and acute coronary syndrome patients shows higher bleeding risk without lower ischemic events, compared to using clopidogrel and aspirin.
www.nature.com/articles/s41591-026-04629-7 -
Nature Medicine
@NatureMedicine
As presented at the 2026 #esccongress: A secondary analysis of the CARDIOTTRansform trial revealed that eplontersen benefited patients with transthyretin amyloid cardiomyopathy who were not on stabilizers, but not those who were.
www.nature.com/articles/s41591-026-04670-6 -
Nature Medicine
@NatureMedicine
A cross-trial analysis of data from 38,753 participants across 9 trials estimates effects of comprehensive medical therapy for heart failure on blood pressure, kidney function, & potassium levels, potentially guiding safer therapy initiation. #esccongress
www.nature.com/articles/s41591-026-04623-z -
Nature Medicine
@NatureMedicine
A trial on #psilocybin-assisted therapy for treatment-resistant #depression shows promising adherence & safety. It also raises questions about access, treatment locations and standards for sustainability. News & Views from Liliana Galindo & colleagues: www.nature.com/articles/s41591-026-04597-y
-
Nature Medicine
@NatureMedicine
In a phase 1 trial, #cd19 #cart treatment of patients with severe, treatment-refractory #rheumatoidarthritis was mostly safe with clinical improvement seen in all patients.
www.nature.com/articles/s41591-026-04603-3 -
Nature Medicine
@NatureMedicine
Ahead of the 20-year anniversary of induced pluripotent stem cells #ipscs, Joseph Wu & colleagues review how this technology has moved from bespoke experimental models toward standardized, engineered biological medicines.
www.nature.com/articles/s41591-026-04584-3 -
Nature Medicine
@NatureMedicine
A natural experiment comparing recipients of the live‑attenuated versus recombinant #herpeszoster #vaccines found that the recombinant vaccine was associated with a lower incidence of #cardiovascular events across seven years of follow‑up
www.nature.com/articles/s41591-026-04606-0 -
Nature Medicine
@NatureMedicine
A trial in 16 hospitals across Benin, Malawi, Tanzania, and Uganda found that a multi-faceted ALERT intervention reduced early perinatal mortality during childbirth. #healthcare #alert
idp.nature.com/authorize?response_type=cookie&client_id=g… -
Nature Medicine
@NatureMedicine
Two new articles argue that eastern DRC's Ebola crisis cannot be separated from health-system strain. Overcrowded treatment centres fuel transmission, while conflict & funding cuts threaten malaria, TB and HIV control.
rdcu.be/fCc1M
dlvr.it/TVB3CR -
Nature Medicine
@NatureMedicine
🌟Great news piece in @Nature. The brain struggles to make new neurons in people with #depression.
www.nature.com/articles/d41586-026-02661-8 -
Nature Medicine
@NatureMedicine
A recent case series of 5 individuals exposed to #bundibugyo #ebolavirus shows that the #mbp134 monoclonal antibody cocktail was well tolerated with no signs of disease. This supports further evaluation for future #outbreaks. #ebola
idp.nature.com/authorize?response_type=cookie&client_id=g… -
Nature Medicine
@NatureMedicine
A case report shows that the monoclonal antibody cocktail MBP134, combined with remdesivir and supportive care, led to recovery from #bundibugyo virus infection in 22 days. This supports further evaluation of MBP134. #ebola @Sander_Lab @c_gaebler
idp.nature.com/authorize?response_type=cookie&client_id=g… -
Nature Medicine
@NatureMedicine
Beyond Ebola: armed conflict and humanitarian funding cuts threaten control of malaria, TB and HIV in eastern DRC www.nature.com/articles/s41591-026-04592-3
-
Nature Medicine
@NatureMedicine
Oligodendrocyte dysfunction in human age-related cognitive decline idp.nature.com/authorize?response_type=cookie&client_id=g…
-
Nature Medicine
@NatureMedicine
A case of Bundibugyo virus disease treated with monoclonal antibodies and remdesivir www.nature.com/articles/s41591-026-04663-5
-
Nature Medicine
@NatureMedicine
Post-Exposure Prophylaxis with a monoclonal antibody cocktail Following Bundibugyo Ebolavirus Exposure in Adults and Children www.nature.com/articles/s41591-026-04664-4
-
Nature Medicine
@NatureMedicine
Citywide implementation of a rapid whole-genome sequencing program for critically ill pediatric patients www.nature.com/articles/s41591-026-04598-x
-
Nature Medicine
@NatureMedicine
Liver DiagnOsis Network (LiON) isan advanced AI system designed to enhance CT scan accuracy for liver cancer diagnosis. This innovative technology aims to reduce missed diagnoses and optimize clinical interventions.
www.nature.com/articles/s41591-026-04589-y -
Nature Medicine
@NatureMedicine
A pilot implementation study of a large-language model clinical decision support system in a tertiary emergency department showed safe integration but steadily declining clinical adoption over four weeks.
www.nature.com/articles/s41591-026-04601-5 -
Nature Medicine
@NatureMedicine
The #cannabinoid #dronabinol shows promise in the treatment of nightmares related to post-traumatic stress disorder (#ptsd), but additional studies are needed to confirm safety and efficacy.
News & Views from Murray Stein @UCSanDiego
www.nature.com/articles/s41591-026-04586-1 -
Nature Medicine
@NatureMedicine
🌟 New research into 16 #epigenetic #agingclocks across 51 studies, revealing insights on their responsiveness to various pharmacological and lifestyle changes. Could these aging clocks be the key to reliable #aging biomarkers?
www.nature.com/articles/s41591-026-04562-9 -
Nature Medicine
@NatureMedicine
The trials of translating psilocybin treatment from research to practice www.nature.com/articles/s41591-026-04597-y
-
Nature Medicine
@NatureMedicine
Putting epigenetic aging clocks on trial idp.nature.com/authorize?response_type=cookie&client_id=g…
-
Nature Medicine
@NatureMedicine
Can traditional medicines go mainstream? idp.nature.com/authorize?response_type=cookie&client_id=g…
-
Nature Medicine
@NatureMedicine
Dysregulated adult hippocampal neurogenesis in major depressive disorders idp.nature.com/authorize?response_type=cookie&client_id=g…
-
Nature Medicine
@NatureMedicine
Responsiveness of epigenetic aging biomarkers to longevity interventions in humans idp.nature.com/authorize?response_type=cookie&client_id=g…
-
Nature Medicine
@NatureMedicine
Intercepting pancreatic cancer with a vaccine www.nature.com/articles/d41591-026-00041-3
-
Nature Medicine
@NatureMedicine
In an early-stage randomized trial, the safety and efficacy of #intramyocardial injection of #hipsc-derived #cardiomyocytes in patients with advanced heart failure were evaluated.
www.nature.com/articles/s41591-026-04605-1 -
Nature Medicine
@NatureMedicine
County surveillance failed to detect that measles transmission reached epidemic threshold in schools www.nature.com/articles/s41591-026-04612-2
-
Nature Medicine
@NatureMedicine
The Global Neurosurgical Study‑1 (GNS‑I), conducted across 100 hospitals in 29 countries, found substantial variation in the causes of traumatic #braininjury and in associated #mortality outcomes across human‑development index tiers. #tbi #neurotrauma
www.nature.com/articles/s41591-026-04600-6 -
Nature Medicine
@NatureMedicine
The Global Neurosurgical Study‑1 (GNS‑I), conducted across 100 hospitals in 29 countries, found substantial variation in the causes of #traumatic #braininjury and in associated #mortality outcomes across human‑development index tiers. #tbi
www.nature.com/articles/s41591-026-04600-6 -
Nature Medicine
@NatureMedicine
Waking from the nightmare of PTSD idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat…
-
Nature Medicine
@NatureMedicine
Multi‑scale modelling shows that measles transmission at the school level in the United States crossed the epidemic threshold after 2022–23, a shift not detectable by county‑ or district‑level surveillance.
www.nature.com/articles/s41591-026-04561-w -
Nature Medicine
@NatureMedicine
Andreas Birkenfeld & colleagues call for a new agenda in #diabetes prevention, informed by mechanistic heterogeneity, a life-course risk architecture, and scalable precision tools.
Read their Perspective: www.nature.com/articles/s41591-026-04550-z -
Nature Medicine
@NatureMedicine
A new study reveals mechanisms of resistance to daraxonrasib, highlighting putative combination approaches. Read the News & Views from Grainne O'Kane & colleagues: www.nature.com/articles/s41591-026-04529-w
-
Nature Medicine
@NatureMedicine
New research shows how #aging affects tissue morphology across 40 types, using histopathological images and blood transcriptomic data to develop #agingclocks that reflect health and disease.
www.nature.com/articles/s41591-026-04566-5 -
Nature Medicine
@NatureMedicine
Research highlights morphological changes in 40 tissue types linked to aging. By integrating these with blood transcriptomic data, we develop aging clocks that reflect tissue integrity and organ health. Learn more: www.nature.com/articles/s41591-026-04566-5
-
Nature Medicine
@NatureMedicine
Whole genome sequencing of clinical isolates of #plasmodiumfalciparum in Uganda reveals rapid selection of a PX1-associated haplotype linked to reduced susceptibility to commonly used #antimalarials. #malaria @karadissKara @melissadconrad @JHMRImalaria
www.nature.com/articles/s41591-026-04590-5 -
Nature Medicine
@NatureMedicine
Manipulating biology in the real world is complex; Eran Segal & colleagues envision an #ai-driven digital organism – a system of integrated multiscale #foundationmodels – detailing how to construct and use it to advance biomedical research.
www.nature.com/articles/s41591-026-04595-0 -
Nature Medicine
@NatureMedicine
Whole genome sequencing of clinical isolates of #plasmodiumfalciparum in Uganda reveals rapid selection of a PX1-associated haplotype linked to reduced susceptibility to commonly used #antimalarials. @karadissKara, @melissadconrad, @JHMRImalaria
www.nature.com/articles/s41591-026-04590-5 -
Nature Medicine
@NatureMedicine
The final agenda for Reframing Precision Medicine is live. Join 400+ attendees in London this October to tackle a defining question: how do we turn precision medicine into real clinical impact? Curated by Nature editors. See the final full agenda: go.nature.com/45ZA6nn
precision-medicine.conferences.nature.com
#rpm26 #precisionmedicine 🧪 -
Nature Medicine
@NatureMedicine
Fabrice André & colleagues discuss the next generation of antibody-drug conjugates, including how to integrate multiple chemistry advances into drug constructs and develop infrastructures and tools to accelerate and de-risk early clinical development.
www.nature.com/articles/s41591-026-04543-y -
Nature Medicine
@NatureMedicine
A new study reveals histidine as a readily measurable and potentially modifiable metabolic biomarker for cancer risk stratification and treatment optimization. Read the News & Views from Alpaslan Tasdogan and colleagues: www.nature.com/articles/s41591-026-04555-8
-
Nature Medicine
@NatureMedicine
How can health communication be reinvented for the digital era? In their Q&A, leaders behind the Quality Health Information for All Commission discuss why access to accurate, timely and evidence-based information is a global health priority. www.nature.com/collections/dbhjieeebi
-
Nature Medicine
@NatureMedicine
How do you successfully deploy AI in healthcare? The first two articles in a new @NatureMedicine series offer lessons from cervical cancer screening and Stanford's ChatEHR, with insights for clinicians and health systems.
dlvr.it/TV0KBy
idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
In a phase 2 trial, treatment-naive patients with advanced triple negative breast cancer showed promising responses to the PD-1/VEGF bispecific antibody ivonescimab plus chemotherapy, warranting a large phase 3 trial.
idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
ctDNA analyses in 44 patients with #pancreatic #cancer receiving the RAS(ON) multi-selective inhibitor #daraxonrasib as part of a phase 1/2 trial, and preclinical translational modeling approaches identify mechanisms of acquired resistance to monotherapy.
idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
A phylogenetic analysis of 22 genomes from the recent #bundibugyo virus #outbreak in the Democratic Republic of the Congo and Uganda suggests the outbreak was caused by a new zoonotic spillover event.
idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
Analysis of longitudinal blood samples shows that #cd19 #carts can be detected at least 10 years post-treatment in patients with #lymphoma, with deeper profiling from a single patient showing that these CARTs have a dominant double negative activated effector memory-like phenotype.
@MarcoRuella @ruellalab @pennmedicine @paruzzol
www.nature.com/articles/s41591-026-04578-1 -
Nature Medicine
@NatureMedicine
A new study reveals that parental age and assisted reproductive technologies affect de novo mutations in families. This highlights potential health implications and the need to refine reproductive practices. Read more: idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat…
#reproductivehealth #genetics -
Nature Medicine
@NatureMedicine
In this phase 1 dose-escalation trial, intracranial delivery of B7-H3-targeting CAR T-cell therapy to patients with glioblastoma showed no dose-limiting toxicity signals and encouraging signals for clinical benefit. #car_tcells #celltherapy
www.nature.com/articles/s41591-026-04557-6 -
Nature Medicine
@NatureMedicine
Explainable #ai, implemented for large language models that assist with #dermatological diagnoses, has differing effects depending on whether the assistance is provided to primary care physicians or to lay users.
www.nature.com/articles/s41591-026-04553-w -
Nature Medicine
@NatureMedicine
Across 810 conversations, an evaluation framework finds that #ai #chatbots often amplify simulated users’ psychological vulnerabilities, revealing persistent safety risks in #mentalhealthh contexts.
www.nature.com/articles/s41591-026-04577-2 -
Nature Medicine
@NatureMedicine
A randomized controlled trial found that #dronabinol significantly reduced both the frequency and intensity of #nightmares in patients with #ptsd over 10 weeks, compared with placebo.
www.nature.com/articles/s41591-026-04546-9 -
Nature Medicine
@NatureMedicine
In a publicly funded #nhs England trial, adults with treatment‑resistant major depression received #psilocybin or placebo alongside standardized #psychological support, with #psilocybin showing significant improvements in #depression symptoms, good tolerability, and support for further research in public #healthcare settings. #psychedelics
www.nature.com/articles/s41591-026-04541-0 -
Nature Medicine reposted
Nature Conferences
@NatureConf
Join @NancyFGoodman, @Gilles_Vassal and 15 other global experts at our event with @StJudeResearch, looking to address urgent challenges and opportunities in childhood cancer care. Secure a seat and submit an abstract by Aug 6. go.nature.com/4sT18WF
-
Nature Medicine
@NatureMedicine
A multi-ancestry genome-wide association study meta-analysis across 2,563,755 individuals identifies 26 risk loci for #fibromyalgia, including HTT, and finds genetic correlations with #chronicpain, #psychiatric, and somatic disorders.
@michaelwainberg
www.nature.com/articles/s41591-026-04492-6 -
Nature Medicine
@NatureMedicine
Longitudinal proteomic analysis of plasma from unaffected carriers of #als-associated pathogenic variants revealed early protein changes before ALS symptoms and enabled mapping of their trajectories as well as prediction of the timing of phenoconversion.
www.nature.com/articles/s41591-026-04528-x -
Nature Medicine
@NatureMedicine
A first-in-human phase 1 study of an allogeneic, clinical-grade #ipsc-derived neural stem/progenitor cell product in patients with subacute complete #spinalcordinjury demonstrates clinical #feasibility and long-term #safety. #sci #stemcelltherapy #regenerativemedicine
-
Nature Medicine
@NatureMedicine
The immune-privileged inner ear environment permits sequential bilateral #genetherapy for one form of congenital deafness, adding to growing evidence of the feasibility, safety & efficacy of this innovative, curative treatment.
News & Views:
www.nature.com/articles/s41591-026-04512-5 -
Nature Medicine
@NatureMedicine
Two early phase clinical trials represent progress in #lassa fever vaccine and therapeutic development, including the first interventional treatment trial in decades. Read the News & Views from Daniel Jenkin @UniofOxford
www.nature.com/articles/s41591-026-04478-4 -
Nature Medicine
@NatureMedicine
New Review: Biological aging clocks in health and disease
Eric Topol and Tony Wyss-Coray survey the state of the field and discuss how aging clocks could help understand pathobiology, reduce the burden of disease, and extend healthspan.
www.nature.com/articles/s41591-026-04495-3 -
Nature Medicine
@NatureMedicine
⚡ Our July issue is out! Featuring new research on #neuroprosthetics (see cover), #e-cigarettes, #bispecific drugs in #cancer and #hiv, #lassa fever vaccines, #glp-1s, #sirnas and much more including reviews, news and opinion.
Read it here: www.nature.com/nm/volumes/32/issues/7 -
Nature Medicine
@NatureMedicine
A double #neural bypass linked brain signals to spinal and cortical #stimulation, restoring real time hand control and touch, promoting lasting movement and sensory recovery after complete #tetraplegia.
#bcis #neuroprosthesis #spinalcordinjury #brainimplants -
Nature Medicine reposted
Weizmann Institute
@WeizmannScience
A phase 1 clinical trial reports positive results for a brain-protective immunotherapy in early Alzheimer's disease. The therapy is based on the discoveries of Prof. Michal Schwartz and was developed by ImmunoBrain >> wis-wander.weizmann.ac.il/technology-applications/immune-… @NatureMedicine
-
Nature Medicine
@NatureMedicine
🌟As presented at #aaic2026: A phase 1b trial shows that IBC-Ab002, a short lived anti-#pdl1 antibody that intermittently activates the peripheral #immunesystem is safe and well tolerated in people with early #alzheimers disease. #alzheimersdisease, #neuroimmunology #immunecheckpoint #clinicaltrials
www.nature.com/articles/s41591-026-04547-8 -
Nature Medicine
@NatureMedicine
Our latest Perspective presents a framework for selecting immune #aging #biomarkers for clinical trials in geroscience, and a roadmap for developing these biomarkers to support the next generation of immune aging studies. #xprizehealthspan
www.nature.com/articles/s41591-026-04493-5 -
Nature Medicine
@NatureMedicine
🌟As presented at #isscr2026:
Phase I/II trial of an off-the-shelf #stemcell-derived #dopaminergic progenitor #therapy for #parkinsondisease showed a favorable 12-month safety profile, with no graft-related adverse events, #dyskinesias, or tumor formation, though risks were associated with the #immunosuppression regimen.
www.nature.com/articles/s41591-026-04525-0 -
Nature Medicine
@NatureMedicine
In the ReMIND trial of tumor-associated antigen-specific T cells in patients w/ pediatric CNS tumors, treatment was well tolerated with one complete response and three long-term responders.
@ScientistStephG @dicioccio_a @CancerGrand
www.nature.com/articles/s41591-026-04449-9 -
Nature Medicine
@NatureMedicine
A locally deployable, case-grounded LLM agent achieved high concordance with hematology tumor board decisions across retrospective, external and prospective evaluations.
www.nature.com/articles/s41591-026-04494-4 -
Nature Medicine
@NatureMedicine
A multimodal platform using VR and sensory neurostimulation has shown better results than traditional rehab for chronic stroke patients, enhancing motor function and body awareness.
www.nature.com/articles/s41591-026-04486-4 -
Nature Medicine
@NatureMedicine
As part of a clinical trial, re-administration of AAV gene therapy in 4 patients with congenital deafness who had previously received a first gene therapy dose, & developed neutralising antibodies, was safe & led to further hearing improvements.
www.nature.com/articles/s41591-026-04505-4 -
Nature Medicine
@NatureMedicine
A pragmatic cluster randomized trial found that ChatGPT‑4o–assisted decision support in Kenyan primary care facilities did not significantly reduce 14‑day treatment failure over usual care.
www.nature.com/articles/s41591-026-04503-6 -
Nature Medicine
@NatureMedicine
From the NI006-101 trial, long-term follow-up of cliramitug treatment in patients with transthyretin amyloidosis cardiomyopathy showed favorable safety and significant improvements in cardiac health.
www.nature.com/articles/s41591-026-04487-3 -
Nature Medicine
@NatureMedicine
Adversarial evaluation of leading AI models uncovers gaps between benchmark success and robustness, highlighting limitations in current health AI benchmarks and their ability to capture clinically relevant performance.
www.nature.com/articles/s41591-026-04501-8 -
Nature Medicine
@NatureMedicine
Findings from mass-spectrometry metabolomic analysis reveal that increased plasma histidine levels may be linked to prolonged survival in patients undergoing immunotherapy across various tumor types.
dlvr.it/TTNH6Y -
Nature Medicine
@NatureMedicine
Early stage ER+/HER2- breast cancer patients showed promising clinical responses to neoadjuvant immune-modulating stereotactic body radiotherapy with durvalumab.
@AlexDeCaluwe @LauBuisseret
www.nature.com/articles/s41591-026-04453-z -
Nature Medicine
@NatureMedicine
From the MajesTEC-5 trial, induction with teclistamab followed by daratumumab + lenalidomide has a comparable toxicity profile to other regimens, with encouraging response rates in newly diagnosed multiple myeloma.
@RaabMarc @RascheLeo @HDMyeloma #mmsm
dlvr.it/TTLPmj -
Nature Medicine
@NatureMedicine
News & Views: Two studies show that adaptive neuromodulation can improve Parkinsonian gait by matching stimulation to the right circuit at the right time, pointing to strategies that decompose complex symptoms into targetable spatial & temporal components
dlvr.it/TTLKMZ -
Nature Medicine
@NatureMedicine
Obesity drug development must move beyond its focus on ever-greater weight loss, prioritizing tolerability and sustainable benefits; two recent trials exemplify this shift, with more on the way.
News & Views from W. Timothy Garvey
www.nature.com/articles/s41591-026-04462-y -
Nature Medicine
@NatureMedicine
Talos, a new tool for the automated analysis of genomic data, demonstrates the feasibility and diagnostic utility of systematic re-analyses of data from large rare disease cohorts.
www.nature.com/articles/s41591-026-04477-5 -
Nature Medicine
@NatureMedicine
Analyses of population cohorts found that young adults exhibited earlier systemic and organ specific aging, which was associated with increased risk of early onset cancer compared with older adults born decades earlier.
www.nature.com/articles/s41591-026-04448-w -
Nature Medicine
@NatureMedicine
The biological age of individual cell types can be evaluated using plasma proteomics, revealing diverse aging profiles across more than 40 cell types and links between the accelerated aging of specific cell types and disease.
www.nature.com/articles/s41591-026-04446-y -
Nature Medicine
@NatureMedicine
In an independent evaluation, frontier LLMs outperformed specialized clinical AI tools on medical knowledge, clinician alignment, and real-world clinical queries.
www.nature.com/articles/s41591-026-04431-5 -
Nature Medicine
@NatureMedicine
This case report details a patient in Uganda who succumbed to Bundibugyo virus disease. Post-mortem tests confirmed Bundibugyo virus infection that is genomically distinct from previous outbreaks in Uganda & the DRC.
@cphluganda @cerslwandegeya
www.nature.com/articles/s41591-026-04510-7 -
Nature Medicine
@NatureMedicine
New research indicates that using #e-cigarettes after quitting smoking may lessen the benefits of smoking cessation on lung cancer risk and mortality; more studies are urgently needed to inform guidance
News & Views from Mahdi Sheikh, Pamela Ling @IARCWHO
www.nature.com/articles/s41591-026-04470-y -
Nature Medicine
@NatureMedicine
An interim report of a first-in-human phase 1 trial found an adjuvanted, combination inactivated rabies-vectored, Lassa fever vaccine to be safe & induced immunogenicity to both Lassa + rabies viruses in healthy participants.
dlvr.it/TTJP0K -
Nature Medicine
@NatureMedicine
Dapagliflozin, an SGLT2 inhibitor, reduces the risk of heart failure hospitalization in T2D patients with a specific genetic variant. This highlights the potential for personalized preventative therapies based on genetics.
www.nature.com/articles/s41591-026-04439-x -
Nature Medicine
@NatureMedicine
#cart cell therapy shows promise in treating #precancers like smoldering myeloma, but requires careful patient selection due to potential risks.
News & Views from Sham Mailankody & Eric Jurgens @MSKCancerCenter.
dlvr.it/TTJKw8 -
Nature Medicine
@NatureMedicine
In the randomized double-blind phase 3 ALTAIR trial, patients w/resected colorectal cancer who became ctDNA+ during post-adjuvant surveillance received trifluridine/tipiracil hydrochloride therapy, which did not prolong disease-free survival vs placebo.
dlvr.it/TTHXFQ -
Nature Medicine
@NatureMedicine
In the Phase 2 EMBRAZE study, participants receiving tirzepatide & apitegromab lost less lean-mass vs participants receiving tirzepatide & placebo.
#clinicaltrials #incretins
dlvr.it/TTHX0l -
Nature Medicine
@NatureMedicine
In this phase 3 trial, weekly subcutaneous injections of survodutide, a glucagon receptor/GLP-1R dual agonist, lowered liver fat content & body weight vs placebo in adults with obesity and at-risk MASLD.
#clinicaltrial #incretins
www.nature.com/articles/s41591-026-04479-3 -
Nature Medicine
@NatureMedicine
This randomized phase 2b trial in adults with overweight or obesity shows that aleniglipron, an oral small molecule GLP1-RA, led to up to 11.3% weight loss vs placebo after 36 weeks of treatment.
#clinicaltrial
dlvr.it/TTGf8r -
Nature Medicine reposted
Nature Japan
@NatureJapan
【注目HL】医学:体重減少後の維持に役立つ可能性のある戦略
www.natureasia.com/ja-jp/research/highlight/15536
Louis Aronneらの@NatureMedicine #oa #論文
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial
www.nature.com/articles/s41591-026-04386-7
#オープンアクセス
Springer Nature
@SpringerNature
Keeping weight off after losing it remains a major challenge. Two studies published in @NatureMedicine suggest new approaches that could help maintain weight loss after dieting or injectable treatments.
-
Nature Medicine
@NatureMedicine
An RCT integrating Purrble, a socially assistive tactile robot, into safety planning found that LGBTQ+ youth at risk of self harm had fewer depressive symptoms vs to safety planning alone.
#mentalhealth
dlvr.it/TTGbgG -
Nature Medicine
@NatureMedicine
A phase 1 trial of 3 individuals with familial hypercholesterolemia showed preliminary evidence for the safety and efficacy of AAV8-mediated LDL receptor gene therapy.
#clinicaltrial
dlvr.it/TTGY0d -
Nature Medicine
@NatureMedicine
A case report of Bundibugyo virus in Uganda shows the clinical features of a patient that passed away, & post-mortem analyses confirmed Bundibugyo infection that is genomically distinct from previous outbreaks in the region. @cphluganda @cerslwandegeya
www.nature.com/articles/s41591-026-04510-7 -
Nature Medicine
@NatureMedicine
Phase 1 results reveal that BBM-P002 is well tolerated and safe in Parkinson's disease, with 12-month motor improvements signaling therapeutic potential.
dlvr.it/TTDSyB -
Nature Medicine
@NatureMedicine
An interim report of a first-in-human phase 1 trial found an adjuvanted, combination inactivated rabies-vectored, Lassa fever vaccine to be safe & induced immunogenicity to both Lassa & rabies viruses in healthy participants.
www.nature.com/articles/s41591-026-04429-z -
Nature Medicine
@NatureMedicine
In a whole-exome sequencing analysis, the beneficial effects of dapagliflozin in reducing risk of heart failure hospitalization in people with T2D was greater in those who carried a cardiomyopathy-associated genetic variant vs non-carriers.
dlvr.it/TTBd8m -
Nature Medicine
@NatureMedicine
In the phase 3 ALTAIR trial, patients with resected colorectal cancer who became ctDNA positive during post-adjuvant surveillance received trifluridine/tipiracil hydrochloride therapy, which did not significantly prolong disease-free survival vs placebo.
www.nature.com/articles/s41591-026-04428-0 -
Nature Medicine
@NatureMedicine
⚡ Our June issue is out! With clinical studies on #benralizumab in hypereosinophilic syndrome (cover); #genetherapy for #glioblastoma; #microbiome signatures in #parkonsons; plasma proteomic signatures; agentic AI, and much more.
Read it here: idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
In the Phase 2 EMBRAZE study, participants receiving tirzepatide & apitegromab lost less lean-mass vs participants receiving tirzepatide & placebo.
www.nature.com/articles/s41591-026-04440-4 -
Nature Medicine
@NatureMedicine
In Ebola outbreaks without vaccines or therapeutics, what works best?
A Nature Medicine Comment argues basic public health measures—not border closures—are key to controlling Bundibugyo Ebola.
Read here: idp.nature.com/authorize?response_type=cookie&client_id=g… -
Nature Medicine
@NatureMedicine
Can biotech systems be redesigned to deliver faster patient impact?
A Nature Medicine Comment explores how China’s reforms have accelerated drug development—and what other countries can learn. @MSKCancerCenter
Read: dlvr.it/TT72zF -
Nature Medicine
@NatureMedicine
Should large randomized trials test whether shingles vaccination reduces dementia risk?
A Nature Medicine Comment argues we already have unusually strong observational evidence—and asks what comes next.
dlvr.it/TT6yCX -
Nature Medicine
@NatureMedicine
In a phase 1 trial, treatment of patients with the seizure-related homolog protein 6 (SEZ6) targeting ABBV-706 had a manageable safety profile & showed preliminary efficacy in patients w/resistant or refractory small cell lung cancer.
idp.nature.com/authorize?response_type=cookie&client_id=g… -
Nature Medicine
@NatureMedicine
A nationwide retrospective analysis of 4.5 million Korean adults found that electronic cigarette use after smoking cessation was linked to higher lung cancer incidence & mortality vs complete quitters.
dlvr.it/TT6qC2 -
Nature Medicine
@NatureMedicine
What does 'manageable toxicity' mean?
A patient feels it misses their lived experience, while a physician insists trial toxicities shouldn't be minimized.
Two sides, one message: patients must be heard.
www.nature.com/articles/s41591-026-04464-w
www.nature.com/articles/s41591-026-04463-x -
Nature Medicine
@NatureMedicine
Inflammation is emerging as a key driver of cardiovascular risk—from AI‑enhanced imaging to immune‑targeting therapies.
A Nature Medicine news analysis by Charlotte Harrison explores how clinicians are tackling the “inflamed heart”.
Read: idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
Review: Georg Schett surveys the fast-developing landscape of #car-T cells in #autoimmune disease from both a technological and clinical standpoint, exploring the concept of deep B-cell depletion and immune ‘reset’.
dlvr.it/TT6Csl -
Nature Medicine
@NatureMedicine
Indian biomedicine is at an inflection point—with potential to scale domestic R&D and shape a new model of global health innovation.
Free to read: Nature Medicine editorial
dlvr.it/TT63fj -
Nature Medicine
@NatureMedicine
In this phase 3 trial, weekly injections of survodutide, a glucagon receptor/GLP-1R dual agonist, lowered liver fat & body weight vs placebo in adults with #obesity & at-risk MASLD.
dlvr.it/TT61gf -
Nature Medicine
@NatureMedicine
Exploring how 'food is medicine' can transform healthcare: Medically tailored meals show promise in reducing healthcare usage and costs, but we need larger studies and supportive policies to broaden this approach.
Read the News & Views: dlvr.it/TT5JHx -
Nature Medicine
@NatureMedicine
Housing impacts health. A new study in Tanzania shows that redesigning the home environment can improve child health outcomes, but success requires community co-design and solutions for cost and scalability.
Read the News & Views:
dlvr.it/TT50Hj -
Nature Medicine
@NatureMedicine
This randomized phase 2b trial in 230 adults with overweight or #obesity shows that aleniglipron, an oral small molecule GLP1-RA, led to up to 11.3% body #weight loss vs placebo after 36 weeks.
dlvr.it/TT4xvG -
Nature Medicine
@NatureMedicine
An automated intracortical brain-computer interface, used at home with no researcher intervention, provides long-term and accurate restoration of speech-based communication and cursor-based computer usage in a person with severe dysarthria due to ALS.
dlvr.it/TT4C3V -
Nature Medicine
@NatureMedicine
An automated #intracortical brain-computer interface, used at home with no researcher intervention, provides long-term and accurate restoration of #speech-based #communication and cursor-based computer usage in a person with severe dysarthria due to ALS. #bci @NS_Card @SergeyStavisky @DrDavidBrandman
www.nature.com/articles/s41591-026-04414-6 -
Nature Medicine
@NatureMedicine
A trial integrating Purrble, a socially assistive tactile robot, into safety planning found that LGBTQ+ youth at risk of self harm experienced improvements in Difficulties in Emotion Regulation Scale & fewer depressive symptoms vs safety planning alone.
dlvr.it/TT45rV -
Nature Medicine
@NatureMedicine
Neural decoding algorithms that leverage physiological principles of #locomotor encoding support activity-dependent #deepbrainstimulation #therapies that improve locomotor deficits in people with #pd. #adbs #pd
Great work from: @valeria_deseta @Jocelyne_Bloch @edmoraud @_NeuroRestore
www.nature.com/articles/s41591-026-04432-4 -
Nature Medicine
@NatureMedicine
A randomized crossover study shows that gait-phase synchronized #adaptive deep brain stimulation is feasible, safe, and reduces falls compared to continuous #stimulation in #parkinsonsdisease. #dbs #pd.
www.nature.com/articles/s41591-026-04434-2
Great work from @DorisWangLab, @UCSFneurosurg, @kennethlouiephd. -
Nature Medicine
@NatureMedicine
After preclinical testing, a phase 1 trial involving three individuals with familial hypercholesterolemia demonstrated preliminary evidence for the safety & efficacy of AAV8-mediated LDL receptor gene therapy.
#genetics #clinicalresearch
dlvr.it/TT39Dz -
Nature Medicine
@NatureMedicine
In this feasibility clinical trial, epidural stimulation of the cervical spinal cord safely improved strength, function & spasticity in seven people with arm hemiparesis.
#neuroscience
@MCapogrosso @rm_defreitas @shovanbhatia
dlvr.it/TT13K0 -
Nature Medicine
@NatureMedicine
Microglia cellular changes underlie divergent #resilience associated mechanisms in human #aging.
#neuroscience
dlvr.it/TT05Wr -
Nature Medicine
@NatureMedicine
We are delighted to announce the @NatureMedicine #commission on Brain Health for Economic Resilience. This a two-year global, transdisciplinary effort to define, measure, and advance #brainhealth and cognitive capacity as foundational drivers of #economicresilience.
See announcement: www.nature.com/articles/s41591-026-04444-0
Nature Medicine
@NatureMedicine
Learn more about the Nature Medicine Commission on Brain Health for Economic Resilience: www.globalbraineconomy.org/nature-medicine-commission-bra…
@neuronman @HarrisAEyre @rym_ayadi @EMEAorg @mtdespo @DrRKDhamija @ekkehardernst @cogscimon @burcin_ikiz @AgustinMIbanez @CristineLegare @PierLuigiSacco @JochenReiser -
Nature Medicine
@NatureMedicine
A study of Exemplar countries- Nepal, Senegal and Zambia- previously recognized for major gains in #maternal & #neonatal health found that, despite high coverage of #childbirth care by skilled health personnel, the quality of care remains substandard.
dlvr.it/TSz7Nl -
Nature Medicine
@NatureMedicine
Between 2020 to 2023, in Massachusetts, receiving medically tailored meals was associated with reductions in hospitalizations, emergency department visits & lower healthcare costs.
#nutrition #diet
dlvr.it/TSxCM6 -
Nature Medicine
@NatureMedicine
In a phase 2 trial , treatment of patients with MET-amplified gastric or gastroesophageal junction adenocarcinoma with savolitinib showed promising clinical efficacy.
#cancerresearch
dlvr.it/TSvFmP -
Nature Medicine
@NatureMedicine
In an interim analysis of a phase 1/2 trial in patients with glioblastoma, a genetically-engineered autologous stem cell transplant was well tolerated, with stable engraftment and evidence for immune reprogramming.
#cancerresearch
dlvr.it/TSv0sq -
Nature Medicine
@NatureMedicine
Microglia cellular changes underlie divergent resilience-associated mechanisms in human aging.
dlvr.it/TStFqw -
Nature Medicine
@NatureMedicine
A phase 1b clinical trial compared fecal #microbiome transplant or a 15-strain live biotherapeutic product derived from the same donor & found similar efficacy & engraftment between treatments.
dlvr.it/TStDcV -
Nature Medicine
@NatureMedicine
Promising results from a feasibility trial suggests that #epidural #stimulation of the cervical #spinalcord safely improves upper-limb strength, function and spasticity in seven people with arm #hemiparesis due to #stroke.
@MCapogrosso @rm_defreitas @shovanbhatia -
Nature Medicine
@NatureMedicine
As presented at the 2026 ASCO Annual Meeting: In a phase 1 trial, treatment of patients with the seizure-related homolog protein 6 (SEZ6) targeting antibody-drug conjugate ABBV-706 demonstrated a manageable safety profile and showed preliminary clinical efficacy in patients with resistant or refractory small cell lung cancer.
www.nature.com/articles/s41591-026-04452-0 -
Nature Medicine
@NatureMedicine
At the 2026 #asco Annual Meeting: A phase 2 trial reveals that the selective MET tyrosine kinase inhibitor #savolitinib has promising clinical efficacy in patients with MET-amplified gastric or #gastroesophageal junction #adenocarcinoma.
www.nature.com/articles/s41591-026-04459-7 -
Nature Medicine
@NatureMedicine
As presented at the 2026 ASCO Annual Meeting: A phase 1a trial of IMA401, a new bispecific TCR-based T cell engager that binds a MAGEA4/8 peptide, has encouraging safety and a preliminary efficacy signal in patients with head & neck cancers and melanoma. dlvr.it/TSpL57
-
Nature Medicine
@NatureMedicine
An open-label randomized controlled phase II trial comparing #favipiravir to #ribavirin for the treatment of mild to moderate #lassafever in Nigeria found that favipiravir was safe, well-tolerated and support its further optimization as a treatment.
dlvr.it/TSnpfD -
Nature Medicine
@NatureMedicine
Part of the Hong Kong Genome Project, genomic analyses of over 20,000 participants provide information on clinically relevant variants for Chinese populations and offer insights on the implementation of genomic medicine initiatives.
dlvr.it/TSnK4v -
Nature Medicine
@NatureMedicine
Analyses of sequencing data from 75,602 children referred for #genetictesting from 2016 to 2025 provide insights on the association between pathogenic germline variants and #childhoodcancer.
dlvr.it/TSnHgf -
Nature Medicine
@NatureMedicine
HPV vaccination has reshaped cancer prevention — but the job isn’t finished.
Karen Canfell (Univ of Sydney) reflects on 20 years of progress, the inequities that remain, and what must happen next.
Read free: dlvr.it/TSnB65
#hpv #globalhealth #cancerprevention -
Nature Medicine
@NatureMedicine
At week 68, in patients that experienced poor #weightloss following #bariatricsurgery, #semaglutide was associated with 18.0% weight loss compared to 0.4% weight gain in patients receiving placebo.
dlvr.it/TSn9h7 -
Nature Medicine
@NatureMedicine
The renaming pf PCOS→PMOS grabbed headlines — but the deeper story is about how naming shapes medicine itself.
This @NatureMedicine analysis argues nomenclature isn’t neutral: it steers diagnosis, research funding, and even patient identity.
🔗 www.nature.com/articles/s41591-026-04456-w -
Nature Medicine
@NatureMedicine
🌟In a multi-center phase 2 trial, the FGFR inhibitor rogaratinib showed encouraging clinical efficacy in patients with SDH deficient gastrointestinal stromal tumors, suggesting a potential new treatment option for this patient population and demonstrating that an epigenetic mechanism of oncogene activation can be successfully targeted with a tyrosine kinase inhibitor.
www.nature.com/articles/s41591-026-04376-9 -
Nature Medicine
@NatureMedicine
A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism:
In a prospective cohort of 166 participants (and in a 63 participant validation cohort) dermal α-Synuclein and 4-repeat #tau seed amplification, with serum #nfl were able to identify #parkinsonian syndromes. #synuclein #pd
www.nature.com/articles/s41591-026-04398-3 -
Nature Medicine
@NatureMedicine
Moritz Kramer & colleagues discuss global approaches to infectious disease analysis and modelling, emphasizing federated approaches and addressing longstanding challenges in data interoperability, equity, & trust.
Part of our Focus on #infectiousdiseases.
dlvr.it/TSmFH7 -
Nature Medicine
@NatureMedicine
Authors from across the African continent propose 5 high-priority areas to close gaps in #diagnostic testing, providing a path to self-reliance in health security and universal health care in #africa. Part of our Focus issue on #infectiousdiseases
dlvr.it/TSm809 -
Nature Medicine
@NatureMedicine
Trusted research environments are transforming access to sensitive biomedical data—but at what cost to usability & discovery?
This Comment explores challenges & solutions 🧬
🔗 www.nature.com/articles/s41591-026-04401-x
By @vincentjstraub & Melinda Mills -
Nature Medicine
@NatureMedicine
Jerome Kim & Nicaise Ndembi review the global #vaccine development landscape, focusing on expanding target populations, emerging technologies, and cross-cutting issues such as societal value, funding & access, and regional manufacturing
@IVIHeadquarters
dlvr.it/TSfk0R -
Nature Medicine
@NatureMedicine
Our latest Review describes how #climate variables affect pathogen transmission, seasonality and outbreak patterns, how these interact with weather extremes and demographic change, & how current data streams can map future disease trajectories.
dlvr.it/TSfVl2 -
Nature Medicine
@NatureMedicine
⚡ Our May issue is live! This special issue is focused on infectious diseases and how to curtail them in a fragmented, conflict-prone world. Featuring reviews, news, opinion and research on #vaccines, #diagnostics, forecasting, surveillance & more 🌍
dlvr.it/TSfFZ2 -
Nature Medicine
@NatureMedicine
Analyses of sequencing data from 75,602 children referred for #genetic testing from 2016 to 2025 provide insights on the association between pathogenic #germline #variants and childhood #cancer.
dlvr.it/TSdq1G -
Nature Medicine
@NatureMedicine
In a prospective cohort of 166 participants (and in a 63 participant validation cohort) dermal α-Synuclein and 4-repeat tau seed amplification, with serum NfL were able to identify parkinsonian syndromes. #synuclein #parkinsonsdisease #pd
dlvr.it/TSdYMT -
Nature Medicine
@NatureMedicine
The proposed clinical features of #traumatic Encephalopathy Syndrome have low predictive value for #cte pathology, raising concerns for incorrect #diagnoses of #neurodegeneration in former athletes. #tbi @JohnDArenaMD
www.nature.com/articles/s41591-026-04392-9 -
Nature Medicine
@NatureMedicine
#fda Grants Breakthrough Therapy Designation to VERTANICAL's VER-01, a First-in-Class Non-Opioid treatment. #pain #drugdiscovery
dlvr.it/TScsFr
See paper: www.nature.com/articles/s41591-025-03977-0 -
Nature Medicine
@NatureMedicine
The #biomede trial, though negative, illustrates the utility of adaptive trial designs and biopsy-informed tumor profiling in diffuse intrinsic pontine #gliomas — and offers mechanistic evidence that can inform future therapeutic strategies.
News & Views: dlvr.it/TScrc0 -
Nature Medicine
@NatureMedicine
A first-in-human trial involving removal of the placental protein sFlt-1 in preterm #pre-eclampsia provides critical safety data, and could herald a new era of targeted therapy for this potentially lethal #pregnancy complication.
News & Views: dlvr.it/TScn6h -
Nature Medicine
@NatureMedicine
News & Views: A study shows that reducing exposure to plastic-associated chemicals - such as phthalates and bisphenols - is possiblie in daily life, but large-scale regulatory actions are needed for true public health impact. www.nature.com/articles/s41591-026-04349-y
-
Nature Medicine
@NatureMedicine
News & Views: New tools that improve triage of febrile children could reshape frontline care in resource-limited settings. www.nature.com/articles/s41591-026-04387-6
-
Nature Medicine
@NatureMedicine
The alarming rise in #colorectalcancer incidence among younger people is probably due to environmental factors; #epigenetic signatures of exposures may help uncover drivers of this trend, but questions remain.
News & Views from @KimmieNgMD & colleagues:
www.nature.com/articles/s41591-026-04369-8 -
Nature Medicine
@NatureMedicine
News & Views: New data reveals that a past #tuberculosis diagnosis increases the risk of death up to 14 years later regardless of treatment outcome, which should prompt urgent prioritization of global prevention efforts. dlvr.it/TSQjQn
-
Nature Medicine
@NatureMedicine
New Perspective on the future of #diagnostics in Africa: 5 high-priority areas to close the current gaps in testing, providing a path to self-reliance in health security and universal health care.
dlvr.it/TSQfs2 -
Nature Medicine
@NatureMedicine
Looking forward to this exciting conference:
Nature Conferences
@NatureConf
Just a few days left to submit an abstract to our event exploring how artificial intelligence is revolutionizing healthcare w/ @ParisTxGroup @NatureMedicine @Nature & @NatComputSci
All submissions will be considered for short-talk + poster presentations. go.nature.com/4cv5Ox5 -
Nature Medicine
@NatureMedicine
Ten lessons from a decade of scientific translation at the Crick www.nature.com/articles/s41591-026-04355-0
-
Nature Medicine
@NatureMedicine
Exciting news in patient-driven research! A groundbreaking trial centered around a single child is changing the game for drug discovery. Learn more from Nature Medicine about this innovative approach! #patientdrivenresearch www.nature.com/articles/s41591-026-04335-4
-
Nature Medicine
@NatureMedicine
in a phase 1b trial, patients with MSS CRC received a FAP/41BB ligand together with the CEA directed T cell engager cibisatamab, the treatment was safe and biomarker analysis shows induction of immunity in line with the biological rationale.
www.nature.com/articles/s41591-026-04380-z -
Nature Medicine
@NatureMedicine
Urinary levels of plastics-associated #phthalates and #bisphenol chemicals were associated with #cardiometabolic risk biomarkers and can be lowered by reducing plastic use in food and personal-care products.
www.nature.com/articles/s41591-026-04324-7 -
Nature Medicine
@NatureMedicine
As the UK grapples with the news that @UKBiobank data was listed for sale in China, our news feature offers crucial context and asks a bigger question: who really owns health data?
🔗 www.nature.com/articles/s41591-026-04378-7 -
Nature Medicine
@NatureMedicine
An analysis of #exposome traits in patients with early onset #crc (<50 yrs) compared with late-onset CRC (≥70 yrs) based on epigenetic markers shows that pesticide usage, in particular picloram, is associated with early onset #colon and #rectal #cancer.
www.nature.com/articles/s41591-026-04342-5 -
Nature Medicine
@NatureMedicine
Human #neuroimaging data across five major #psychedelics reveal a convergent #brain signature, highlighting a shared pattern of large-scale network #reorganization. These findings help understand how #psychedelic compounds reshape brain architecture.
www.nature.com/articles/s41591-026-04287-9 -
Nature Medicine
@NatureMedicine
#microbiome analysis reveals gut microbial changes in #parkinsonsdisease evolve progressively from healthy individuals to genetically at-risk individuals #pd patients, with the degree of #dysbiosis correlating with disease progression @TonySchapira
www.nature.com/articles/s41591-026-04318-5 -
Nature Medicine
@NatureMedicine
The authors developed a microfluidic device, FINDChip, to automate & enhance oocyte recovery from follicular fluid. In clinical settings, the device recovered oocytes missed during manual screening, increasing the number of viable oocytes for #ivf
www.nature.com/articles/s41591-026-04207-x -
Nature Medicine
@NatureMedicine
To accelerate drug development for #alzheimersdisease and equip stakeholders with clear benchmarks, Jeffrey Cummings and colleagues @CEOi_Alz outline target product profiles for therapies designed to delay or prevent the onset of clinical symptoms 🧠
www.nature.com/articles/s41591-026-04305-w -
Nature Medicine
@NatureMedicine
Human #neuroimaging data across five major #psychedelics reveal a convergent #brain signature, highlighting a shared pattern of large-scale network #reorganization. These findings help understand how #psychedelic compounds reshape brain architecture. www.nature.com/articles/s41591-026-04287-9
-
Nature Medicine
@NatureMedicine
Long-term follow-up of participants in the ADVENT #trial, comparing pulsed field ablation to conventional thermal ablation in patients with paroxysmal atrial fibrillation, shows preserved effectiveness of pulsed field ablation over 4y.
www.nature.com/articles/s41591-026-04246-4 -
Nature Medicine
@NatureMedicine
In a study of 4 brain-dead human decedents, extracorporeal liver cross-circulation using genetically-modified pig livers provides evidence for provision of essential hepatic function, supporting its feasibility for temporary liver support.
www.nature.com/articles/s41591-025-04196-3 -
Nature Medicine
@NatureMedicine
In a randomized controlled study of 1,298 participants, performance of humans when assisted by an #llm was inferior to the LLM alone when assessing 10 medical scenarios.
www.nature.com/articles/s41591-025-04074-y -
Nature Medicine
@NatureMedicine
What if YOUR local infectious disease risk were as easy to check as the weather, or the pollen forecast?
In a @NatureMedicine Correspondence, Natalie Dean & Caitlin Rivers argue for local, interpretable disease data to support everyday decisions.
🔓 www.nature.com/articles/s41591-026-04328-3 -
Nature Medicine
@NatureMedicine
-
Nature Medicine
@NatureMedicine
In a phase 2 trial, the live-attenuated Chikungunya Vaccine (VLA1553) was given to children < 12y old in Honduras & the Dominican Republic, & was found to be safe & immunogenic.
www.nature.com/articles/s41591-025-04197-2 -
Nature Medicine
@NatureMedicine
Five tenets for advancing evidence-based #precisionmedicine.
A new Perspective from Paul Franks, Daniel Coral and colleagues outlines five key tenets to promote clinically meaningful, reproducible, scalable, and equitable health outcomes through precision medicine. -
Nature Medicine
@NatureMedicine
#healthequity must be integrated into energy transitions and #climate governance. News & Views from Tiantian Li & colleagues at China CDC
www.nature.com/articles/s41591-026-04290-0 -
Nature Medicine
@NatureMedicine
In a randomized study involving 9 general cardiologists & 107 patient cases, assistance from an #llm led to preferable responses on complex case management vs physicians alone.
www.nature.com/articles/s41591-025-04190-9 -
Nature Medicine
@NatureMedicine
New Review on #cancervaccines: John Haanen and colleagues highlight insights from recent clinical trials and discuss critical factors for optimization, with a focus on proxies for efficacy, #neoantigen selection, modular platforms and early intervention.
www.nature.com/articles/s41591-026-04241-9 -
Nature Medicine
@NatureMedicine
In a case series of 8 pediatric patients with systemic lupus erythematosus, dermatomyositis or systemic sclerosis, autologous anti-CD19 CAR-T cell therapy was feasible, safe & effective in reducing disease activity.
www.nature.com/articles/s41591-025-04191-8 -
Nature Medicine
@NatureMedicine
In the phase 1/2 TRIDENT-1 #trial, treatment of patients with NRTK fusion–positive advanced solid tumors with repotrectinib led to systemic & intracranial clinical response. @BenjaminBesseMD @alexdrilon @bensolomon1.
www.nature.com/articles/s41591-025-04079-7 -
Nature Medicine
@NatureMedicine
Elevated serum pTau levels are not specific to Alzheimer´s disease and may also serve as diagnostic tool for the most common types of systemic amyloidosis, with potential utility in distinguishing amyloidosis-related polyneuropathy from polyneuropathy of other etiologies @MathiasJucker www.nature.com/articles/s41591-026-04272-2
-
Nature Medicine
@NatureMedicine
The phase 2/3 DEVOTE #trial demonstrated that high-dose nusinersen improved motor function & was safe in patients with spinal muscular atrophy, vs a matched sham control.
www.nature.com/articles/s41591-025-04193-6 -
Nature Medicine
@NatureMedicine
Global cancer estimates across 185 countries show that 7.1 million new cancer cases were attributable to 30 modifiable risk factors in 2022, with smoking, infections & alcohol consumption leading contributors to cancer burden.
www.nature.com/articles/s41591-026-04219-7 -
Nature Medicine
@NatureMedicine
Data from the WHO STEPS survey helps provide a new framework to understand the impact of physical activity on health, with a focus beyond cardiometabolic disease www.nature.com/articles/s41591-026-04237-5
-
Nature Medicine
@NatureMedicine
In a phase 1 trial enrolling 6 patients with heterozygous familial hypercholesterolemia, treatment with lipid nanoparticles designed for base editing and inactivation of PCSK9 in hepatocytes showed preliminary evidence of low-density lipoprotein lowering without the occurrence of serious adverse events or evidence of off-target editing.
www.nature.com/articles/s41591-026-04254-4 -
Nature Medicine
@NatureMedicine
In a post-hoc analysis of the COSMOS randomized trial, supplementation with daily multivitamins, but not with cocoa extract, over the course of 2 years decreased biological aging, as measured by epigenetic aging clocks www.nature.com/articles/s41591-026-04239-3
-
Nature Medicine
@NatureMedicine
Implementation of the Y-Check health check program is feasible & acceptable for adolescents in Zimbabwe, offering screening for 25 health conditions & behaviors, health promotion, on-site care & referral.
www.nature.com/articles/s41591-025-04156-x -
Nature Medicine
@NatureMedicine
In this phase 3 #trial, patients with tx-naive stage III-IV non-small cell lung cancer who received sintilimab or pembrolizumab & chemotherapy early in the day had longer progression-free survival vs those receiving late time of day infusions.
www.nature.com/articles/s41591-025-04181-w -
Nature Medicine
@NatureMedicine
In this phase-1, open label dose escalation study in healthy adults found that the mRNA vaccine (mRNA-1215), encoding the Nipah virus Malaysian strain chimeric pre-fusion F protein linked to glycoprotein G, was safe and induced elevated immune responses at one year follow-up, indicating this is a promising vaccine candidate for further development www.nature.com/articles/s41591-026-04265-1
-
Nature Medicine
@NatureMedicine
Using individual-level data from the Swedish Prescribed Drug Register and fecal metagenomes of 14979 individuals in Sweden, the authors examined the association between oral antibiotic use over 8 years and gut microbiome and found evidence that antibiotics can have long-lasting impacts on the gut microbiome. www.nature.com/articles/s41591-026-04284-y
-
Nature Medicine
@NatureMedicine
This five-year follow-up of the double-blinded, placebo-controlled phase 3 DEN-03-IB trial evaluating the efficacy and safety of the Butantan-Dengue Vaccine in participants aged 2-59 years in Brazil found that a single dose of the vaccine was effective against DENV-1 and DENV-2, regardless of serostatus at baseline, and was safe.
www.nature.com/articles/s41591-026-04255-3 -
Nature Medicine
@NatureMedicine
In this phase 2, randomized trial in early #alzheimers disease, the #trem2 agonistic antibody AL002 showed target engagement but did not meet the primary endpoint of change from baseline in Clinical Dementia Rating-Sum of Boxes. #microglia #ad #clinicaltrials
-
Nature Medicine
@NatureMedicine
Soon to be launched - Nature Progress Brain Health is looking for an Associate or Senior Editor
springernature.wd3.myworkdayjobs.com/SpringerNatureCareer… -
Nature Medicine
@NatureMedicine
A phase 1 study demonstrates proof-of-concept of liver-targeted PCSK9 #baseediting for familial hypercholesterolemia, but turning this into a transformative therapy will require stringent optimization of editing efficiency, safety, patient selection and trial design.
News & Views from Robert Rosenson, Sascha Goonewardena
@IcahnMountSinai @umichCVC
www.nature.com/articles/s41591-026-04220-0 -
Nature Medicine
@NatureMedicine
In this phase-1, open label dose escalation study in healthy adults found that the mRNA vaccine (mRNA-1215), encoding the Nipah virus Malaysian strain chimeric pre-fusion F protein linked to glycoprotein G, was safe and induced elevated immune responses at one year follow-up, indicating this is a promising vaccine candidate for further development www.nature.com/articles/s41591-026-04265-1
-
Nature Medicine
@NatureMedicine
Elevated serum pTau levels are not specific to Alzheimer´s disease and may also serve as diagnostic tool for the most common types of systemic amyloidosis, with potential utility in distinguishing amyloidosis-related polyneuropathy from polyneuropathy of other etiologies @MathiasJucker www.nature.com/articles/s41591-026-04272-2
-
Nature Medicine
@NatureMedicine
Using individual-level data from the Swedish Prescribed Drug Register and fecal metagenomes of 14979 individuals in Sweden, the authors examined the association between oral antibiotic use over 8 years and gut microbiome and found evidence that antibiotics can have long-lasting impacts on the gut microbiome. www.nature.com/articles/s41591-026-04284-y
-
Nature Medicine
@NatureMedicine
Data from the WHO STEPS survey helps provide a new framework to understand the impact of physical activity on health, with a focus beyond cardiometabolic disease www.nature.com/articles/s41591-026-04237-5
-
Nature Medicine
@NatureMedicine
In a post-hoc analysis of the COSMOS randomized trial, supplementation with daily multivitamins, but not with cocoa extract, over the course of 2 years decreased biological aging, as measured by epigenetic aging clocks www.nature.com/articles/s41591-026-04239-3
-
Nature Medicine
@NatureMedicine
⭐Research highlight: Testing #llms on acute-pain vignettes reveals biases in opioid recommendations that particularly affect marginalized groups, according to a study in Nature Health.
www.nature.com/articles/d41591-026-00013-7 -
Nature Medicine
@NatureMedicine
In a phase 1 trial enrolling 6 patients with heterozygous familial hypercholesterolemia, treatment with lipid nanoparticles designed for base editing and inactivation of PCSK9 in hepatocytes showed preliminary evidence of low-density lipoprotein lowering without the occurrence of serious adverse events or evidence of off-target editing.
www.nature.com/articles/s41591-026-04254-4 -
Nature Medicine
@NatureMedicine
This five-year follow-up of the double-blinded, placebo-controlled phase 3 DEN-03-IB trial evaluating the efficacy and safety of the Butantan-Dengue Vaccine in participants aged 2-59 years in Brazil found that a single dose of the vaccine was effective against DENV-1 and DENV-2, regardless of serostatus at baseline, and was safe.
www.nature.com/articles/s41591-026-04255-3 -
Nature Medicine
@NatureMedicine
In this phase 2, randomized trial in early #alzheimers disease, the #trem2 agonistic antibody AL002 showed target engagement but did not meet the primary endpoint of change from baseline in Clinical Dementia Rating-Sum of Boxes. #microglia #ad #clinicaltrials
-
Nature Medicine
@NatureMedicine
An ‘off-the-shelf’ neoantigen #vaccine shows safety and immunogenicity in individuals with #lynchsyndrome, further advancing hopes for preventive vaccines for hereditary #cancer syndromes. News & Views from Zsofia Stadler and Yonina Murciano-Goroff @MSKCancerCenter
www.nature.com/articles/s41591-026-04248-2 -
Nature Medicine
@NatureMedicine
An ‘off-the-shelf’ neoantigen #vaccine shows safety and immunogenicity in individuals with #lynchsyndrome, further advancing hopes for preventive vaccines for hereditary #cancer syndromes. News & Views from Zsofia Stadler and Yonina Murciano-Goroff @MSKCancerCenter
www.nature.com/articles/s41591-026-04248-2 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Moderate intake of caffeinated #coffee or #tea was associated with a reduction in #dementia risk, according to a large, decades-long cohort study. @JAMA_current
www.nature.com/articles/d41591-026-00012-8 -
Nature Medicine
@NatureMedicine
As presented at the 2026 ASCO Genitourinary Cancers Symposium: Results from a phase 1 trial of a first-in-class small molecule inverse agonist of PPARG in solid tumors show an acceptable safety profile and preliminary tumor activity in urothelial carcinoma.
-
Nature Medicine
@NatureMedicine
As presented at the 2026 ASCO Genitourinary Cancers Symposium: in the phase 2 INDIBLADE trial, induction therapy with ipilimumab and nivolumab followed by consolidating chemoradiotherapy in stage 2/3 muscle invasive bladder cancer led to encouraging bladder-intact event free survival outcomes that were associated with ctDNA clearance. @MichvdHeijden www.nature.com/articles/s41591-026-04271-3
-
Nature Medicine
@NatureMedicine
⭐Research highlight: Researchers show that in mice, tumor-secreted cystatin-C crosses the blood–brain barrier and stimulates microglia to degrade #amyloid plaques, which opens interesting avenues for translational clinical studies.@CellCellPress
www.nature.com/articles/d41591-026-00010-w -
Nature Medicine
@NatureMedicine
With a cover inspired by the MexVar database and Mexican biobank study, our February issue includes clinical studies on #genetherapy in #sma, PD-1 blockade in cancer and HIV, #tb therapies, #malaria control, and much more including reviews, news & opinion.
www.nature.com/nm/volumes/32/issues/2 -
Nature Medicine
@NatureMedicine
Making #antibiotic stewardship guidelines work in real-world settings: a large, pragmatic trial in China shows that it's feasible. Read the News & Views from Dan Wu & colleagues.
www.nature.com/articles/s41591-026-04226-8 -
Nature Medicine
@NatureMedicine
🌟A p-tau217 blood test can be used to develop clocks that can predict when cognitively unimpaired individuals may develop symptoms of #alzheimer’s disease. @kkpetersen @SuzanneESchind1 #biomarkers #alzheimers #cognition
www.nature.com/articles/s41591-026-04206-y -
Nature Medicine
@NatureMedicine
A single intravenous dose of the #psychedelic #dmt, combined with #psychological support, produces rapid and lasting reductions in #depressive symptoms in adults with major depressive disorder. #mdd #depression #psychedelics @david_erritzoe @tommaso_barba @ellenheather @CybinInc #dimethyltryptamine
www.nature.com/articles/s41591-025-04154-z -
Nature Medicine
@NatureMedicine
🌍 Boghuma Titanji: global health research must not exploit scarcity or deny proven interventions to vulnerable communities. Ethics must protect—not exploit.
🔗 www.nature.com/articles/d41591-026-00007-5
#globalhealth #medicalethics #healthequity #naturemedicine -
Nature Medicine
@NatureMedicine
New Review: The science of #psychedelic medicine.
Joshua Siegel & colleagues integrate mechanistic knowledge with clinical evidence across neuropsychiatric indications — highlighting challenges, controversies, and opportunities.
@realJoshSiegel @RCarhartHarris @nyugrossman
www.nature.com/articles/s41591-025-04194-5 -
Nature Medicine
@NatureMedicine
To be safe and effective, medical #ai must adapt automatically to new contexts — to differences in users, health systems, geographies and diseases.
Our latest Review proposes context-switching as the defining paradigm of medical AI, outlining early strategies and opportunities for development. @marinkazitnik @_michellemli @harvard_data
www.nature.com/articles/s41591-025-04184-7 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Social interactions in the nursery have a huge impact on babies’ and toddlers' #microbiome development, according to a new paper in @Nature
www.nature.com/articles/d41591-026-00006-6 -
Nature Medicine
@NatureMedicine
Researchers studied blood-based metabolome of over 23,000 individuals from 10 ethnically diverse cohorts. They identified 235 metabolites associated with future risk of T2D. By integrating genetic and modifiable lifestyle factors, their findings provide insights into T2D mechanisms and could improve risk prediction and inform precision prevention.
www.nature.com/articles/s41591-025-04105-8 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Using a new approach to control for genetic and environmental confounders, a review and meta-analysis finds no link between paracetamol use during pregnancy and neurodevelopmental outcomes in children.
www.nature.com/articles/d41591-026-00005-7 -
Nature Medicine
@NatureMedicine
⭐Research highlight: In patients with T cell acute lymphoblastic leukemia, base-edited CAR T cells — capable of destroying leukemic T cells while they themselves are protected — induced remission and allowed progression to stem-cell transplantation. @NEJM
-
Nature Medicine
@NatureMedicine
In this phase III trial, HIV-negative Vietnamese adults with tuberculosis meningitis were stratified by LTA4H genotype to assess whether this underlies corticosteroid response, however they found that outcomes were not significantly better according to genotype.
-
Nature Medicine
@NatureMedicine
The Nature Medicine Commission on #dialysis policy in low- and middle-income countries aims to resolve the current dialysis policy challenges in Thailand and generate lessons for the global kidney community.
Read the report (free) and check out the Collection page for related research, commentary and opinion. www.nature.com/articles/s41591-025-04084-w -
Nature Medicine
@NatureMedicine
An in-depth analysis of tissue biopsies from patients with multiple myeloma and CART-associated immune-related adverse events (CirAE) after treatment with commercial BCMA-CART shows that CD4+ CARTs mediate off tumor toxicities and that high CD4/CD8 ratio at apheresis, robust early CART expansion, ICANS, and cilta-cel treatment are independently associated with the development of CirAEs.
www.nature.com/articles/s41591-025-04121-8 -
Nature Medicine
@NatureMedicine
In a long-term follow-up of the FAME 2 trial, fractional flow reserve-guided percutaneous coronary intervention plus medical therapy in patients with stable coronary artery disease reduced cardiovascular events compared to medical therapy alone, primarily due to a decrease in urgent revascularization events.
www.nature.com/articles/s41591-025-04132-5 -
Nature Medicine
@NatureMedicine
In a prespecified secondary analysis of the SURMOUNT-OSA trial it was found that #tirzepatide improves #cardiometabolic outcomes in patients with moderate-to-severe OSA and #obesity.
www.nature.com/articles/s41591-025-04071-1 -
Nature Medicine
@NatureMedicine
Genomic and transcriptomic analysis of samples from patients with multiple myeloma, followed by in vitro validation, indicate mechanisms of antigen escape in response to GPRC5D T cell engager talquetamab, including biallelic deletions, small nucleotide variants and insertion-deletions and chromatin silencing.
www.nature.com/articles/s41591-025-04175-8 -
Nature Medicine
@NatureMedicine
⚡Our January issue is live! Including the first Nature Medicine Commission Report (featured on the cover, and introduced in our Editorial), new research on #infertility, #huntingtonsdisease, #cancer #cachexia, #hiv, #malaria, #genetherapy, #microbiome therapy, and much more including News, Reviews and Opinion. Read it here: www.nature.com/nm/volumes/32/issues/1
-
Nature Medicine
@NatureMedicine
A new trial provides direct human evidence that the #placeboeffect can shape humoral #immunity, showing that reward-related brain activity correlates with #vaccine induced antibody production and opening new avenues for treating many medical conditions. News & Views from @jonykipnis & colleagues @BIG_CenterWashU
www.nature.com/articles/s41591-025-04168-7 -
Nature Medicine
@NatureMedicine
Plasma proteome analysis uncovers systemic effects of feminizing gender-affirming #hormonetherapy; more research like this will inform better healthcare for #transgender people. News & Views from @BrodinPetter
www.nature.com/articles/s41591-025-04146-z -
Nature Medicine
@NatureMedicine
Following the negative phase 3 BRAIN-AF trial with the anticoagulant rivaroxaban, @MProiettiMD and @GiulioFRomiti argue that we need a better understanding of the mechanisms linking #atrialfibrillation and #dementia. Read their News & Views article:
www.nature.com/articles/s41591-025-04127-2 -
Nature Medicine
@NatureMedicine
A randomized controlled trial illustrates the challenges of passive cooling in hot humid Africa, where temperatures are rising and millions of new housing units will be needed by the middle of the century. Read the News & Views from Lorenz von Seidlein & colleagues
www.nature.com/articles/s41591-025-04155-y -
Nature Medicine
@NatureMedicine
In a multicenter, randomized trial of patients with #atrialfibrillation and a low risk of #thromboembolic events, treatment with the anti-coagulant #rivaroxaban as compared to placebo showed no benefit in reducing cognitive decline, #stroke or transient ischemic attack. #cognitivehealth
www.nature.com/articles/s41591-025-04101-y -
Nature Medicine
@NatureMedicine
Researchers studied blood-based metabolome of over 23,000 individuals from 10 ethnically diverse cohorts. They identified 235 metabolites associated with future risk of T2D. By integrating genetic and modifiable lifestyle factors, their findings provide insights into T2D mechanisms and could improve risk prediction and inform precision prevention.
www.nature.com/articles/s41591-025-04105-8 -
Nature Medicine
@NatureMedicine
In this phase III trial, HIV-negative Vietnamese adults with tuberculosis meningitis were stratified by LTA4H genotype to assess whether this underlies corticosteroid response, however they found that outcomes were not significantly better according to genotype.
-
Nature Medicine
@NatureMedicine
A Bayesian analysis of diagnostic data reported to the WHO reveals that approximately 2 million people were incorrectly diagnosed with tuberculosis (received a false-positive result) and 1 million received a false-negative result, emphasizing the critical need for higher-sensitivity bacteriological tests in the future.
www.nature.com/articles/s41591-025-04097-5 -
Nature Medicine
@NatureMedicine
In a randomized phase 2 trial in patients with acute #coronary syndrome and high levels of the inflammation #biomarker CRP, treatment with low-dose interleukin-2 increased the numbers of regulatory T cells and reduced arterial #inflammation, as compared to placebo.
-
Nature Medicine
@NatureMedicine
This multi-center study demonstrates that dried and capillary blood as a minimally invasive, scalable approach for #alzheimers #biomarker testing in research, with potential for widely scalable population-based research, especially in resource-limited settings. @NicholasAshton @wagnersbrum
www.nature.com/articles/s41591-025-04080-0 -
Nature Medicine
@NatureMedicine
High-dimensional immune profiling of a living recipient of a pig-to-human xenotransplant provides insight into the immune landscape of xenotransplantation and directions for improved immunosuppression strategies.
www.nature.com/articles/s41591-025-04053-3 -
Nature Medicine
@NatureMedicine
🧬 A Nature Medicine Comment outlines a new research vision for NIAID (National Institute of Allergy and Infectious Diseases), authored by Jeffery K. Taubenberger, John H. Powers & NIH Director Jay Bhattacharya. They discuss the agency's shifting priorities in infectious disease & immunology research.
🔗 www.nature.com/articles/s41591-025-04160-1 -
Nature Medicine
@NatureMedicine
Multiomic single-cell analyses of 15 #downsyndrome fetal cortical samples identify widespread disruption of neurodevelopmental transcriptional programs, driven by three dosage-sensitive chromosome 21 transcription factors. #neurodevelopment #multiomics
www.nature.com/articles/s41591-026-04211-1 -
Nature Medicine
@NatureMedicine
An in-depth analysis of tissue biopsies from patients with multiple myeloma and CART-associated immune-related adverse events (CirAE) after treatment with commercial BCMA-CART shows that CD4+ CARTs mediate off tumor toxicities and that high CD4/CD8 ratio at apheresis, robust early CART expansion, ICANS, and cilta-cel treatment are independently associated with the development of CirAEs.
www.nature.com/articles/s41591-025-04121-8 -
Nature Medicine
@NatureMedicine
In the phase 1/2 CASTLE basket trial, autologous CD19 CART therapy in patients with treatment-refractory SLE, SSc or IIM was safe with improved disease activity and patient-reported global health in most patients. #carttherapy #sleresearch
www.nature.com/articles/s41591-025-04185-6 -
Nature Medicine
@NatureMedicine
In a prespecified secondary analysis of the SURMOUNT-OSA trial it was found that #tirzepatide improves #cardiometabolic outcomes in patients with moderate-to-severe OSA and #obesity.
www.nature.com/articles/s41591-025-04071-1 -
Nature Medicine
@NatureMedicine
In a long-term follow-up of the FAME 2 trial, fractional flow reserve-guided percutaneous coronary intervention plus medical therapy in patients with stable coronary artery disease reduced cardiovascular events compared to medical therapy alone, primarily due to a decrease in urgent revascularization events.
www.nature.com/articles/s41591-025-04132-5 -
Nature Medicine
@NatureMedicine
Please join our editor Lia Parkin at @KeystoneSymp Human Microbiome: From Models and Mechanism to Medicine January 19-22 in Banff! Hope to see you there! keysym.us/KSMicrobiome26 #ksmicrobiome26
-
Nature Medicine
@NatureMedicine
A clinical cohort-based biomarker study in patients with metastatic renal cell carcinoma demonstrates that blood levels of soluble mucosal addressin cell adhesion molecule 1 (sMAdCAM-1) are prognostic for survival in patients treated with tyrosine kinase inhibitors and immune checkpoint inhibitors and may serve as a surrogate marker for gut dysbiosis, based on integrated data from three clinical trials.
www.nature.com/articles/s41591-025-04067-x -
Nature Medicine
@NatureMedicine
Genomic and transcriptomic analysis of samples from patients with multiple myeloma, followed by in vitro validation, indicate mechanisms of antigen escape in response to GPRC5D T cell engager talquetamab, including biallelic deletions, small nucleotide variants and insertion-deletions and chromatin silencing.
www.nature.com/articles/s41591-025-04175-8 -
Nature Medicine
@NatureMedicine
A study shows that interpersonal conflict and excessive #socialmedia use are associated with increased levels of #depression during political protests — but we should not lose sight of the wider contexts in which such protests take place.
News & Views from Jon Roozenbeek and Ili Ma -
Nature Medicine
@NatureMedicine
🚨 Worried about infections? In a sobering World View essay @AngelaLRasmussen explains how removing six vaccines to match Denmark’s schedule risks a measles comeback amid immune amnesia & fragile public health systems. Urgent plea: return to evidence‑led US vaccine policy🧬#vaccineswork
👉FREE to read www.nature.com/articles/d41591-026-00002-w -
Nature Medicine
@NatureMedicine
Including data from 1,047 patients across 19 inflammatory diseases, a new atlas presents a comprehensive model of inflammation in circulating immune cells.
www.nature.com/articles/s41591-025-04126-3 -
Nature Medicine
@NatureMedicine
🚨 Worried about measles? In a sobering World View essay @AngelaLRasmussen explains how removing six vaccines to match Denmark’s schedule risks a measles comeback amid immune amnesia & fragile public health systems. Urgent plea: return to evidence‑led US vaccine policy🧬#vaccineswork Read full article >> www.nature.com/articles/d41591-026-00002-w
-
Nature Medicine
@NatureMedicine
In a multicenter, randomized trial of patients with #atrialfibrillation and a low risk of #thromboembolic events, treatment with the anti-coagulant #rivaroxaban as compared to placebo showed no benefit in reducing cognitive decline, #stroke or transient ischemic attack. #cognitivehealth
www.nature.com/articles/s41591-025-04101-y -
Nature Medicine
@NatureMedicine
Generative AI models based on electronic health records aren’t “zero‑shot predictors”—they simulate patient timelines, not actual risk. Misinterpreting them as oracles could mislead clinical decisions. @suhanabedi, @JasonFriesMD & @NigamShah propose safer evaluation criteria in Nature Medicine: www.nature.com/articles/s41591-025-04094-8
-
Nature Medicine
@NatureMedicine
A Bayesian analysis of diagnostic data reported to the WHO reveals that approximately 2 million people were incorrectly diagnosed with tuberculosis (received a false-positive result) and 1 million received a false-negative result, emphasizing the critical need for higher-sensitivity bacteriological tests in the future.
www.nature.com/articles/s41591-025-04097-5 -
Nature Medicine
@NatureMedicine
In the phase 1/2 CASTLE basket trial, autologous CD19 CART therapy in patients with treatment-refractory SLE, SSc or IIM was safe with improved disease activity and patient-reported global health in most patients. #carttherapy #sleresearch
www.nature.com/articles/s41591-025-04185-6 -
Nature Medicine
@NatureMedicine
A clinical cohort-based biomarker study in patients with metastatic renal cell carcinoma demonstrates that blood levels of soluble mucosal addressin cell adhesion molecule 1 (sMAdCAM-1) are prognostic for survival in patients treated with tyrosine kinase inhibitors and immune checkpoint inhibitors and may serve as a surrogate marker for gut dysbiosis, based on integrated data from three clinical trials.
www.nature.com/articles/s41591-025-04067-x -
Nature Medicine
@NatureMedicine
High-dimensional immune profiling of a living recipient of a pig-to-human #xenotransplant provides insight into the immune landscape of #xenotransplantation and directions for improved #immunosuppression strategies.
www.nature.com/articles/s41591-025-04053-3 -
Nature Medicine
@NatureMedicine
In a randomized phase 2 trial in patients with acute #coronary syndrome and high levels of the inflammation #biomarker CRP, treatment with low-dose interleukin-2 increased the numbers of regulatory T cells and reduced arterial #inflammation, as compared to placebo.
-
Nature Medicine
@NatureMedicine
This multi-center study demonstrates that dried and capillary blood as a minimally invasive, scalable approach for #alzheimers #biomarker testing in research, with potential for widely scalable population-based research, especially in resource-limited settings. @NicholasAshton @wagnersbrum
www.nature.com/articles/s41591-025-04080-0 -
Nature Medicine
@NatureMedicine
When is yogurt not yogurt? Nature Medicine authors Alyssa J. Moran (@_alyssamoran), Neha Khandpur & Christina A. Roberto (@RobertoCA) propose reversing the definition of ultra‑processed foods—focus on what UPFs are not—to close regulation loopholes.
👉 Read their call to action: www.nature.com/articles/s41591-025-04108-5
Also covered in #statnews: www.statnews.com/2026/01/07/ultra-processed-foods-researc…
📚 #nutrition #foodpolicy -
Nature Medicine
@NatureMedicine
When science meets violence — @NatureMedicine features Dr. Luana Araujo’s courageous World View essay. She faced threats & misogyny for speaking truth during Brazil’s COVID‑19 crisis. Five years on and not enough has changed for women in science & public health. Full article here 👉
-
Nature Medicine
@NatureMedicine
🚨Lyme disease is surging. Researchers are testing next‑gen approaches: tetracycline for post‑treatment cases, peptidoglycan-targeted therapy, Pfizer’s Valor vaccine trial, and TP‑05, an oral pill that kills ticks before infection spreads. 🧪🐜 Story by Mike May. Read more here: www.nature.com/articles/d41591‑026‑00001‑x
#lymedisease #vaccines -
Nature Medicine
@NatureMedicine
A new landscape review of #glp1 medicines by @DanielJDrucker discusses new indications, key questions around benefits and long-term safety, and areas of uncertainty requiring further research. @sinaihealth
www.nature.com/articles/s41591-025-04124-5 -
Nature Medicine
@NatureMedicine
🤖 New Comment in Nature Medicine: “Building a code of conduct for AI-driven clinical consultations” by Ernest Lim (@UfoniaHealth), Arun Thirunavukarasu (@LSHTM), Ibrahim Habli (@AssuringAutonomy) & colleagues.
The authors propose a “highway code” for clinical AI—defining essential ‘cure’ and ‘care’ behaviors to ensure safety, empathy & trust.
📖 Read: doi.org/10.1038/s41591-025-04068-w
#aiinhealthcare #patientsafety #naturemedicine -
Nature Medicine
@NatureMedicine
A large population-based study reveals both the promise and the limits of genomic profiling in #cancer care, and highlights the need for multidimensional data to guide therapy. Read the News & Views from @MarkARubin1 and Irene Paassen @unibern
www.nature.com/articles/s41591-025-04153-0 -
Nature Medicine reposted
Eric Topol
@EricTopol
The first sleep AI foundation model for predicting diseases was published today @NatureMedicine by @james_y_zou and colleagues
www.nature.com/articles/s41591-025-04133-4
With @NotebookLM I made this infographic that tells the rich story pretty well -
Nature Medicine
@NatureMedicine
📢 New Comment in Nature Medicine: “The ethics of multi-cancer screening” by Thomas Callender (@CamPublicHealth), Anne Mackie & Anne-Marie Slowther.
Multi-cancer detection tests (MCDs) promise early detection across many cancers—but raise tough ethical questions:
✅ Balancing harms vs benefits
✅ Informed consent & autonomy
✅ Equity & resource use
Read more: www.nature.com/articles/s41591-025-04111-w
#cancerscreening #bioethics #publichealth -
Nature Medicine
@NatureMedicine
Mechanistic insights from recent studies are reframing cancer #cachexia as a pharmacologically treatable condition. Read the News & Views from @arihakimi and colleagues @MSKCancerCenter.
www.nature.com/articles/s41591-025-04109-4 -
Nature Medicine
@NatureMedicine
🌍 New in Nature Medicine: “Silenced Genomes” by Sofia Moutinho (@sofia_moutinho)
Why it matters:
• 86% of genomic studies still focus on European ancestry
• This leads to misdiagnosis & inequitable care
• Projects in Brazil, Africa & Canada aim to close the gap
📖 Read: www.nature.com/articles/s41591-025-04161-0
#genomics #healthequity #precisionmedicine -
Nature Medicine reposted
Eric Topol
@EricTopol
Even though the 1st GLP-1 drug was approved 20 years ago, there are dozens of new molecules and combinations in the pipeline , including muscle building drugs (Table). A new @NatureMedicine review by @DanielJDrucker, a pioneer of this field.
www.nature.com/articles/s41591-025-04124-5 -
Nature Medicine
@NatureMedicine
🩺 Insightful Comment in Nature Medicine: “Lessons in public trust” by @ProfHeidiLarson (@LSHTM, @IHME_UW) and Alexander H. Toledo, MD. It explores how learning from vaccine trust strategies can help rebuild confidence in the US organ donation system following recent breaches—highlighting transparency, shared decision-making, and accountability. **Crucial read as more than 100K Americans await life-saving transplants.**
🔗 www.nature.com/articles/s41591-025-04056-0
#publictrust #organdonation #vaccinelessons -
Nature Medicine
@NatureMedicine
🚨 End-of-year treat!
“Eleven clinical trials that will shape medicine in 2026” is now FREE to access 🧬
Discover next-gen vaccines, gene-editing tools, and long COVID therapies poised to redefine treatment.
👉 www.nature.com/articles/s41591-025-04083-x
#naturemedicine #clinicaltrial -
Nature Medicine
@NatureMedicine
In a year that has dealt many blows to biomedical research, many breakthroughs nevertheless continued to inspire us. From regenerative medicine to reproductive technologies and everything in between — here is our selection of critical developments that moved medicine forward in 2025.
www.nature.com/articles/s41591-025-04098-4 -
Nature Medicine
@NatureMedicine
⚡Our December issue is live! Check out our Year in Review for 2025 highlights and a what to look out for in 2026; also featuring news, opinioin and new research on #agingclocks, #ai diagnostics, #liquidbiopsies, #alzheimersdisease, #pcos, #sepsis, #backpain, #prostatecancer and much more.
Read it here: www.nature.com/nm/volumes/31/issues/12 -
Nature Medicine
@NatureMedicine
Our latest Review discusses current and emerging #liquidbiopsy approaches and their clinical validity and utility — and highlights opportunities to support their implementation throughout the entire #cancer care continuum. From Valsamo Anagnostou, Victor Velculescu & colleagues @HopkinsMedicine
www.nature.com/articles/s41591-025-04093-9 -
Nature Medicine
@NatureMedicine
A lifespan clock tells the biology of time.
Derived from millions of routine clinical records, a full‑lifecycle clock reveals insights into human development and aging, enabling early disease detection and mechanistic insights. News & Views from Nathan Price and colleagues @BuckInstitute
www.nature.com/articles/s41591-025-04095-7 -
Nature Medicine
@NatureMedicine
As presented at the American Heart Association Conference 2025, patients with chest pain and without obstructive coronary artery disease benefit from treatment informed by cardiovascular magnetic resonance. www.nature.com/articles/s41591-025-04044-4
-
Nature Medicine
@NatureMedicine
A phase 1/2 and a phase 3 trials testing an AAV-FIX Padua gene therapy in patients with hemophilia B in China show that the treatment was well tolerated and effective in reducing annualized bleeding rate. www.nature.com/articles/s41591-025-04012-y
-
Nature Medicine
@NatureMedicine
A new study provides the first evidence in humans that tirzepatide modulates brain electrophysiology, with changes in low-frequency accumbens power linked to food preoccupation.
www.nature.com/articles/s41591-025-04035-5 -
Nature Medicine
@NatureMedicine
How can we measure the value of #genomics in #healthcare? How can #hta, #implementation & data management be adapted to suit the rapidly evolving nature of genomics technologies? A new Review from Zornitza Stark, @IliasGoranitis & colleagues addresses these questions.
www.nature.com/articles/s41591-025-04061-3 -
Nature Medicine
@NatureMedicine
In this phase 1 trial, treatment of patients with fibrolamellar hepatocellular carcinoma with a therapeutic peptide vaccine targeting the fusion kinase DNAJB1::PRKACA, which is the driver of the disease, together with nivolumab and ipilimumab, was safe and led to encouraging preliminary clinical responses and translational analysis showed activation of immune responses. www.nature.com/articles/s41591-025-03995-y
-
Nature Medicine
@NatureMedicine
A combination of high resolution spatial imaging, spatial proteomics and transcriptional data reveals sparse and heterogeneous bacterial signals in gliomas and brain metastases. @GolnazMorad @JenWargoMD www.nature.com/articles/s41591-025-03957-4
-
Nature Medicine
@NatureMedicine
Cities are often at the forefront of creative thinking on policy opportunities;our latest Perspective from Ana Diez-Roux and Usama Bilal outlines an agenda for policy-focused #urbanhealth research, in which #populationhealth and environmental sustainability support and reinforce each other.
www.nature.com/articles/s41591-025-04031-9 -
Nature Medicine
@NatureMedicine
In this phase 1 trial, treatment of patients with fibrolamellar hepatocellular carcinoma with a therapeutic peptide vaccine targeting the fusion kinase DNAJB1::PRKACA, which is the driver of the disease, together with nivolumab and ipilimumab, was safe and led to encouraging preliminary clinical responses and translational analysis showed activation of immune responses. www.nature.com/articles/s41591-025-03995-y
-
Nature Medicine
@NatureMedicine
As presented at the American Heart Association Conference 2025, patients with chest pain and without obstructive coronary artery disease benefit from treatment informed by cardiovascular magnetic resonance. www.nature.com/articles/s41591-025-04044-4
-
Nature Medicine
@NatureMedicine
A phase 1/2 and a phase 3 trials testing an AAV-FIX Padua gene therapy in patients with hemophilia B in China show that the treatment was well tolerated and effective in reducing annualized bleeding rate. www.nature.com/articles/s41591-025-04012-y
-
Nature Medicine
@NatureMedicine
A new study provides the first evidence in humans that tirzepatide modulates brain electrophysiology, with changes in low-frequency accumbens power linked to food preoccupation.
www.nature.com/articles/s41591-025-04035-5 -
Nature Medicine
@NatureMedicine
The first clinical trial of a gene therapy infusion for hemophilia B brought unexpected insights—marking a turning point for genetic medicine.
Read the Nature Medicine essay: www.nature.com/articles/s41591-025-04069-9
#genetherapy #hemophiliab #turningpoint #naturemedicine -
Nature Medicine reposted
World Health Summit
@WorldHealthSmt
"Without academic freedom and genuine international cooperation, we cannot overcome global health challenges.”
In the #whsacademicalliance Correspondence published in @NatureMedicine, members of the WHS Academic Alliance highlight the importance of free science and global partnerships to achieve worldwide health goals.
The key messages by the WHS Academic Alliance:
1⃣Define, respect, and safeguard academic freedom
2⃣Strengthen international collaboration and multilateral institutions
3️⃣Combat misinformation and rebuild trust in science
Read the full statement here: rdcu.be/eN2Zj -
Nature Medicine
@NatureMedicine
🌍 Climate change is a health crisis — especially for women, children & adolescents.
New @NatureMedicine article by Rajat Khosla, Helen Clark, Soumya Swaminathan, Anders Nordström & Flavia Bustreo calls for evidence-based solutions to build resilience.
Read FREE: www.nature.com/articles/d41591-025-00066-0
#climatehealth #wcah #openaccess -
Nature Medicine
@NatureMedicine
A combination of high resolution spatial imaging, spatial proteomics and transcriptional data reveals sparse and heterogeneous bacterial signals in gliomas and brain metastases. @GolnazMorad @JenWargoMD www.nature.com/articles/s41591-025-03957-4
-
Nature Medicine
@NatureMedicine
⚡Our November issue is out! Featuring trials of #cartcells for #lupus, an antibody-drug conjugate for #lungcancer, cardiac #genetherapy, an #ebola #vaccine trial, discovery of microbial elements in #braintumors, #liquidbiopsies, #newbornscreening, and much more - including reviews, news and opinion.
Read it here: www.nature.com/nm/volumes/31/issues/11 -
Nature Medicine
@NatureMedicine
Pretrained using 335,645 whole-slide images, a foundation model is developed to provide representations for slide- and patient-level tasks. It is capable of performing clinical tasks and generating reports even in data-scarce scenarios, such as rare cancer diagnosis and survival prediction, without further fine-tuning. www.nature.com/articles/s41591-025-03982-3
-
Nature Medicine
@NatureMedicine
A study meticulously uncovers bacterial elements within malignant brain tumors; the approach opens avenues for understanding #braincancer biology and provides a blueprint for studying #microbial signals in other low-biomass tissues. News & Views from Allyson L. Byrd & Jayanth Jawahar @BRIseattle
www.nature.com/articles/s41591-025-03980-5 -
Nature Medicine
@NatureMedicine
A new study reveals that as patients approach the end stages of #cancer, tumors may exploit the body’s largest highways — infiltrating major blood vessels and unleashing clusters of tumor cells into the circulation. Read the News & Views from Anirban Maitra & colleagues @nyugrossman.
@Aiims1742
www.nature.com/articles/s41591-025-04052-4 -
Nature Medicine
@NatureMedicine
In cognitively normal older adults at risk for Alzheimer’s dementia, physical inactivity was associated with faster tau protein buildup and cognitive decline www.nature.com/articles/s41591-025-03955-6 @WendyYau01 @HarvardAging @MGHNeurology
-
Nature Medicine
@NatureMedicine
⭐Research highlight: #adjuvant #atezolizumab improved survival outcomes in patients with muscle-invasive #bladdercancer who had no radiographic disease but had detectable circulating tumor DNA in their blood. #imvigor011 #liquidbiopsy #esmo @NEJM
www.nature.com/articles/d41591-025-00065-1 -
Nature Medicine
@NatureMedicine
In a follow up study presenting 96 week results, cabotegravir and rilpivirine long-acting therapy is still non-inferior to oral therapy for HIV, had acceptable safety and tolerability profiles and resulted in durable virologic suppression. www.nature.com/articles/s41591-025-04041-7
-
Nature Medicine
@NatureMedicine
In a meta-analysis of 48 randomized trials of chronic kidney disease progression, reduction in the 6-month urinary albumin:creatinine ratio was associated with lower hazard ratios of established kidney disease endpoints, supporting the use of albuminuria change as a surrogate endpoint in clinical trials for chronic kidney disease. www.nature.com/articles/s41591-025-04057-z
-
Nature Medicine
@NatureMedicine
New Perspective: Research doesn’t always ‘speak for itself’; uptake of science into #publichealth policy requires active engagement between researchers & policymakers. @jjaimemiranda & colleagues offer tangible recommendations to help bridge this gap.
www.nature.com/articles/s41591-025-04015-9 -
Nature Medicine
@NatureMedicine
In a meta-analysis of 48 randomized trials of chronic kidney disease progression, reduction in the 6-month urinary albumin:creatinine ratio was associated with lower hazard ratios of established kidney disease endpoints, supporting the use of albuminuria change as a surrogate endpoint in clinical trials for chronic kidney disease. www.nature.com/articles/s41591-025-04057-z
-
Nature Medicine
@NatureMedicine
A new study expands the utility of the gold-standard ferret model to assess risks associated with consuming raw milk and cheese contaminated with #influenzaa virus — marking an important step toward improving risk assessments in #publichealth. News & Views from Taronna Maines, Jessica Belser @CDCgov
www.nature.com/articles/s41591-025-04020-y -
Nature Medicine
@NatureMedicine
In a follow up study presenting 96 week results, cabotegravir and rilpivirine long-acting therapy is still non-inferior to oral therapy for HIV, had acceptable safety and tolerability profiles, resulted in durable virologic suppression and provides further evidence that this should be considered for African treatment programs. www.nature.com/articles/s41591-025-04041-7
-
Nature Medicine
@NatureMedicine
In cognitively normal older adults at risk for Alzheimer’s dementia, physical inactivity was associated with faster tau protein buildup and cognitive decline www.nature.com/articles/s41591-025-03955-6 @WendyYau01 @HarvardAging @MGHNeurology
-
Nature Medicine
@NatureMedicine
The first-in-human trial of AAV2i8-I1c (AB-1002) suggests a cautious return of #cardiac #genetherapy after earlier setbacks, with a new target, dose optimization and improved vector design shaping future directions. News & Views from Oliver Müller & colleagues @dzhk_germany
www.nature.com/articles/s41591-025-04002-0 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Creativity enhances #brainhealth by improving connectivity in age-vulnerable regions, highlighting the importance of supporting creative activities in public health strategies. @NatureComms
www.nature.com/articles/d41591-025-00063-3 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Baby wraps treated with the insecticide permethrin reduced the incidence of #malaria in infants by 66%, according to a randomized controlled trial in Uganda. @NEJM
www.nature.com/articles/d41591-025-00061-5 -
Nature Medicine reposted
Prof Ada Cheung (she/her)
@DrAdaCheungAU
A world-first! 🏳️⚧️🧬Our new study, the first #transhealth original research in @NatureMedicine shows how gender-affirming hormones reshape the body’s proteins to align with gender identity.
www.nature.com/articles/s41591-025-04023-9 #genderaffirmingcare #transgender #transresearch @UniMelbMDHS -
Nature Medicine
@NatureMedicine
Now at #esmo25: In the phase 2/3 AGITG DYNAMIC-III trial, post-surgery ctDNA was prognostic but de-escalated chemotherapy in patients with ctDNA-negative stage III colon cancer did not meet non-inferiority for 3 year recurrence-free survival www.nature.com/articles/s41591-025-04030-w
-
Nature Medicine
@NatureMedicine
⚡Our October issue is live! Featuring new research in #glioblastoma, #breastcancer, #myocardialinfarction, #obesity, #upfs, #glp1 drugs, #bispecifics, #ai- and #proteomics-based diagnostics, and much more including Review, News & Opinion.
Read it here: www.nature.com/nm/volumes/31/issues/10 -
Nature Medicine
@NatureMedicine
Now at #esmo25: In patients with locally advanced or metastatic solid tumors, treatment with a first in class inhibitor of the Hippo-YAP-TEAD pathway was safe and led to encouraging clinical response rates in patients with mesothelioma www.nature.com/articles/s41591-025-04029-3
-
Nature Medicine
@NatureMedicine
Now at #esmo25: In a phase 2 trial, first-line treatment of patients with advanced gastric cancer, GEJ cancer or esophageal adenocarcinoma with anti-TIGIT + anti-PD-1 + FOLFOX led to encouraging objective response rates and survival outcomes www.nature.com/articles/s41591-025-04022-w
-
Nature Medicine
@NatureMedicine
Now at #esmo25: In the phase 2 IKF/AIO PHERFLOT trial, perioperative FLOT + anti-PD-1 + anti-HER2 led to a pathological complete response rate of 48.4% in patients with resectable HER2+ esophagogastric adenocarcinoma @JosephTintelnot www.nature.com/articles/s41591-025-03979-y
-
Nature Medicine
@NatureMedicine
Now at #esmo25: in the phase 3 RELATIVITY-098 trial, nivolumab + relatlimab did not significantly change recurrence free survival for patients with stage III/IV resected melanoma, and the absence of tumor infiltrating LAG3+ T cells may play a role. www.nature.com/articles/s41591-025-04032-8
-
Nature Medicine
@NatureMedicine
A new study provides physiological insights into the dying process, which could have substantial implications for resuscitation science, death determination and organ donation.
Read the News & Views from Michael Rubin and Matthew Kirschen
@PennMedicine @UTSWMedCenter
www.nature.com/articles/s41591-025-03941-y -
Nature Medicine reposted
Lawrence Gostin
@LawrenceGostin
Delighted to be at #whs2025 in Berlin. Tomorrow, the @NatureMedicine Commission on Quality Health Information for All will official launch at @WorldHealthSmt
Our aim is to provide a framework for innovative solutions to advance quality health information equitably and for all -
Nature Medicine reposted
Penn Medicine CSO
@PennMedCSO
In @NatureMedicine, Caleb Rhodes (@PennMedicine), @HollyLynchez (@PennMEHP/ @PennCarey_Law) & @reshmagar (@YaleMed) outline strategies to help strengthen the integrity of @US_FDA drug approval decisions www.nature.com/articles/s41591-025-03948-5
-
Nature Medicine reposted
EASO
@EASOobesity
Semaglutide or tirzepatide should be first-line medication treatment for people living with obesity and complications, according to the new EASO framework for the pharmacological treatment of obesity and its complications published in @NatureMedicine
easo.org/semaglutide-and-tirzepatide-recommended-as-first… -
Nature Medicine
@NatureMedicine
Lots of great AI content in Nature Medicine this month!
🧠 @THBoussard on the fragile intelligence of ChatGPT — why we must tread carefully with generative AI in healthcare.
🩺 Our editorial urges more support for the human in the loop to build trustworthy AI.
🔗 www.nature.com/articles/s41591-025-04008-8
🔗 www.nature.com/articles/s41591-025-04033-7
#ai #medtech #humanintheloop #naturemedicine @NatureMedicine -
Nature Medicine
@NatureMedicine
Three studies that leverage blood-based gene expression data identify molecular and cellular host response signatures in #sepsis and critical illnesses, opening a pathway to mechanism-anchored #precisiontherapy. News & Views from Robert Stevens and Carl Harris @HopkinsMedicine
www.nature.com/articles/s41591-025-04005-x -
Nature Medicine
@NatureMedicine
Two phase 1 studies report promising outcomes with #cartcell therapies in systemic #lupus erythematosus, but the next stage of development must address pitfalls around comparator arms and ancillary immune-modulating treatments. News & Views from Joan Merill and Judith James @UofOklahoma
www.nature.com/articles/s41591-025-03987-y -
Nature Medicine
@NatureMedicine
A post-hoc analysis of a multi-centre, randomized trial, showed that #prediabetes remission is possible without total weight loss – providing weight is distributed to subcutaneous deposits as opposed to visceral ones. #diabetesawareness
www.nature.com/articles/s41591-025-03944-9 -
Nature Medicine
@NatureMedicine
In the proof-of-concept phase 2 ROME trial, comprehensive genomic profiling followed by Molecular #tumor Board evaluation and randomization of patients with metastatic solid #cancer to receive personalized therapy or standard of care led to a significantly higher objective response rate and longer progression-free survival in patients who received #personalizedtherapy.
www.nature.com/articles/s41591-025-03918-x -
Nature Medicine
@NatureMedicine
A phase 3 trial found that VER-01, a full-spectrum #cannabis extract, reduces chronic low #backpain, improves function and sleep, and shows no signs of dependence or withdrawal. #chronicpain, #lowbackpain #chronicpainrelief #painrelief
www.nature.com/articles/s41591-025-03977-0 -
Nature Medicine
@NatureMedicine
A clinical trial of pregnant women provides critical safety and immunogenicity data in support of a two-dose #ebola #vaccine — and reinforces the importance of maternal immunization research, urgently needed for other preventable diseases.
News & Views from Beate Kampmann, Alice Hucko @ChariteBerlin
www.nature.com/articles/s41591-025-04000-2 -
Nature Medicine
@NatureMedicine
#generativeai in #medicine: Our latest Review summarizes recent technical advancements, outlines how new models might improve #healthcare, and discusses validation approaches — using lessons from recent successes and failures in the field. @dukenus @DanielTing20 @drnigam @curtlanglotz
www.nature.com/articles/s41591-025-03983-2 -
Nature Medicine
@NatureMedicine
In a randomized trial of patients with a previous #myocardialinfarction and with residual #inflammation, a monoclonal antibody targeting the protein LOX-1, thought to contribute to #atherosclerotic plaque progression and #inflammation, reduced soluble LOX-1 and IL-6 levels but did not lead to a significant reduction in #coronary plaque volume.
www.nature.com/articles/s41591-025-03951-w -
Nature Medicine
@NatureMedicine
New in @NatureMedicine: “The damage done” explores the global impact of sudden NIH funding cuts on clinical trials & patient care.
Thank you to Marianne Guenot & all contributors for this vital reporting.
🔗 www.nature.com/articles/s41591-025-03994-z
#clinicalresearch #globalhealth -
Nature Medicine reposted
EASO
@EASOobesity
📢The EASO Algorithm for the pharmacological treatment of obesity and its complications has been published in @NatureMedicine
Developed using rigorous analysis, it provides clinically relevant guidance for personalised medication management. www.nature.com/articles/s41591-025-03765-w
@busetto_luca -
Nature Medicine
@NatureMedicine
⭐Research highlight: Patients with #obesity achieved significant weight loss and cardiometabolic benefits with oral orforglipron — offering a potential alternative to injectable #glp-1 receptor agonists. @NEJM
www.nature.com/articles/d41591-025-00060-6 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Health impacts of wildfires travel far and wide.
Smoke from 2023 Canadian wildfires led to increased PM2.5 exposure across North America and Europe, leading to thousands of acute and chronic deaths. @Nature
www.nature.com/articles/d41591-025-00059-z -
Nature Medicine
@NatureMedicine
Despite mixed efficacy outcomes, a phase 1/2 umbrella trial (NOA-20) sets a new bar for clinical trials in #glioblastoma, moving the field closer to diagnostic precision and targeted therapy.
Read the News & Views from Joshua Bernstock @jbernstock1 @HarvardMed
www.nature.com/articles/s41591-025-03952-9 -
Nature Medicine
@NatureMedicine
A post-hoc analysis of a multi-centre, randomized trial, showed that #prediabetes remission is possible without total weight loss – providing weight is distributed to subcutaneous deposits as opposed to visceral ones. #diabetesawareness
www.nature.com/articles/s41591-025-03944-9 -
Nature Medicine
@NatureMedicine
In the proof-of-concept phase 2 ROME trial, comprehensive genomic profiling followed by Molecular #tumor Board evaluation and randomization of patients with metastatic solid #cancer to receive personalized therapy or standard of care led to a significantly higher objective response rate and longer progression-free survival in patients who received #personalizedtherapy.
www.nature.com/articles/s41591-025-03918-x -
Nature Medicine
@NatureMedicine
In a randomized trial of patients with a previous #myocardialinfarction and with residual #inflammation, a monoclonal antibody targeting the protein LOX-1, thought to contribute to #atherosclerotic plaque progression and #inflammation, reduced soluble LOX-1 and IL-6 levels but did not lead to a significant reduction in #coronary plaque volume.
www.nature.com/articles/s41591-025-03951-w -
Nature Medicine
@NatureMedicine
A phase 3 trial found that VER-01, a full-spectrum #cannabis extract, reduces chronic low #backpain, improves function and sleep, and shows no signs of dependence or withdrawal. #chronicpain, #lowbackpain #chronicpainrelief #painrelief
www.nature.com/articles/s41591-025-03977-0 -
Nature Medicine
@NatureMedicine
A model developed with data from 19,403 patients with #colorectal #cancer for prediction of one-year mortality is used as a decision support tool in a prospective cohort, showing promising results in reducing post-operative complications. #cancerprediction #decisionsupport
-
Nature Medicine
@NatureMedicine
A retrospective, observational study shows that completion of a #diabetes prevention programme in England (the #nhs Diabetes Prevention Programme) was associated with decreased incidence of type 2 diabetes and long-term conditions such as #dementia and pulmonary #heartdisease at 24 months.
www.nature.com/articles/s41591-025-03922-1 -
Nature Medicine
@NatureMedicine
Interim trial results of #myr101, a novel recombinant vector with selective tropism for #oligodendrocytes, support its tolerability and indicate improved #myelination and reduced CSF NAA in children with #canavandisease. #genetherapy #clinicaltrials #neurology
-
Nature Medicine
@NatureMedicine
A brief self-administered digital #cognitive test, in combination with a blood test, accurately detects clinical #alzheimers disease in #primarycare. #digitalhealth #alzheimersawareness @OskarHansson9 @karlssonlinda1 @biofinder_study
www.nature.com/articles/s41591-025-03965-4 -
Nature Medicine
@NatureMedicine
A purpose-built implantable system based on biomimetic epidural electrical stimulation of the spinal cord reduces the severity of hypotensive complications in people with #spinalcordinjury and improves quality of life. @_NeuroRestore @gcourtine #epiduralstimulation #neurorehabilitation
www.nature.com/articles/s41591-025-03614-w -
Nature Medicine
@NatureMedicine
⭐Research highlight: A new study challenges previous assumptions that the brain’s body map undergoes reorganization after limb amputation, finding that it remains remarkably stable — with implications for brain–computer interfaces and the treatment of phantom limb pain. @NatureNeuro
www.nature.com/articles/d41591-025-00057-1 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Offering free-of-charge in-hospital #influenza #vaccination improves survival and reduces changes of readmission in patients with advanced #heartfailure, according to a large cluster-randomized trial. @TheLancet
www.nature.com/articles/d41591-025-00058-0 -
Nature Medicine
@NatureMedicine
⚡Our September issue features research, reviews and opinion related to the #exposome, from #airpollution to #microplastics and #aging, as well as a plethora of other topics including #obesity, #diabetes, #gastriccancer, #sexualhealth, #spinalcordinjury, and much more.
Read it here: www.nature.com/nm/volumes/31/issues/9 -
Nature Medicine
@NatureMedicine
In a phase 1/2a umbrella trial in patients with #glioblastoma matching targeted therapies according to tumor molecular profiling, #temsirolimus plus radiotherapy improved PFS compared to standard of care in patients with #phosphomtor activation. @wick_wolfgang @sahm_lab #glioblastomaresearch @CancerNeurosci1
www.nature.com/articles/s41591-025-03928-9 -
Nature Medicine
@NatureMedicine
As presented at the 2025 World Conference on #lungcancer: In a multi-arm phase 2 trial, perioperative immunotherapy was safe and feasible in patients with resectable diffuse pleural #mesothelioma with exploratory data suggesting that #ctdna kinetics could be informative of tumor regression and post-treatment survival. @ValsamoA @hopkinsthoracic @hopkinskimmel @MolcularOncLab
www.nature.com/articles/s41591-025-03958-3 -
Nature Medicine
@NatureMedicine
A report from the first 2,000 newborns enrolled in the #earlycheck programme, that offered genome screening covering 178 genes associated with early onset diseases, shows the feasibility and potential clinical utility of the approach, leading to 28 positive results. @RTI_Intl #genomicscreening #childhealth #diseaseprevention
www.nature.com/articles/s41591-025-03945-8 -
Nature Medicine reposted
Eric Topol
@EricTopol
Don't underestimate the effect of the arts—music, dance, visual, gardening, crafts, theater—for promoting health, a systematic review @NatureMedicine
www.nature.com/articles/s41591-025-03962-7 -
Nature Medicine
@NatureMedicine
A model developed with data from 19,403 patients with #colorectal #cancer for prediction of one-year mortality is used as a decision support tool in a prospective cohort, showing promising results in reducing post-operative complications. #cancerprediction #decisionsupport
-
Nature Medicine
@NatureMedicine
The #arts, according to a systematic synthesis of data from 95 studies (across 26 countries), may support #noncommunicablediseases prevention by providing opportunities for increased physical activity, and helping to address social forces that contribute to health inequities.
-
Nature Medicine
@NatureMedicine
In this phase III trial, a 2-dose #ebola #vaccine regimen in healthy pregnant women in #rwanda was found to be safe and produced immunogenicity in women and in offspring through passive transfer. @EmoryRollins MaternalHealth #vaccinetrial #ebolavaccine
www.nature.com/articles/s41591-025-03932-z -
Nature Medicine
@NatureMedicine
In a Phase 3 trial for Huntington’s disease, pridopidine did not meet its primary endpoints but was safe and favored pridopidine in some prespecified subgroup analyses. #clinicaltrials #pridopidine #neurodegeneration #huntingtonsdisease
www.nature.com/articles/s41591-025-03920-3 -
Nature Medicine
@NatureMedicine
Genotype-phenotype data from over 450,000 individuals was analysed to discover 205 genomic loci where an allele associated with increased adiposity was associated with a lower cardiometabolic disease risk to an individual www.nature.com/articles/s41591-025-03931-0
-
Nature Medicine
@NatureMedicine
A purpose-built implantable system based on biomimetic epidural electrical stimulation of the spinal cord reduces the severity of hypotensive complications in people with #spinalcordinjury and improves quality of life. @_NeuroRestore @gcourtine #epiduralstimulation #neurorehabilitation
www.nature.com/articles/s41591-025-03614-w -
Nature Medicine
@NatureMedicine
Interim trial results of #myr101, a novel recombinant vector with selective tropism for #oligodendrocytes, support its tolerability and indicate improved #myelination and reduced CSF NAA in children with #canavandisease. #genetherapy #clinicaltrials #neurology
-
Nature Medicine
@NatureMedicine
In an observational study comparing individuals with #type2diabetes and obesity who underwent metabolic surgery with similar individuals who received #glp_1 receptor agonist treatment, #metabolic surgery was associated with a lower risk of macrovascular and microvascular outcomes, including major adverse #cardiovascular events, #nephropathy, and #retinopathy. www.nature.com/articles/s41591-025-03893-3
-
Nature Medicine
@NatureMedicine
A retrospective, observational study shows that completion of a #diabetes prevention programme in England (the #nhs Diabetes Prevention Programme) was associated with decreased incidence of type 2 diabetes and long-term conditions such as #dementia and pulmonary #heartdisease at 24 months.
www.nature.com/articles/s41591-025-03922-1 -
Nature Medicine
@NatureMedicine
As presented at the 2025 World Conference on #lungcancer: In a multi-arm phase 2 trial, perioperative immunotherapy was safe and feasible in patients with resectable diffuse pleural #mesothelioma with exploratory data suggesting that #ctdna kinetics could be informative of tumor regression and post-treatment survival. @ValsamoA @hopkinsthoracic @hopkinskimmel @MolcularOncLab
www.nature.com/articles/s41591-025-03958-3 -
Nature Medicine
@NatureMedicine
In this single arm phase 2 trial in patients with HR+/HER2- advanced #breastcancer, treatment with the HER3 targeting, antibody-drug conjugate paritumab deruxtecan led to encouraging objective response rates, and comprehensive exploratory analyses indicate potential biomarkers of response. @BarbaraPistill2; @FAndreMD #her3_dxd #antibodydrugconjugates
www.nature.com/articles/s41591-025-03885-3 -
Nature Medicine reposted
Nature Portfolio
@NaturePortfolio
There are strong indications that micro- and nanoplastics exposure negatively impacts human health, but a robust evidence base is lacking. A Review in @NatureMedicine focuses on the current state of the science. go.nature.com/47H9Q3s
-
Nature Medicine
@NatureMedicine
A brief self-administered digital #cognitive test, in combination with a blood test, accurately detects clinical #alzheimers disease in #primarycare. #digitalhealth #alzheimersawareness @OskarHansson9 @karlssonlinda1 @biofinder_study
www.nature.com/articles/s41591-025-03965-4 -
Nature Medicine reposted
Emory Global Diabetes Research Center
@egdrc
A major long-term CARRS Cohort study in @NatureMedicine sheds light on how #diabetes develops and progresses among native South Asian populations living in Indian megacities. 📎www.nature.com/articles/s41591-025-03947-6
-
Nature Medicine reposted
Eric Topol
@EricTopol
On the consequences of our pervasive exposure to micro- and nanoplastics
A new stellar review @NatureMedicine
www.nature.com/articles/s41591-025-03902-5 -
Nature Medicine reposted
INSIGHTeyehub
@INSIGHTeyehub
Writing for @NatureMedicine's 30th year anniversary, @pearsekeane reflects on a 2018 cover story - a breakthrough study in medical AI for eye care and the result of a landmark collaboration between @Moorfields and @GoogleDeepMind.
-
Nature Medicine reposted
UCL Institute of Ophthalmology
@UCLeye
Researchers from @UCLeye, @Moorfields, @NUSMedicine, @CUHKofficial will develop an AI model using a dataset of over 100 million colour fundus photographs of the retina, sourced from more than 65 countries. Published yesterday in @NatureMedicine.
www.ucl.ac.uk/brain-sciences/news/2025/sep/building-world… -
Nature Medicine reposted
John-Arne Røttingen
@jarottingen
Functions of the global health system in a new era. I have written a thought piece together with a cross regional group of global health colleagues - Nature Medicine www.nature.com/articles/s41591-025-03936-9
-
Nature Medicine reposted
Alliance for HPSR
@AllianceHPSR
Global health is at a crossroads.
Efforts at reform of the global health system need to answer key questions on functions, what should be delivered in different contexts and levels, and how the system should operate.
New in Nature Medicine 👉 doi.org/10.1038/s41591-025-03936-9 -
Nature Medicine
@NatureMedicine
Imaging data support the clinical effects of #rnainterference agent vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy — and point to a potential new role for echocardiographic parameters in monitoring individual treatment responses.
News & Views from Diana Bonderman @wiengesundheit
www.nature.com/articles/s41591-025-03940-z -
Nature Medicine
@NatureMedicine
A Review of the global #cancer #clinicaltrials landscape - based on WHO’s International Clinical Trials Registry Platform - provides critical empirical evidence to inform policy, practice and investment. @Raffa_Casolino @WHO
www.nature.com/articles/s41591-025-03926-x -
Nature Medicine
@NatureMedicine
RESEARCH
In a #clinicaltrials of patients w/ heart failure w/ preserved ejection fraction & recent decompensation, treatment w/ volenrelaxin, a long-acting form of human #relaxin, was associated with worsening congestion across multiple endpoints.
www.nature.com/articles/s41591-025-03939-6 -
Nature Medicine
@NatureMedicine
Location, Location, Location: A study demonstrates the feasibility of a multi-site infusion approach to ensure broad distribution of an AAV-based #genetherapy for GM2 gangliosidosis, providing valuable lessons for the treatment of this and other rare lysosomal storage disorders.
News & Views from Guilherme Baldo @ufrgsnoticias
www.nature.com/articles/s41591-025-03914-1 -
Nature Medicine
@NatureMedicine
⭐Research highlight: A study of over 1.2 million children found no links between aluminum-adjuvanted childhood #vaccines and over 50 #chronicdiseases, including neurological, autoimmune and allergic conditions. @AnnalsofIM
www.nature.com/articles/d41591-025-00055-3 -
Nature Medicine
@NatureMedicine
In this single arm phase 2 trial in patients with HR+/HER2- advanced #breastcancer, treatment with the HER3 targeting, antibody-drug conjugate paritumab deruxtecan led to encouraging objective response rates, and comprehensive exploratory analyses indicate potential biomarkers of response. @BarbaraPistill2; @FAndreMD #her3_dxd #antibodydrugconjugates
www.nature.com/articles/s41591-025-03885-3 -
Nature Medicine
@NatureMedicine
Ultra-processed diets promote excess calorie consumption:
A clinical trial confirms that individuals consume more calories from ultra-processed diets than from minimally processed diets, even when both diets meet UK dietary guidelines and participants are losing weight. @marionnestle puts the results in context:
www.nature.com/articles/s41591-025-03910-5 -
Nature Medicine
@NatureMedicine
A proteomic study begins to identify direct and indirect effects of #glp-1 treatment on metabolic dysfunction-associated steatohepatitis (#mash), and reveals insights into treatment-induced changes in liver histology.
News & VIews from @schattenbergJ and @MMichel_MD
www.nature.com/articles/s41591-025-03927-w -
Nature Medicine
@NatureMedicine
In a phase 1/2a umbrella trial in patients with #glioblastoma matching targeted therapies according to tumor molecular profiling, #temsirolimus plus radiotherapy improved PFS compared to standard of care in patients with #phosphomtor activation. @wick_wolfgang @sahm_lab #glioblastomaresearch @CancerNeurosci1
www.nature.com/articles/s41591-025-03928-9 -
Nature Medicine
@NatureMedicine
RESEARCH
By matching antigenicity prediction w/ a forecast of circulating strains in the next season, this model outperforms standard recommendations for #vaccine design (effectiveness & disease burden) throughout different #influenza seasons 💉
www.nature.com/articles/s41591-025-03917-y -
Nature Medicine
@NatureMedicine
RESEARCH
Training & validated on 14.5 million images from multi-country datasets, a foundation model is shown to increase #diagnosis & referral accuracy of clinicians when used as an assistant for #retina disease screening.
www.nature.com/articles/s41591-025-03900-7 -
Nature Medicine
@NatureMedicine
In a Phase 3 trial for Huntington’s disease, pridopidine did not meet its primary endpoints but was safe and favored pridopidine in some prespecified subgroup analyses. #clinicaltrials #pridopidine #neurodegeneration #huntingtonsdisease
www.nature.com/articles/s41591-025-03920-3 -
Nature Medicine
@NatureMedicine
A report from the first 2,000 newborns enrolled in the #earlycheck programme, that offered genome screening covering 178 genes associated with early onset diseases, shows the feasibility and potential clinical utility of the approach, leading to 28 positive results. @RTI_Intl #genomicscreening #childhealth #diseaseprevention
www.nature.com/articles/s41591-025-03945-8 -
Nature Medicine
@NatureMedicine
In this phase III trial, a 2-dose #ebola #vaccine regimen in healthy pregnant women in #rwanda was found to be safe and produced immunogenicity in women and in offspring through passive transfer. @EmoryRollins MaternalHealth #vaccinetrial #ebolavaccine
www.nature.com/articles/s41591-025-03932-z -
Nature Medicine
@NatureMedicine
RESEARCH
In a small trial of patients with severe systemic #lupus erythematosus & nephritis, treatment with genetically edited allogeneic T cells was safe & linked to reduced disease.
#genetics #research
www.nature.com/articles/s41591-025-03899-x -
Nature Medicine
@NatureMedicine
RESEARCH
Longitudinal analyses reveal misalignment between global #research efforts & disease burden, a gap expected to widen over the next 20y by the withdrawal of US public #funding for international research.
#publichealth
www.nature.com/articles/s41591-025-03923-0 -
Nature Medicine reposted
Penn Medicine 2-PREVENT Breast Cancer TCE
@PennBreastTCE
New proof-of-concept trial by @PennMedicine in @NatureMedicine researched dormant DTCs link to breast cancer recurrence. The CLEVER trial showed HCQ and EVE reduced DTCs & improved recurrence-free survival. Read more here 🔗: doi.org/10.1038/s41591-025-03877-3
-
Nature Medicine reposted
China Science
@ChinaScience
A Chinese-led international team has developed EyeFM, an AI system trained on 14.5 million ocular images and paired clinical texts from global, multi-ethnic datasets. As the world's first multimodal vision–language eye imaging foundation model, it has demonstrated how AI can soon assist doctors in settings ranging from primary care clinics to specialist centers.
In a single-center, double-masked trial involving 668 high-risk patients in China, EyeFM support raised diagnostic accuracy to 92.2%, compared with 75.4% in the control group.
Published in @NatureMedicine, the study offers a ready-to-reuse playbook for turning AI into an effective everyday clinical practice tool. -
Nature Medicine reposted
Fundación Alfonso Martín Escudero
@Fundame_org
👏Queremos felicitar a nuestro becario Dr. Manuel Dote-Montero por su reciente publicación en la prestigiosa revista @NatureMedicine . Si quieres saber más de los efectos del ayuno intermitente en la salud 🥗, visita nuestra web ➡️fundame.org/efecto-del-ayuno-intermitente-en-la-salud/
-
Nature Medicine
@NatureMedicine
RESEARCH
Analyzing data from the SURMOUNT-1 trial, the authors show that the weight loss effects of tirzepatide treatment are similar in carriers & non-carriers of MC4R pathogenic mutations.
#obesity #genetics #clinicalresearch
www.nature.com/articles/s41591-025-03913-2 -
Nature Medicine
@NatureMedicine
RESEARCH
The genetic background, plasma metabolome & dietary data from 4,215 women & 1,490 males revealed 57 metabolites whose associations with #dementia risk vary by APOE4 genotype.
#metabolomics #mentalhealth #genetics
www.nature.com/articles/s41591-025-03891-5 -
Nature Medicine
@NatureMedicine
RESEARCH
@bambinogesu et al: In the final analysis of a phase 1/2 trial of autologous GD2-targeting CAR T cells in pediatric patients with high risk, metastatic relapsed or refractory neuroblastoma, treatment was well tolerated with 66% objective response rate.
#cancerresearch #clinicaltrials
www.nature.com/articles/s41591-025-03876-4 -
Nature Medicine
@NatureMedicine
RESEARCH
In the first attempt at #xenotransplantation of a lung from a genetically-modified pig into a brain-dead recipient, although the grafted lung initially maintained viability & functionality, antibody-mediated rejection rapidly occurred, contributing to xenograft damage.
www.nature.com/articles/s41591-025-03861-x -
Nature Medicine reposted
Nature Portfolio
@NaturePortfolio
A study in @NatureMedicine identifies the Mediterranean diet as a promising approach to mitigate genetically dependent Alzheimer’s disease-related dementias risk by targeting a broad spectrum of metabolic pathways. go.nature.com/45Dwb0p
-
Nature Medicine reposted
Eric Topol
@EricTopol
A randomized trial of eye care by ophthalmologists with A.I. vs ophthalmologists without A.I. demonstrated much higher accuracy in diagnosis (92 vs 74%) and many other improved outcomes @NatureMedicine
www.nature.com/articles/s41591-025-03900-7 -
Nature Medicine
@NatureMedicine
RESEARCH
Serological profiles from 2 observational cohort studies in The Gambia characterize surrogates of protection against S. pyogenes & reveals an antibody response against antigens that are currently in #vaccines development.
#immunology
www.nature.com/articles/s41591-025-03868-4 -
Nature Medicine reposted
Eric Topol
@EricTopol
Severe, refractory lupus successfully treated with engineered T cells derived from a healthy donor product
www.nature.com/articles/s41591-025-03899-x -
Nature Medicine reposted
Nature Asia-Pacific
@NatureAsia
[Highlight] Gene-edited pig lung functions in human for 9 days
Pig-to-human lung xenotransplantation into a brain-dead recipient
www.nature.com/articles/s41591-025-03861-x
@NatureMedicine paper by Jianxing He, Toyofumi F. Chen-Yoshikawa et al.
For reading: rdcu.be/eCpnw
@NagoyaUniv_info
Nature Portfolio
@NaturePortfolio
A genetically modified pig lung remained viable and functional over a period of nine days after being transplanted into a human recipient who had been declared brain dead, according to research in @NatureMedicine. go.nature.com/45yGy5v
-
Nature Medicine reposted
Eric Topol
@EricTopol
Adherence to a Mediterranean diet linked to reduced dementia-related metabolites, many of which showed causal relationships (via MR), and lower risk Alzheimer's disease. Notable relationship with APOE4 genotyopes www.nature.com/articles/s41591-025-03891-5
-
Nature Medicine
@NatureMedicine
RESEARCH
High-resolution geospatial mapping found that the annual incidence of #cholera shifted from western to central & eastern Africa between 2011-2020, with the latter regions more likely to report cholera in 2022-2023, reflecting instability in cholera burden patterns that can impact disease control.
#globalhealth 🌍
www.nature.com/articles/s41591-025-03847-9 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Long seen a ‘holy grail’ of transplant research, a first-in-human, single case study marks a step toward immunosuppression-free islet transplantation in patients with #diabetes, with the help of #geneediting techniques. @NEJM
www.nature.com/articles/d41591-025-00053-5 -
Nature Medicine reposted
Giulio Maria Pasinetti, MD, PhD
@IcahnCMIN
In observational study of healthcare professionals, Yuxi Liu, Xiao Gu, Yanping Li, Dong D. Wang, et al. found that people who carried #alzheimers APOE4 risk gene had lower risk of developing #dementia if they followed #mediterraneandiet. @NatureMedicine
www.nature.com/articles/s41591-025-03891-5 -
Nature Medicine reposted
ANSA Salute & Benessere
@ANSA_Salute
Uno studio pubblicato su @NatureMedicine indica la #dietamediterranea come fattore protettivo per ridurre il rischio di #demenza nelle persone con maggiore rischio di sviluppare il morbo di #alzheimer, malattia dalla forte componente genetica.
#ansasalute
www.ansa.it/canale_saluteebenessere/notizie/medicina/2025… -
Nature Medicine reposted
Beijing Daily
@DailyBeijing
In a world's first, #chinese surgeons transplanted a genetically modified pig lung into a brain-dead man and functioned for 9 days, according to findings published on Aug. 25 in the journal @NatureMedicine.
-
Nature Medicine
@NatureMedicine
The detrimental impact of #airpollution on health is well-known, but why is it so difficult to control? Our latest Review evaluates multi-level interventions in the context of the evolving #climatecrisis and discusses what works and does not work. @ProfJohnJi @DrMariaNeira @francescadomin8
www.nature.com/articles/s41591-025-03929-8 -
Nature Medicine
@NatureMedicine
RESEARCH
Two phase 2 trials show that immunosenescence as a mechanism of resistance to immunotherapy can be overcome with the #senolytics dasatinib & quercetin in patients with head & neck squamous cell carcinoma.
#cancerresearch
www.nature.com/articles/s41591-025-03873-7 -
Nature Medicine
@NatureMedicine
RESEARCH
In this analysis of the placebo-controlled CheckMate 274 trial, a composite model of adaptive immunity biomarkers & clinical parameters predicted benefit from nivolumab treatment in patients with muscle-invasive urothelial cancer.
#cancerresearch #clinicaltrials
www.nature.com/articles/s41591-025-03802-8 -
Nature Medicine
@NatureMedicine
RESEARCH
An integrated dataset combining genetics & multi-omics from 1342 people living with #hiv illuminates molecular pathways driving immune responses & comorbidities in this population.
#immune #omics
www.nature.com/articles/s41591-025-03887-1 -
Nature Medicine
@NatureMedicine
RESEARCH
Using large cohorts from published clinical trials (>8K patients), a probabilistic machine learning model reconstructs the transition probabilities from data-derived diseases statuses, showing patterns that suggest how progression to severe stages occur & potential inversion of the process.
#neurotwitter
www.nature.com/articles/s41591-025-03901-6 -
Nature Medicine
@NatureMedicine
RESEARCH
A phase 1/2 trial on dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis administered by bilateral intrathalamic, cisterna magna & intrathecal delivery found a dose-dependent biochemical correction of the disease.
#genetherapy #clinicaltrials
www.nature.com/articles/s41591-025-03822-4 -
Nature Medicine reposted
Nature Portfolio
@NaturePortfolio
A genetically modified pig lung remained viable and functional over a period of nine days after being transplanted into a human recipient who had been declared brain dead, according to research in @NatureMedicine. go.nature.com/45yGy5v
-
Nature Medicine reposted
Springer Nature
@SpringerNature
A genetically modified pig lung remained viable and functional over a period of 9 days after being transplanted into a human recipient who had been declared brain-dead, says research in @NatureMedicine. spklr.io/6012BGAky
-
Nature Medicine
@NatureMedicine
RESEARCH
In the HELIOS-B RCT in patients with transthyretin amyloid cardiomyopathy, treatment with the RNA interference agent vutrisiran improved echocardiographic measures of cardiac structure & function vs placebo ❤️🩹
#clinicaltrials #cardiovascular
www.nature.com/articles/s41591-025-03851-z -
Nature Medicine
@NatureMedicine
RESEARCH
In cohort B of the phase 2 SWOG S1512 trial, pembrolizumab monotherapy in patients with unresectable desmoplastic melanoma elicited a complete response rate of 37% & an objective response rate of 89%, supporting a new treatment option for this tumor type.
#clinicaltrials #cancerresearch
www.nature.com/articles/s41591-025-03875-5 -
Nature Medicine
@NatureMedicine
Location, Location, Location: A study demonstrates the feasibility of a multi-site infusion approach to ensure broad distribution of an AAV-based #genetherapy for GM2 gangliosidosis, providing valuable lessons for the treatment of this and other rare lysosomal storage disorders.
News & Views from Guilherme Baldo @ufrgsnoticias
www.nature.com/articles/s41591-025-03914-1 -
Nature Medicine
@NatureMedicine
A pair of phase 1 trials evaluating antibody–drug conjugates identify potential strategies to treat advanced gastroesophageal #cancers and highlight the rapid expansion of claudin18.2-targeting drug development in solid tumors.
News & Views from @KlempnerSam and @sundar__raghav
@YaleMed @harvardmed #adcs
www.nature.com/articles/s41591-025-03898-y -
Nature Medicine reposted
Marion Nestle
@marionnestle
My editorial on the British study of ultra-processed foods [www.nature.com/articles/s41591-025-03842-0] has been published at long last in Nature Medicine. Take a look! www.nature.com/articles/s41591-025-03910-5
-
Nature Medicine reposted
Samuel Dicken
@SamuelDickenUK
Thank you to Professor @marionnestle for writing a fantastic editorial summarising the UPDATE trial in @NatureMedicine; the first ever trial comparing UPF and MPF diets following healthy dietary guidelines.
📰 www.nature.com/articles/s41591-025-03910-5 -
Nature Medicine
@NatureMedicine
RESEARCH
A clinical trial using continuous glucose monitoring found that a Dietary Approaches to Stop Hypertension (DASH)-style diet tailored for diabetes reduced hyperglycemia & improved glucose control vs a typical American diet in patients with T2D.
#diet #nutrition #clinicaltrials #diabetes
www.nature.com/articles/s41591-025-03823-3 -
Nature Medicine
@NatureMedicine
RESEARCH
Based on 337 human kidney & plasma samples, the authors generate the first kidney pQTL dataset & explore novel risk loci relevant for cardio-kidney-metabolic health.
#metabolism #liver #proteomics
www.nature.com/articles/s41591-025-03872-8 -
Nature Medicine
@NatureMedicine
RESEARCH
A RCT found no difference in paranoid ideations between virtual reality-based & gold-standard cognitive behavioral therapy for patients with schizophrenia spectrum disorders, in contrast to previous trials using wait-list or passive controls.
#mentalhealth #virtualreality
www.nature.com/articles/s41591-025-03880-8 -
Nature Medicine
@NatureMedicine
RESEARCH
A deep learning model shows that acute aortic syndrome can be diagnosed directly from noncontrast CT, increasing accuracy & decreasing time to #diagnosis.
#artificial_intelligence
www.nature.com/articles/s41591-025-03916-z -
Nature Medicine
@NatureMedicine
RESEARCH
A large language model designed for health monitoring provides personalized sleep & fitness predictions, insights & advice.
#digitalhealth #llm #personalizedmedicine
www.nature.com/articles/s41591-025-03888-0 -
Nature Medicine
@NatureMedicine
RESEARCH
Plasma #proteomics analysis of presymptomatic individuals with amyotrophic lateral sclerosis identifies novel disease-associated proteins & enables development of an accurate diagnostic #biomarker panel.
www.nature.com/articles/s41591-025-03890-6 -
Nature Medicine
@NatureMedicine
RESEARCH
A free-living trial in people with overweight/obesity found that minimally processed diets led to greater weight loss & cardiometabolic improvements vs ultra processed diets following UK healthy eating guidelines at 8 weeks.
#obesity #diet #nutrition #upf
www.nature.com/articles/s41591-025-03842-0 -
Nature Medicine reposted
Nature Medicine
@NatureMedicine
🔆AUGUST ISSUE 🔆
Read about #research from the Global Neurodegeneration Proteomics Consortium (GNPC), which provide insights into #proteomics changes and potential #biomarkers & drug targets for neurodegenerative diseases.
#neurotwitter #brainhealth
www.nature.com/nm/volumes/31/issues/8 -
Nature Medicine reposted
Raghav Sundar
@sundar__raghav
Targeting Claudin18.2 beyond monoclonal antibodies like zolbetixumab is arriving! In this article by @KlempnerSam and myself in @NatureMedicine we discuss two promising Claudin18.2 targeting Antibody-Drug Conjugates. www.nature.com/articles/s41591-025-03898-y
-
Nature Medicine
@NatureMedicine
RESEARCH
5y follow up from the phase 3 KEYNOTE426 trial show that pembrolizumab + axitinib vs sunitinib as 1st line #therapy shows overall & progression free survival benefits in patients with advanced clear cell renal cell carcinoma.
#cancerresearch #clinicaltrials
www.nature.com/articles/s41591-025-03867-5 -
Nature Medicine
@NatureMedicine
RESEARCH
In the multicenter phase 2 OptiTROP-Lung01 trial in patients with treatment naive advanced non-small cell lung cancers, sacituzumab tirumotecan with anti-PDL1 tagitanlimab was safe & showed clinical efficacy.
#cancerresearch #clinicaltrial
www.nature.com/articles/s41591-025-03883-5 -
Nature Medicine
@NatureMedicine
🔆AUGUST ISSUE 🔆
Read about #research from the Global Neurodegeneration Proteomics Consortium (GNPC), which provide insights into #proteomics changes and potential #biomarkers & drug targets for neurodegenerative diseases.
#neurotwitter #brainhealth
www.nature.com/nm/volumes/31/issues/8 -
Nature Medicine reposted
Nature Medicine
@NatureMedicine
Analyses from the largest neurodegeneration focused proteomics database - the Global Neurodegeneration Proteomics Consortium @_neuroproteome are published today in @NatureMedicine and @NatureAging
The findings reveal unique protein biomarkers that correlate with @neurodegenerative diseases and the @ageing process, and may help with the early detection, and improve outcomes, of major neurodegenerative diseases.
Read the collection here: www.nature.com/collections/ecegeajbhg -
Nature Medicine
@NatureMedicine
Unique biological, exposomal, economic, and sociocultural factors shape #resilience and #brainhealth across the globe.
Agustin Ibanez, Chi Udeh-Momoh & colleagues discuss underlying mechanisms of resilience, measurement approaches, operationalization and research gaps. @AgustinMIbanez @BrainlatUAI @AKU_BMI @GBHI_Fellows
www.nature.com/articles/s41591-025-03846-w -
Nature Medicine
@NatureMedicine
Biological and health effects of fire smoke exposure:
A new study leverages powerful #multiomics techniques to analyze immune dysregulation in smoke-exposed individuals, offering crucial insights for the development of novel diagnostics and interventions.
Read the News & Views from Katherine Zychowski & Mijung Oh @UNMHSC #wildfires #exposome
www.nature.com/articles/s41591-025-03866-6 -
Nature Medicine
@NatureMedicine
Strengthening Africa’s #brainhealth and economic #resilience:
In our latest Perspective, authors present a five-year action plan that prioritizes high-impact, practical interventions in brain health across six key areas — to safeguard the continent’s health and economic stability alongside projected demographic shifts. @DavosAlzheimers
www.nature.com/articles/s41591-025-03863-9 -
Nature Medicine
@NatureMedicine
The economics of investing in women and health:
Our latest Review from Beverly Essue, @FeliciaKnaul & colleagues explores the intrinsic returns that would stem from comprehensive, gender-responsive investments in the health of women, by allowing full access to education and fair labour force participation – and wider benefits for communities and societies. @dgsomucla @UofT @HarvardChanSPH @UW
www.nature.com/articles/s41591-025-03864-8 -
Nature Medicine
@NatureMedicine
The phase 2 TUXEDO-3 trial identifies the HER3-targeting #antibodydrugconjugate patritumab deruxtecan as a promising new therapeutic option for patients with #leptomeningeal #metastasis from solid tumors.
Carey Anders & colleagues @DukeCancer discuss the study and its implications.
www.nature.com/articles/s41591-025-03853-x -
Nature Medicine
@NatureMedicine
Polygenic scores for BMI and obesity constructed using data from 5M individuals with different ancestries were associated with distinct weight gain trajectories from early childhood to adulthood @novonordiskfond @IcahnMountSinai www.nature.com/articles/s41591-025-03827-z
-
Nature Medicine
@NatureMedicine
In an updated report on 70 laboratory-confirmed highly pathogenic avian H5N1 cases in the US between March 2024-April 2025, the absence of human to human transmission to date is confirmed, with no known mutations of resistance to neuroaminidase inhibitors. www.nature.com/articles/s41591-025-03905-2
-
Nature Medicine
@NatureMedicine
In a phase 1b trial in 3 patients with Fanconi anemia, an irradiation and busulfan-free conditioning regimen containing an anti-CD117 antibody, combined with T- and B-cell depleted haploidentical hematopoietic stem cell transplant, was safe and led to high levels of engraftment. @StanfordMed www.nature.com/articles/s41591-025-03817-1
-
Nature Medicine
@NatureMedicine
⭐Research highlight: For women carrying pathogenic mitochondrial DNA variants, a novel technique — involving transfer of their nuclear DNA to an enucleated donor egg — resulted in successful pregnancies and healthy children. @NEJM
www.nature.com/articles/d41591-025-00047-3 -
Nature Medicine
@NatureMedicine
In a prospective study including 2,300 pediatric and adult patients with liquid and solid tumors, RNA sequencing provided actionable molecular information in 87% of cases, including for diagnostic and therapy matching purposes.
@CHawkinsLab
www.nature.com/articles/s41591-025-03848-8 -
Nature Medicine
@NatureMedicine
Unique biological, exposomal, economic, and sociocultural factors shape #resilience and #brainhealth across the globe.
Agustin Ibanez, Chi Udeh-Momoh & colleagues discuss underlying mechanisms of resilience, measurement approaches, operationalization and research gaps. @AgustinMIbanez @BrainlatUAI @AKU_BMI @GBHI_Fellows
www.nature.com/articles/s41591-025-03846-w -
Nature Medicine
@NatureMedicine
In this phase 1 trial, treatment with IBI343, a CLDN18.2- targeting antibody drug conjugate, was safe and showed encouraging clinical responses in patients with advanced gastroesophageal junction adenocarcinoma.
@JiaJennyLiu #antibodydrugconjugate www.nature.com/articles/s41591-025-03783-8 -
Nature Medicine
@NatureMedicine
In this multicenter phase 1 trial, patients with advanced gastric and gastroesophageal junction cancer were safely treated with the CLDN18.2- targeting antibody drug conjugate SHR-A1904, leading to encouraging objective response rates. #antibodydrugconjugate
-
Nature Medicine
@NatureMedicine
In a phase 1 trial, treatment of individuals with mixed #hyperlipidemia with a monoclonal antibody targeting the angiopoietin-like protein 3/8 complex resulted in dose-dependent reductions in the levels of #triglycerides and low-density lipoprotein cholesterol, while increasing the levels of high-density lipoprotein. www.nature.com/articles/s41591-025-03830-4
-
Nature Medicine
@NatureMedicine
A combination of animal studies, data from a clinical trial, and insights from an observational cohort suggest that, in individuals with MASH, semaglutide improves liver histology by reverting patient proteomes to better mimic the proteome of individuals without the disease.
-
Nature Medicine
@NatureMedicine
Anti-sense oligonucleotide rugonersen has acceptable safety and tolerability in children with #angelman syndrome and shows partial normalization of EEG abnormalities and clinical improvements relative to natural history.
www.nature.com/articles/s41591-025-03784-7 -
Nature Medicine
@NatureMedicine
In the Human Phenotype Project, home sleep apnea testing data was collected for a total of 16,812 nights in 6,410 individuals, allowing for a comprehensive study of the association of sleep traits with physiological features across 16 body systems. www.nature.com/articles/s41591-025-03790-9
-
Nature Medicine
@NatureMedicine
In the dose expansion cohort of this phase 1b trial, the EGFR x HER3 bispecific antibody-drug conjugate BL-B01D1 given to patients with metastatic esophageal squamous cell carcinoma led to encouraging clinical response rates that need to be confirmed in larger efficacy trials.
-
Nature Medicine
@NatureMedicine
Preliminary results from a phase 1/2 trial show that an AAV-OTOF gene therapy is safe and leads to hearing improvements in 10 patients with congenital deafness with 6-12 months follow up, including a teenager and a young adult, expanding the age range from previous trials.
-
Nature Medicine
@NatureMedicine
In an updated report on 70 laboratory-confirmed highly pathogenic avian H5N1 cases in the US between March 2024-April 2025, the absence of human to human transmission to date is confirmed, with no known mutations of resistance to neuroaminidase inhibitors. www.nature.com/articles/s41591-025-03905-2
-
Nature Medicine
@NatureMedicine
Positive results from a first-in-human clinical trial validate the ANGPTL3–ANGPTL8 complex as a new therapeutic target for reducing #triglycerides and, potentially, #cardiovasculardisease risk. Read the News & Views from Daniel Rader and Archna Bajaj @Penn
www.nature.com/articles/s41591-025-03845-x -
Nature Medicine
@NatureMedicine
⭐Research highlight: A tiny, low-cost device could replace #endoscopy surveillance for some patients with #barrettsesophagus, according to a prospective implementation study @TheLancet
www.nature.com/articles/d41591-025-00046-4 -
Nature Medicine
@NatureMedicine
⚡Our July issue is live! Featuring news, opinion and clinical research on topics spanning #migraine, #genetherapy, #virtualreality, #stemcelltherapy, #cancer, #mash, #chikungunya, #microbiome, #upfs, #polygenic scores, #transplant medicine and much more!
-
Nature Medicine
@NatureMedicine
Analyses from the largest neurodegeneration focused proteomics database - the Global Neurodegeneration Proteomics Consortium @_neuroproteome are published today in @NatureMedicine and @NatureAging
The findings reveal unique protein biomarkers that correlate with @neurodegenerative diseases and the @ageing process, and may help with the early detection, and improve outcomes, of major neurodegenerative diseases.
Read the collection here: www.nature.com/collections/ecegeajbhg -
Nature Medicine
@NatureMedicine
When tested in a multiethnic cohort of ~2.5 million US veterans, the PREVENT equations, recently developed by the American Heart Association for sex-specific and race-free prediction of cardiovascular disease risk, were shown to accurately estimate this risk with some variability across race and ethnicity groups and to outperform the previously used PCE risk score. www.nature.com/articles/s41591-025-03789-2
-
Nature Medicine
@NatureMedicine
In a phase 1b trial in 3 patients with Fanconi anemia, an irradiation and busulfan-free conditioning regimen containing an anti-CD117 antibody, combined with T- and B-cell depleted haploidentical hematopoietic stem cell transplant, was safe and led to high levels of engraftment. @StanfordMed www.nature.com/articles/s41591-025-03817-1
-
Nature Medicine
@NatureMedicine
A combination of animal studies, data from a clinical trial, and insights from an observational cohort suggest that, in individuals with MASH, semaglutide improves liver histology by reverting patient proteomes to better mimic the proteome of individuals without the disease.
-
Nature Medicine
@NatureMedicine
Polygenic scores for BMI and obesity constructed using data from 5M individuals with different ancestries were associated with distinct weight gain trajectories from early childhood to adulthood @novonordiskfond @IcahnMountSinai www.nature.com/articles/s41591-025-03827-z
-
Nature Medicine
@NatureMedicine
ICYMI @BillGates wrote a World View for @NatureMedicine about how his father's death from Alzheimer's disease prompted him to support a global collaboration of top dementia researchers @_neuroproteome to accelerate proteomics discovery.
Read Gates here: www.nature.com/articles/d41591-022-00044-w
News summary: idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat…
All the content: idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat… -
Nature Medicine
@NatureMedicine
Preliminary results from a phase 1/2 trial show that an AAV-OTOF gene therapy is safe and leads to hearing improvements in 10 patients with congenital #deafness with 6-12 months follow up, including a teenager and a young adult, expanding the age range from previous trials. #genetherapy
www.nature.com/articles/s41591-025-03773-w -
Nature Medicine
@NatureMedicine
Our latest Review summarizes the current knowledge on mortality-defining toxicities of #cartcell therapies, beyond CRS and ICANS. @KRejeski & colleagues discuss underlying mechanisms of rare and long-term toxicities and how these affect timing and management, and outline key unmet needs and future priorities. @LMU_Muenchen @MoffittNews
www.nature.com/articles/s41591-025-03813-5 -
Nature Medicine reposted
Pradeep Natarajan
@pnatarajanmd
Congrats to R. Loos, J. Hirschhorn, & colleagues developing a new polygenic risk score for obesity. Very interesting that it predicts response with weight loss across 2 lifestyle intervention RCTs www.nature.com/articles/s41591-025-03827-z @NatureMedicine
My comments in @nytimes www.nytimes.com/2025/07/21/health/obesity-genetic-risk-sc… by @ginakolata -
Nature Medicine
@NatureMedicine
In a silent trial involving 197 lung cancer patients over the span of four months, a pathology foundation model was able to identify presence of EGFR mutations with high accuracy, potentially preventing further genetic testing in 43% of cases. www.nature.com/articles/s41591-025-03780-x
-
Nature Medicine
@NatureMedicine
#stemcell therapies for #diabetes have entered the clinic; our latest Review summarizes the advances that got us here, lessons learned from early trials & the clinical, manufacturing & regulatory challenges that must now be overcome
www.nature.com/articles/s41591-025-03767-8 -
Nature Medicine
@NatureMedicine
Read about the scientific and technological breakthroughs reshaping transplant medicine - including the transformative role of AI, xenotransplantation and tissue engineering, and novel approaches to immunosuppression.
www.nature.com/articles/s41591-025-03801-9 -
Nature Medicine
@NatureMedicine
An explosion of #digitaltools and #ai is catalyzing innovations in the mission to scale up #mentalhealth support worldwide. These paradigms currently rely on a ‘human in the loop’ — but who is the human in question, and does it matter? News & Views from Anushka Patel and Ernesto Isaac Lara @harvardmed
www.nature.com/articles/s41591-025-03755-y -
Nature Medicine
@NatureMedicine
In this multicenter phase 1 trial, patients with advanced gastric and gastroesophageal junction cancer were safely treated with the CLDN18.2- targeting antibody drug conjugate SHR-A1904, leading to encouraging objective response rates. #antibodydrugconjugate
-
Nature Medicine
@NatureMedicine
In this phase 1 trial, treatment with IBI343, a CLDN18.2- targeting antibody drug conjugate, was safe and showed encouraging clinical responses in patients with advanced gastroesophageal junction adenocarcinoma.
@JiaJennyLiu #antibodydrugconjugate www.nature.com/articles/s41591-025-03783-8 -
Nature Medicine
@NatureMedicine
In a prospective study including 2,300 pediatric and adult patients with liquid and solid tumors, RNA sequencing provided actionable molecular information in 87% of cases, including for diagnostic and therapy matching purposes.
@CHawkinsLab
www.nature.com/articles/s41591-025-03848-8 -
Nature Medicine
@NatureMedicine
When tested in a multiethnic cohort of ~2.5 million US veterans, the PREVENT equations, recently developed by the American Heart Association for sex-specific and race-free prediction of cardiovascular disease risk, were shown to accurately estimate this risk with some variability across race and ethnicity groups and to outperform the previously used PCE risk score. www.nature.com/articles/s41591-025-03789-2
-
Nature Medicine
@NatureMedicine
Preliminary results from a phase 1/2 trial show that an AAV-OTOF gene therapy is safe and leads to hearing improvements in 10 patients with congenital deafness with 6-12 months follow up, including a teenager and a young adult, expanding the age range from previous trials.
-
Nature Medicine
@NatureMedicine
In a silent trial involving 197 lung cancer patients over the span of four months, a pathology foundation model was able to identify presence of EGFR mutations with high accuracy, potentially preventing further genetic testing in 43% of cases.
www.nature.com/articles/s41591-025-03780-x -
Nature Medicine
@NatureMedicine
In a phase 1 trial, treatment of individuals with mixed #hyperlipidemia with a monoclonal antibody targeting the angiopoietin-like protein 3/8 complex resulted in dose-dependent reductions in the levels of #triglycerides and low-density lipoprotein cholesterol, while increasing the levels of high-density lipoprotein. www.nature.com/articles/s41591-025-03830-4
-
Nature Medicine
@NatureMedicine
In the Human Phenotype Project, home sleep apnea testing data was collected for a total of 16,812 nights in 6,410 individuals, allowing for a comprehensive study of the association of sleep traits with physiological features across 16 body systems. www.nature.com/articles/s41591-025-03790-9
-
Nature Medicine
@NatureMedicine
Anti-sense oligonucleotide rugonersen has acceptable safety and tolerability in children with #angelman syndrome and shows partial normalization of EEG abnormalities and clinical improvements relative to natural history.
www.nature.com/articles/s41591-025-03784-7 -
Nature Medicine
@NatureMedicine
Part of the Global Neurodegeneration Proteomics Consortium collection www.nature.com/collections/ecegeajbhg, our friends @NatureAging published a commentary for GNPC authors discussing the technical and legal challenges that had to be overcome to establish the Consortium.
-
Nature Medicine
@NatureMedicine
Taking a deep dive into the Global Neurodegeneration Proteomics Consortium dataset, Catilin Finney and colleagues identified a cerebrospinal fluid and plasma protein signature associated with carriers of the APOE ε4 allele which suggests the variant has a role in neurodegeneration beyond AD.
www.nature.com/articles/s41591-025-03835-z
And Tony Wyss-Coray @wysscoray and colleagues identified age-related changes in proteins that correlate with cognitive function.
www.nature.com/articles/s41591-025-03831-3 -
Nature Medicine
@NatureMedicine
Farhad Iman and colleagues present the Global Neurodegeneration Proteomics Consortium dataset – 250 million unique protein measurements from 35,000 samples. Samples were provided by 23 research communities. Authors identify proteins associated with AD, PD and ALS. www.nature.com/articles/s41591-025-03834-0
Carlos Cruchaga @ccrugom and colleagues identified disease-specific plasma biomarker profiles and a protein signature across Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia.
www.nature.com/articles/s41591-025-03833-1 -
Nature Medicine
@NatureMedicine
Analyses from the largest neurodegeneration focused proteomics database - the Global Neurodegeneration Proteomics Consortium @_neuroproteome are published today in @NatureMedicine and @NatureAging
The findings reveal unique protein biomarkers that correlate with @neurodegenerative diseases and the @ageing process, and may help with the early detection, and improve outcomes, of major neurodegenerative diseases.
Read the collection here: www.nature.com/collections/ecegeajbhg -
Nature Medicine
@NatureMedicine
In the dose expansion cohort of this phase 1b trial, the EGFR x HER3 bispecific antibody-drug conjugate BL-B01D1 given to patients with metastatic esophageal squamous cell carcinoma led to encouraging clinical response rates that need to be confirmed in larger efficacy trials.
-
Nature Medicine
@NatureMedicine
In the MOBILIZE trial, exercise therapy improved patient reported QoL in individuals with multiple chronic conditions. Given the personal and societal burden of having multiple conditions, the findings can have significant clinical impact idp.nature.com/transit?redirect_uri=https%3A%2F%2Fwww.nat…
-
Nature Medicine reposted
EASO
@EASOobesity
An EASO publication in @NatureMedicine proposes a framework for diagnosing, staging & managing adult obesity. Prof. @busetto_luca highlights the need for comprehensive clinical evaluations beyond BMI.
easo.org/professor-luca-busetto-responds-to-the-new-easo-… -
Nature Medicine
@NatureMedicine
🍔🍩Is ultra-processed food worse for your health than regular junk food? Carrie Arnold @edbites asks the experts if food companies are designing products to make us overeat, even though obesity is our number one health problem. 🧁🍔
www.nature.com/articles/s41591-025-03796-3 -
Nature Medicine
@NatureMedicine
🏳️⚧️"The UK, USA and Brazil — three of the world’s largest democracies — have enacted or reinforced limits on gender-affirming care" say A. Saadeh and co-authors from @usponline. "This moment is a test of medicine’s commitment to evidence over ideology."🏳️⚧️
www.nature.com/articles/s41591-025-03805-5 -
Nature Medicine
@NatureMedicine
Jeffrey Friedman @RockefellerUniv recalls the heady excitement of the discovery of leptin 30 years ago -- a hormone that arrived in the middle of the night. Read all about the hormone that regulates your appetite here >> www.nature.com/articles/s41591-025-03797-2
-
Nature Medicine
@NatureMedicine
"It is extraordinary that menstrual periods remain taboo," write Hilary Critchley and colleagues, who argue that heavy menstrual bleeding contributes to anaemia and iron deficiency in women and girls and must no longer be ignored.
www.nature.com/articles/s41591-025-03778-5 -
Nature Medicine reposted
PATH
@PATHtweets
With research trials in Nigeria, Kenya & Rwanda, PATH & partners are addressing the striking lack of evidence on the use of #ai tools in African health settings.
More in @naturemedicine ➡️ www.nature.com/articles/s41591-025-03815-3
@keprecon @PendaHealth @c4ir_rw @ViamoGlobal @gatesfoundation -
Nature Medicine
@NatureMedicine
🌈 #pridemonth2025 is ending this week but the fight for LGBTQIA+ rights continues. David Kinitz and colleagues @stanford discuss the impact of defunded federal research on LGBTQIA+ research and communities🌈
www.nature.com/articles/s41591-025-03794-5 -
Nature Medicine reposted
Nan Liu, Duke-NUS
@nliulab
🌏 Advancing international partnership for governing generative #ai (#genai) models in #medicine and #healthcare. We introduce POLARIS-GM initiative: a scenario-based, consensus-driven framework for GenAI #governance and #regulation. @NatureMedicine
www.nature.com/articles/s41591-025-03787-4 -
Nature Medicine
@NatureMedicine
#stemcell therapies for #diabetes have entered the clinic; our latest Review summarizes the advances that got us here, lessons learned from early trials & the clinical, manufacturing & regulatory challenges that must now be overcome
@NUSingapore @UAlberta
www.nature.com/articles/s41591-025-03767-8 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Merging synthetic organic chemistry and biotechnology, researchers have engineered Escherichia coli that can synthesize small molecules (including paracetamol) from a plastic waste product. @NatureChemistry
www.nature.com/articles/d41591-025-00041-9 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Greater diversity of dietary flavonoid intake correlates with reduced all-cause mortality risk and chronic disease incidence among UK Biobank participants. @NatureFoodJnl
www.nature.com/articles/d41591-025-00040-w -
Nature Medicine
@NatureMedicine
A new study identifies a novel subset of mast cells that cross-present tumor antigens in triple-negative #breastcancer — and a pilot trial shows how these can be exploited in immunotherapy strategies. News & Views from Ignacio Melero et al @ClinicaNavarra
www.nature.com/articles/s41591-025-03740-5 -
Nature Medicine
@NatureMedicine
#virtualreality sports offer a novel, effective strategy to reduce fat mass and holistically promote health in adolescents with excess body weight. News & Views from Francisco Ortega and colleagues @CanalUGR
www.nature.com/articles/s41591-025-03757-w -
Nature Medicine reposted
Joseph Burclaff
@JosephBurclaff
A new paper discussing the importance of federal, institutional, and programmatic support for physician scientist trainees. The same can easily apply to biomedical trainees. We as a nation need to support the next generation of doctors and researchers! rdcu.be/etaiE
APSA
@A_P_S_A
A powerful new piece in @NatureMedicine by APSA past presidents & board members discusses how funding cuts could disrupt the physician-scientist pipeline and future of biomedical innovation, and outline urgent solutions to safeguard the next generation. rdcu.be/etaiE
-
Nature Medicine
@NatureMedicine
⚡Our June issue is live! Featuring new research on #polycysticovarysyndrome, #antimicrobialresistance, #ivf, antibocy-drug conjugates, bispecifics, #alzheimersdisease, #dementia, the infant #microboime, as well as Reviews, News & much more
Check it out: www.nature.com/nm/volumes/31/issues/6 -
Nature Medicine
@NatureMedicine
Insights into #tb heterogeneity are informing strategies for patient stratification & treatment shortening; our latest Review discusses the formidable challenge of treating this complex disease with strategies that can be implemented across global settings
www.nature.com/articles/s41591-025-03742-3 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Taking part in a structured #exercise program after adjuvant therapy reduced the risk of #coloncancer recurrence by 28% in a phase 3 trial — highlighting a powerful strategy for improving recovery and survival. #asco2025 @NEJM
www.nature.com/articles/d41591-025-00038-4 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Researchers develop a personalized base-editing therapy within 6 months for a newborn with a rare genetic disease — using rapid workflow that could be customized to other patients too. #genetherapy @NEJM
www.nature.com/articles/d41591-025-00037-5 -
Nature Medicine
@NatureMedicine
#climatechange is acting as a catalyst for #antimicrobialresistance — a new study provides valuable data to support health system strengthening to combat this, but more data and coordinated global action are needed.
News & Views from Kevin Tetteh @FINDdx
www.nature.com/articles/s41591-025-03705-8 -
Nature Medicine
@NatureMedicine
⭐Research highlight: In an ongoing phase 3 trial, treatment of #mash liver disease with #semaglutide brought about reductions in steatohepatitis and liver fibrosis, in addition to cardiometabolic benefits. #glp1
www.nature.com/articles/d41591-025-00034-8 -
Nature Medicine
@NatureMedicine
As presented at #asco25: Intracerebroventricular infusion of bivalent EGFR and IL13Rα2-targeting #cartcells in patients with recurrent #glioblastoma was well tolerated with 1 patient with a partial response and 1 patient with durable stable disease www.nature.com/articles/s41591-025-03745-0
-
Nature Medicine
@NatureMedicine
As presented at #asco25: In the phase 2 NeoCOAST-2 platform trial, neoadjuvant durvalumab + chemotherapy + a TROP2-targeting antibody-drug conjugate led to a high pathologic complete response rate in patients with resectable non-small cell #lungcancer www.nature.com/articles/s41591-025-03746-z
-
Nature Medicine
@NatureMedicine
As presented at #asco25: In the phase 3 CREST trial, the combination of subcutaneous sasanlimab, an anti-PD-1 inhibitor, with BCG induction and maintenance treatment significantly improved event-free survival vs. standard of care therapy www.nature.com/articles/s41591-025-03738-z
-
Nature Medicine
@NatureMedicine
As presented at #asco25: In the phase 2 TUXEDO-3 trial, patients with leptomeningeal metastatic disease from any solid tumor had encouraging 3 month overall survival after treatment with the HER3-targeting antibody-drug conjugate patritumab deruxtecan www.nature.com/articles/s41591-025-03744-1
-
Nature Medicine
@NatureMedicine
In the Tumor Profiler proof-of-concept observational study, a #multiomics approach for profiling tumors from patients with #melanoma was feasible, returning data within four weeks and informing treatment recommendations in 75% of cases.
www.nature.com/articles/s41591-025-03715-6 -
Nature Medicine
@NatureMedicine
⭐Research highlight: In a phase 2 trial, complete responses to #neoadjuvant #dostarlimab allowed most patients with early-stage mismatch repair-deficient solid tumors to avoid surgery, allowing preservation of affected organs. @NEJM
www.nature.com/articles/d41591-025-00033-9 -
Nature Medicine
@NatureMedicine
In a prospective study of asymptomatic individuals with average risk for cancer, a #multicancer early-detection test based on plasma cell-free DNA genomics and fragmentomics showed encouraging accuracy in identifying ongoing disease and tissue of origin.
www.nature.com/articles/s41591-025-03735-2 -
Nature Medicine
@NatureMedicine
New Review on #precisionnutrition
Marta Gausch Ferre, Jordi Merino & colleagues critically examine the evidence, the challenges in translating short-term studies into long-term clinical effectiveness, and opportunities ahead
@UCPH_Research @novonordiskfond
www.nature.com/articles/s41591-025-03669-9 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Three studies reveal elevated mitochondrial metabolism as a driver of #clonalhematopoiesis and suggest that targeting the former — for example, with metformin — could reduce the risk of associated diseases.
www.nature.com/articles/d41591-025-00032-w -
Nature Medicine
@NatureMedicine
⭐Research highlight: A modeling study predicts a resurgence of previously eliminated infectious diseases if current child #vaccination rates continue to fall — with #measles being the first to reach endemic levels. @JAMA_current
www.nature.com/articles/d41591-025-00031-x -
Nature Medicine
@NatureMedicine
⚡Our May issue is out! Our #futureofmedicine theme is food and nutrition (see our editorial and 2 reviews); we also have News, Opinion and new research on #airpollution, #aging, #diets, #ctdna, #mpox, #hiv, #glioblastoma, #alzheimersdisease & much more!
www.nature.com/nm/volumes/31/issues/5 -
Nature Medicine
@NatureMedicine
Integrated analysis of the KRASG12C inhibitor sotorasib clinical efficacy biomarkers show that low expression of TTF-1 and high expression of NRF2 determine antitumor efficacy of sotorasib in non-small cell #lungcancer. #nsclc
www.nature.com/articles/s41591-025-03732-5 -
Nature Medicine
@NatureMedicine
Post-hoc analysis of #ctdna levels from patients with metastatic prostate cancer treated with [177Lu]Lu-PSMA-617 or cabazitaxel, low ctDNA levels were predictive of clinical benefit, and PTEN or ATM alterations were potential biomarkers of response.
www.nature.com/articles/s41591-025-03704-9 -
Nature Medicine
@NatureMedicine
We are recruiting!
We are seeking a talented individual to join Nature Medicine’s international team to champion research in #ai, digital medicine and health informatics. The position is open for applicants in New York and Milan - deadline is May 30.
springernature.wd3.myworkdayjobs.com/SpringerNatureCareer… -
Nature Medicine
@NatureMedicine
In a first-in-human Phase 1/2 study in 7 patients with #sicklecelldisease, autologous HSC lentiviral #genetherapy using reduced intensity conditioning was considered feasible and safe, achieving 80% reduction in vaso-occlusive events
www.nature.com/articles/s41591-025-03662-2 -
Nature Medicine reposted
Vivek Subbiah, MD
@VivekSubbiah
🚨🥁Exciting Nature Medicine Publication Announcement
👉Hot off the press on this #clinicaltrialsday !
Thrilled to share our @NatureMedicine paper:
"Cancer treatment paradigms in the precision medicine era"
👉We propose 5 BOLD strategic recommendations to modernize cancer care-moving from one-size-fits-all to truly personalized interventions #precisionmedicine #cancerresearch #clinicaltrials #worldbeeday @curijoey @Dr_R_Kurzrock @JasonSicklick @united4cancer @OncoAlert @Nature @VincentRK @SaheliSadanand @JMinImmunoland
👉Please read our paper & share your comments
Link:
www.nature.com/articles/s41591-025-03711-w -
Nature Medicine
@NatureMedicine
Get your health boost @NatureMedicine! Reporter @anita_makri talked to researchers @j_artshealthlab and elsewhere about using the arts (dance, music, singing) to support better health. Go here -> www.nature.com/articles/s41591-025-03701-y
@Daisy_Fancourt #artsinhealth -
Nature Medicine
@NatureMedicine
Authors present results from the IMpower151 trial, they found the drug combination (which had previously been found to be effective in the Impower150 trial) was not significantly effective in a Chinese population.
www.nature.com/articles/s41591-025-03658-y -
Nature Medicine
@NatureMedicine
Analysis of the phase 3 PRODROME trial reveals that treatment with# ubrogepant during the prodromal phase of #migraine may ameliorate common prodromal symptoms, with improvements as early as 1 hour after dose administration
www.nature.com/articles/s41591-025-03679-7 -
Nature Medicine
@NatureMedicine
Health impacts of exposure to synthetic chemicals in food:
Our latest Review summarizes the sources, types & health effects of synthetic chemicals in foods (particularly #upfs), and regulatory shortcomings & research needs.
www.nature.com/articles/s41591-025-03697-5 -
Nature Medicine
@NatureMedicine
A promising phase 1 trial in patients with refractory #hodgkinlymphoma underscores the potential value of allogeneic natural killer (NK) #celltherapy guided by NK cell-specific engagers.
News & Views from Karl-Johan Malmberg, Ebba Sohlberg
www.nature.com/articles/s41591-025-03712-9 -
Nature Medicine
@NatureMedicine
28,841 individuals provided cardiac and liver MRI before being followed for a median of 4.3 years, detection of both liver and cardiac impairment by MRI was associated with cardiovascular and liver hospitalisations.
www.nature.com/articles/s41591-025-03654-2 -
Nature Medicine
@NatureMedicine
A combination of seroprevalence analyses and #modeling indicates that availability of an infection blocking CHIKV #vaccine would have prevented 88% of cases during an outbreak.
www.nature.com/articles/s41591-025-03684-w -
Nature Medicine
@NatureMedicine
In a trial examining #infant mental health service targeting birth and foster families of children aged 0-5 years, no differences in #mentalhealth of #children were found between multidisciplinary infant mental health team or social work services as usual
www.nature.com/articles/s41591-025-03534-9 -
Nature Medicine
@NatureMedicine
Just out: A standardized framework for amino acid #pet imaging of #brainmetastases – for use in clinical trials and eventually in clinical practice. #nmn2025 #rano #neurooncology @LMU_Muenchen @MedUni_Wien
www.nature.com/articles/s41591-025-03633-7 -
Nature Medicine
@NatureMedicine
Controlling #bloodpressure helps protect the brain from #dementia, according to a large, cluster-randomized trial.
Read the News & Views from Josef Coresh & colleagues @nyugrossman @AKUGlobal @NIH_NINDS
www.nature.com/articles/s41591-025-03694-8 -
Nature Medicine
@NatureMedicine
For recent and compelling examples of #microbiome based interventions that are ripe for clinical adoption, and discussion of challenges and opportunities facing the field, check out this review from Jack Gilbert and colleagues
@gilbertjacka
www.nature.com/articles/s41591-025-03615-9 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Two early-phase trials demonstrate the safety of #stemcell based therapies in patients with #parkinsonsdisease and suggest promising clinical activity — paving the way for larger efficacy studies. @Nature
www.nature.com/articles/d41591-025-00029-5 -
Nature Medicine
@NatureMedicine
A family-focused intervention for children in care takes a bold step toward filling the gap in quality evaluation of #childwelfare, but novel trial designs are needed in this complex field. News & Views from Bethany Kotlar, Henning Tiemeier @HarvardChanSPH
www.nature.com/articles/s41591-025-03643-5 -
Nature Medicine
@NatureMedicine
⭐Research highlight: #neonatal #antibiotic exposure was found to negatively impact #vaccine responses, probably mediated by decreased #bifidobacterium levels — which highlights potential strategies for enhancing vaccine efficacy in infants. @Nature
www.nature.com/articles/d41591-025-00028-6 -
Nature Medicine
@NatureMedicine
New Review on #precisionnutrition
Marta Gausch Ferre, Jordi Merino & colleagues critically examine the evidence, the challenges in translating short-term studies into long-term clinical effectiveness, and opportunities ahead
@UCPH_Research @novonordiskfond
www.nature.com/articles/s41591-025-03669-9 -
Nature Medicine
@NatureMedicine
This upcoming June, meet our editors at the Keystone Meeting on Climate Change & Infectious Diseases Threats #ksclimateid25 www.keystonesymposia.org/conferences/conference-listing/m…
-
Nature Medicine
@NatureMedicine
The new #spirit2025 statement provides updated guidance to authors, reviewers and editors, when preparing clinical trial protocols to enhance their transparency and completeness.
www.nature.com/articles/s41591-025-03668-w -
Nature Medicine
@NatureMedicine
⭐Research highlight: A polygenic risk score (#prs) for #prostatecancer, calculated using DNA from a saliva sample, led to the detection of more cancers than would have been found with standard screening pathways. @NEJM
www.nature.com/articles/d41591-025-00027-7 -
Nature Medicine
@NatureMedicine
Among 1,767 patients in 5 centers, a fully automated blood test showed high accuracy for Alzheimer’s pathology in secondary and primary care using a predefined cutoff.
www.nature.com/articles/s41591-025-03622-w -
Nature Medicine
@NatureMedicine
Intracytoplasmic sperm injection, usually reserved for cases of male infertility, was found to be non-superior to conventional in vitro fertilization in couples without male infertility concerns.
www.nature.com/articles/s41591-025-03621-x -
Nature Medicine
@NatureMedicine
An #ai screener for #opioid use disorder in hospitals could increase referrals to addiction services, but it is crucial that treatment is accessible and unintended harms such as stigma are avoided.
News & Views from Louisa Picco, Suzanne Nielsen @MonashUni
www.nature.com/articles/s41591-025-03673-z -
Nature Medicine
@NatureMedicine
⭐Research highlight: Despite a negative primary outcome, a trial of #gantenerumab showed a clinically meaningful slowing of disease onset in asymptomatic people with dominantly inherited #alzheimersdisease. @TheLancetNeuro
www.nature.com/articles/d41591-025-00026-8 -
Nature Medicine
@NatureMedicine
New data links social disadvantage to #proteomics signatures of #aging, helping to explain the association between social disparities and more than 60 age-related diseases. Read the News & Views from @PotenteCecilia @erasmusuni
www.nature.com/articles/s41591-025-03657-z -
Nature Medicine
@NatureMedicine
Results from the randomized ProfiLER-02 trial shows that a broader gene panel led to the identification of more molecular-based recommended therapies compared to a more limited gene panel. #precisionmedicine #oncology #genetictesting
www.nature.com/articles/s41591-025-03613-x -
Nature Medicine
@NatureMedicine
Analyses of single-cell transcriptomic data from patients with VEXAS syndrome combined with xenotransplant experiments in a mouse model of the disease provide insights on the mechanisms of clonal dominance of mutated cells leading to bone marrow failure.
www.nature.com/articles/s41591-025-03623-9 -
Nature Medicine
@NatureMedicine
In the OptiTROP-Breast01 phase 3 trial, patients with metastatic triple-negative breast cancer treated with sacituzumab tiristam had longer progression-free survival than those on chemotherapy. www.nature.com/articles/s41591-025-03630-w
-
Nature Medicine
@NatureMedicine
In a large trial involving 180 schools in different contexts in China, interactions with a chatbot provided to parents increased uptake and appointments for HPV vaccination, with stronger increases in rural areas.
www.nature.com/articles/s41591-025-03618-6 -
Nature Medicine
@NatureMedicine
A randomized crossover trial showed that transitions to a Western diet resulted in pro-inflammatory changes, whereas transition to African heritage diets rich in fruits and vegetables, legumes and fermented products led to opposite effects.
www.nature.com/articles/s41591-025-03602-0 -
Nature Medicine
@NatureMedicine
An #ai screener for #opioid use disorder in hospitals could increase referrals to addiction services, but it is crucial that treatment is accessible and unintended harms such as stigma are avoided.
News & Views from Louisa Picco, Suzanne Nielsen @MonashUni
www.nature.com/articles/s41591-025-03673-z -
Nature Medicine
@NatureMedicine
⚡Our April issue is out! Our #futureofmedicine theme this month is clinical #microbiome research, with 2 in-depth reviews; we have news & opinion and new research on #carmacrophage therapy, #baseediting, #ai, #telemedicine, #stemcelltherapy, #cfdna & more
www.nature.com/nm/volumes/31/issues/4 -
Nature Medicine
@NatureMedicine
Can AI-powered brain–computer interfaces boost human intelligence? The latest BCIs in pre-clinical testing receive — and send — signals, training the brains of participants. #braincomputerinterface #bci
News Feature from Paul Webster
www.nature.com/articles/s41591-025-03641-7 -
Nature Medicine
@NatureMedicine
In our latest Turning Points article, cancer biologist Johanna Joyce reflects on how, over a decade ago, disrupting tumor-associated macrophages showed the importance of the #tumormicroenvironment in treating #cancer — and what this has meant for the field
www.nature.com/articles/s41591-025-03636-4 -
Nature Medicine
@NatureMedicine
#consort 2025 is now out... providing updated guidance to authors, reviewers and editors on writing and evaluating manuscripts of randomized, controlled trials for clarity and transparency.
www.nature.com/articles/s41591-025-03635-5 -
Nature Medicine
@NatureMedicine
A map of microbiome-metabolome dynamics in people with diabetes type 2 identifies over 500 blood metabolites associated with impaired glucose control, with approximately one third linked to an altered gut microbiome.
www.nature.com/articles/s41591-025-03642-6 -
Nature Medicine
@NatureMedicine
Read our latest Review for recent and compelling examples of #microbiome based interventions that are ripe for clinical adoption, and discussion of challenges and opportunities facing the field. @gilbertjacka @CMIdigest
www.nature.com/articles/s41591-025-03615-9 -
Nature Medicine
@NatureMedicine
Intracytoplasmic sperm injection, usually reserved for cases of male infertility, was found to be non-superior to conventional in vitro fertilization in couples without male infertility concerns.
www.nature.com/articles/s41591-025-03621-x -
Nature Medicine
@NatureMedicine
What next for the #who?
The inaugural Investment Round aims to instill stability in the face of global health headwinds and a US exit.
Read our latest News Feature: www.nature.com/articles/s41591-025-03649-z -
Nature Medicine
@NatureMedicine
⭐Research highlight: The first pig liver to be transplanted into a human showed sustained function without rejection — marking another step toward #xenotransplantation as a viable solution to the organ-shortage crisis. @Nature
www.nature.com/articles/d41591-025-00025-9 -
Nature Medicine
@NatureMedicine
The #oncobiome network has generated novel tools to measure dysbiosis, and completed trials aimed at modifying the #microbiome to enhance #cancer treatment. Our latest Review from Laurence Zitvbogel & colleagues summarizes the key advances
@GustaveRoussy
www.nature.com/articles/s41591-025-03608-8 -
Nature Medicine
@NatureMedicine
Among 1,767 patients in 5 centers, a fully automated blood test showed high accuracy for Alzheimer’s pathology in secondary and primary care using a predefined cutoff.
www.nature.com/articles/s41591-025-03622-w -
Nature Medicine
@NatureMedicine
A trial in rural Pakistan showed that cognitive behavioral therapy by peers via a digital platform was non-inferior to community health workers in sustaining remission from perinatal depression over 6 months. www.nature.com/articles/s41591-025-03655-1
-
Nature Medicine
@NatureMedicine
In a large pragmatic trial across 74 sites in 2 US health systems, a real-time alert system for nurses cut mortality risk by 35.6%, also improving length of stay.
www.nature.com/articles/s41591-025-03609-7 -
Nature Medicine
@NatureMedicine
Plasma eMTBR-tau243 is a specific #biomarker of #tau tangles in #alzheimer’s disease and enables the detecting and tracking of Alzheimer’s clinical impairment. #neurodegenerativediseases #alzheimersawareness #biomarkers
www.nature.com/articles/s41591-025-03617-7 -
Nature Medicine
@NatureMedicine
The success of new #nonopioid drugs and other treatments for #pain offer some relief for sufferers.
Read the new Clinical Pipeine article from Mike May
www.nature.com/articles/d41591-025-00024-w -
Nature Medicine
@NatureMedicine
In the OptiTROP-Breast01 phase 3 trial, patients with metastatic triple-negative breast cancer treated with sacituzumab tiristam had longer progression-free survival than those on chemotherapy. www.nature.com/articles/s41591-025-03630-w
-
Nature Medicine
@NatureMedicine
In a unique cohort of twins followed from birth to 8 years of age, shotgun sequencing of stool samples reveals that the transmission, persistence and evolutionary adaptation of bacterial strains is structured by early-life diet and weaning. #microbiome
www.nature.com/articles/s41591-025-03610-0 -
Nature Medicine
@NatureMedicine
The ratio between levels of two synaptic proteins in cerebrospinal fluid predicts future cognitive resilience versus decline among presymptomatic & early #alzheimer’sDisease individuals harboring amyloid and tau pathology. #biomarkers @hammy_oh @wysscoray
www.nature.com/articles/s41591-025-03565-2 -
Nature Medicine
@NatureMedicine
In a phase 2 trial, patients with metastatic, treatment-refractory #gastrointestinal cancers responded to neoantigen-reactive tumor-infiltrating #lymphocytes, not bulk ones, showing promise for refined immune cell therapy. #immunetherapy #neoantigens
www.nature.com/articles/s41591-025-03627-5 -
Nature Medicine
@NatureMedicine
Whole #diets, whole health:
Studies of holistic dietary patterns and healthy #aging can build on insights from studies of individual nutrients, foods & diseases, with implications for #publichealth
News & Views from Eirini Trichia & colleagues @Oxford_NDPH
www.nature.com/articles/s41591-025-03646-2 -
Nature Medicine
@NatureMedicine
Results from a phase 3 randomized controlled trial suggest that escitalopram is not effective in treating agitation in Alzheimer's dementia and is associated with cardiac conduction delays.
www.nature.com/articles/s41591-025-03569-y -
Nature Medicine
@NatureMedicine
A pre-infusion inflammation biomarker signature predicts treatment failure in non-Hodgkin lymphoma patients treated with CAR T cell therapy, with inflammatory cluster assignment indicating clinical response and survival outcomes. @SSRaj017 @RShouval
www.nature.com/articles/s41591-025-03532-x -
Nature Medicine
@NatureMedicine
"Performance claims risk being tethered to narrow contexts rather than reflecting genuine scientific and translational impact" says Faisal Mahmood. Read now -> www.nature.com/articles/s41591-025-03637-3
@AI4Pathology @harvardmed -
Nature Medicine
@NatureMedicine
A map of microbiome-metabolome dynamics in people with diabetes type 2 identifies over 500 blood metabolites associated with impaired glucose control, with approximately one third linked to an altered gut microbiome.
www.nature.com/articles/s41591-025-03642-6 -
Nature Medicine
@NatureMedicine
An AI model defines a data-driven set of Total Parenteral Nutrition compositions to assist clinicians in personalized treatment of neonates in intensive care and is able to adapt recommendations to patient's status, with validation in external cohorts. www.nature.com/articles/s41591-025-03601-1
-
Nature Medicine
@NatureMedicine
A trial in rural Pakistan showed that cognitive behavioral therapy by peers via a digital platform was non-inferior to community health workers in sustaining remission from perinatal depression over 6 months. www.nature.com/articles/s41591-025-03655-1
-
Nature Medicine
@NatureMedicine
Combating #vaccine #revisionism:
In our latest editorial, we call on the scientific community to take a strong and active stand against the false narrative that there is insufficient evidence to support the safety and efficacy of vaccines.
Read it here: www.nature.com/articles/s41591-025-03682-y -
Nature Medicine
@NatureMedicine
In a large trial involving 180 schools in different contexts in China, interactions with a chatbot provided to parents increased uptake and appointments for HPV vaccination, with stronger increases in rural areas.
www.nature.com/articles/s41591-025-03618-6 -
Nature Medicine
@NatureMedicine
A panel of 9 Large language models examined simulated clinical cases with switched sociodemographic features, revealing differences in treatment, referral, and follow-up recommendations based on these factors.
www.nature.com/articles/s41591-025-03626-6 -
Nature Medicine
@NatureMedicine
Analyses of single-cell transcriptomic data from patients with VEXAS syndrome combined with xenotransplant experiments in a mouse model of the disease provide insights on the mechanisms of clonal dominance of mutated cells leading to bone marrow failure.
www.nature.com/articles/s41591-025-03623-9 -
Nature Medicine
@NatureMedicine
Results from the randomized ProfiLER-02 trial shows that a broader gene panel led to the identification of more molecular-based recommended therapies compared to a more limited gene panel. #precisionmedicine #oncology #genetictesting
www.nature.com/articles/s41591-025-03613-x -
Nature Medicine
@NatureMedicine
An interim analysis of a phase 1/2 trial shows that a new mRNA influenza and SARS-CoV-2 combination #vaccine is safe and triggers an encouraging immune response. www.nature.com/articles/s41591-025-03591-0
-
Nature Medicine
@NatureMedicine
Application of a nanopore sequencing workflow for real-time analysis of #braintumors results in molecular classification within a 30-minute intraoperative window, followed by comprehensive profiling within 24 hours.
www.nature.com/articles/s41591-025-03562-5 -
Nature Medicine
@NatureMedicine
In a unique cohort of twins followed from birth to 8 years of age, shotgun sequencing of stool samples reveals that the transmission, persistence and evolutionary adaptation of bacterial strains is structured by early-life diet and weaning. #microbiome
www.nature.com/articles/s41591-025-03610-0 -
Nature Medicine
@NatureMedicine
Alzheimer’s disease remains one of the most formidable challenges in medicine, requiring innovative strategies -- including AI -- to expedite the development of effective diagnostics and therapeutics.
www.nature.com/articles/s41591-025-03632-8 -
Nature Medicine
@NatureMedicine
Post-hoc analysis of molecular residual disease (MRD) from the ADAURA trial of adjuvant osimertinib in resected EGFR-mutated stage IB–IIIA non-small cell #lungcancer shows that MRD detection predicts disease recurrence with adjuvant osimertinib treatment.
www.nature.com/articles/s41591-025-03577-y -
Nature Medicine
@NatureMedicine
In a large pragmatic trial across 74 sites in 2 US health systems, a real-time alert system for nurses cut mortality risk by 35.6%, also improving length of stay.
www.nature.com/articles/s41591-025-03609-7 -
Nature Medicine
@NatureMedicine
How humans interact with mpox has changed across its entire endemic range, revealing the endemic and pandemic risk of monkeypox virus and the current knowledge gaps that hamper virus control. #monkeypox #diseasecontrol #globalhealth
www.nature.com/articles/s41591-025-03589-8 -
Nature Medicine
@NatureMedicine
A randomized crossover trial showed that transitions to a Western diet resulted in pro-inflammatory changes, whereas transition to African heritage diets rich in fruits and vegetables, legumes and fermented products led to opposite effects.
www.nature.com/articles/s41591-025-03602-0 -
Nature Medicine
@NatureMedicine
The TAILORED-AF trial used #ai -guided mapping to enhance catheter ablation in persistent #atrialfibrillation & demonstrated reductions in recurrent AF - but the net clinical benefit is unclear.
News & Views from @JonPicciniSr & @ZakLoringMD @DukeMedSchool
www.nature.com/articles/s41591-025-03611-z -
Nature Medicine
@NatureMedicine
The ratio between levels of two synaptic proteins in cerebrospinal fluid predicts future cognitive resilience versus decline among presymptomatic & early #alzheimer’sDisease individuals harboring amyloid and tau pathology. #biomarkers @hammy_oh @wysscoray
www.nature.com/articles/s41591-025-03565-2 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Foreign aid #sanctions reverse progress on child and #maternalhealth and increase mortality rates, according to an analysis of three decades’ worth of data from 113 countries. @LancetGH
www.nature.com/articles/d41591-025-00022-y -
Nature Medicine
@NatureMedicine
The role of distress in female sexual dysfunction during #menopause.
Correspondence from Lan Zhu & colleagues @UniMelb, Peking Union Medical College
www.nature.com/articles/s41591-025-03593-y -
Nature Medicine
@NatureMedicine
#climatechange is altering the frequency and intensity of weather-related hazards, which can harm #mentalhealth and wellbeing and thus elevate risks for suicidal behaviors.
Comment from Francis Vergunst & colleagues @mcgillu @unil University of Oslo
www.nature.com/articles/s41591-025-03528-7 -
Nature Medicine
@NatureMedicine
Plasma eMTBR-tau243 is a specific #biomarker of #tau tangles in #alzheimer’s disease and enables the detecting and tracking of Alzheimer’s clinical impairment. #neurodegenerativediseases #alzheimersawareness #biomarkers
www.nature.com/articles/s41591-025-03617-7 -
Nature Medicine
@NatureMedicine
Lessons from a detailed case report reveal avenues for research into #neoadjuvant combination #immunotherapy in newly diagnosed #glioblastoma.
Read the News & Views from @gelarehzadeh and @YosefEllenbogen
@MayoClinic @pmcancercentre
www.nature.com/articles/s41591-025-03607-9 -
Nature Medicine
@NatureMedicine
A pre-infusion inflammation biomarker signature predicts treatment failure in non-Hodgkin lymphoma patients treated with CAR T cell therapy, with inflammatory cluster assignment indicating clinical response and survival outcomes. @SSRaj017 @RShouval
www.nature.com/articles/s41591-025-03532-x -
Nature Medicine
@NatureMedicine
Conflict zones are plagued by #airpollution from warfare-related activities, which exacerbates #publichealth challenges, especially for vulnerable populations and the environments they live in.
Comment from Karen Cloete, Goran Bandov &Samer Abuzerr
@unisa
www.nature.com/articles/s41591-025-03594-x -
Nature Medicine
@NatureMedicine
In a phase 2 trial, patients with metastatic, treatment-refractory #gastrointestinal cancers responded to neoantigen-reactive tumor-infiltrating #lymphocytes, not bulk ones, showing promise for refined immune cell therapy. #immunetherapy #neoantigens
www.nature.com/articles/s41591-025-03627-5 -
Nature Medicine
@NatureMedicine
In two cohorts followed for 30 years, the associations of 8 different dietary patterns with healthy #aging - encompassing cognitive, physical and mental health - were studied, identifying food constituents linked to greater or lesser odds of healthy aging.
www.nature.com/articles/s41591-025-03570-5 -
Nature Medicine
@NatureMedicine
An AI model defines a data-driven set of Total Parenteral Nutrition compositions to assist clinicians in personalized treatment of neonates in intensive care and is able to adapt recommendations to patient's status, with validation in external cohorts.
www.nature.com/articles/s41591-025-03601-1 -
Nature Medicine
@NatureMedicine
Targeting #gdf-15 in cancer:
Recent, early-phase trials show positive effects on two very challenging aspects of cancer care — #immunotherapy response and #cachexia symptoms.
Read the News & Views from Jayesh Desai & colleagues @PeterMacCC
www.nature.com/articles/s41591-025-03557-2 -
Nature Medicine
@NatureMedicine
Geospatial modelling analyses in Malawi identified #hiv treatment deserts, clusters of communities with either very low or high levels of access to HIV treatment services, reflecting extreme geographic misalignment of healthcare resource allocation www.nature.com/articles/s41591-025-03561-6
-
Nature Medicine
@NatureMedicine
Rwanda’s science-led response to Marburg virus holds lessons for other outbreaks in Africa. Correspondence from @Dr_JeanKaseya @AfricaCDC and colleagues
-
Nature Medicine
@NatureMedicine
As part of Mobile WACh NEO, a parallel, randomized controlled trial at six health facilities across kenya, a text messaging communication intervention had no effect on neonatal mortality compared to standard of care.
www.nature.com/articles/s41591-025-03576-z -
Nature Medicine
@NatureMedicine
A transcriptomic atlas of the #endometrium of women with polycystic ovary syndrome uncovers both disease signatures and treatment responses. #pcos
www.nature.com/articles/s41591-025-03592-z -
Nature Medicine
@NatureMedicine
A global call to action for #disability #inclusion in health research.
Comment from Anna Anderson @UniversityLeeds and & colleagues around the globe.
@otago @BrighamWomens @StellenboschUni @uonbi @ifakarahealth
www.nature.com/articles/s41591-025-03587-w -
Nature Medicine
@NatureMedicine
⭐Research highlight: Using a novel #federatedlearning approach, organizations can pool resources to develop better drug-discovery #ai models — without sharing any private data. @NatMachIntell
www.nature.com/articles/d41591-025-00021-z -
Nature Medicine
@NatureMedicine
A new study provides a cross-trait atlas of genetic and phenotypic associations across 42 female reproductive health diagnoses. @genomicstartu #reproductivehealth
www.nature.com/articles/s41591-025-03543-8 -
Nature Medicine
@NatureMedicine
Improving scientific integrity in Chinese medical institutions with the Hospital Research Integrity Alliance. Comment from Guo Hua.
www.nature.com/articles/s41591-025-03595-w -
Nature Medicine
@NatureMedicine
Using implementation science to navigate the integration of genomics into healthcare. Comment from @ZornitzaS and colleagues at Australian Genomics @AusGenomics
www.nature.com/articles/s41591-025-03588-9 -
Nature Medicine
@NatureMedicine
In a large-scale, international multicenter phase 1/1b trial, treatment of patients with advanced solid tumors with the B7H3-targeting antibody-drug conjugate YL201 was safe and showed preliminary clinical efficacy.
www.nature.com/articles/s41591-025-03600-2 -
Nature Medicine
@NatureMedicine
Analyses from 5 cohorts show that individuals with social disadvantage, during both early and later life, have an increased risk of 56 age-related diseases mediated by 14 age-related proteins @MikaKivimaki
www.nature.com/articles/s41591-025-03563-4 -
Nature Medicine
@NatureMedicine
Results from a phase 3 randomized controlled trial suggest that escitalopram is not effective in treating agitation in Alzheimer's dementia and is associated with cardiac conduction delays.
www.nature.com/articles/s41591-025-03569-y -
Nature Medicine
@NatureMedicine
In a randomized phase 3 trial the combination of the the BET inhibitor pelabresib with the JAK inhibitor ruxolitinib resulted in a significantly higher spleen volume reduction from baseline versus placebo with ruxolitinib in patients with #myelofibrosis.
www.nature.com/articles/s41591-025-03572-3 -
Nature Medicine
@NatureMedicine
#h5n1 strain-specific antibodies are higher in older individuals and correlate more with birth year than with age, suggesting that younger individuals are potentially more likely to benefit from H5N1 #vaccination.
www.nature.com/articles/s41591-025-03599-6 -
Nature Medicine
@NatureMedicine
Application of a nanopore sequencing workflow for real-time analysis of #braintumors results in molecular classification within a 30-minute intraoperative window, followed by comprehensive profiling within 24 hours.
www.nature.com/articles/s41591-025-03562-5 -
Nature Medicine
@NatureMedicine
Nationwide implementation of stringent air #pollution prevention and monitoring policies in China was associated with reduced hospital admissions for cardiorespiratory and neuropsychiatric diseases over a period of 5 years. www.nature.com/articles/s41591-025-03515-y
-
Nature Medicine
@NatureMedicine
Analyses of the phase 3 CheckMate649 trial show that in patients with gastroesophageal cancer, KRAS alterations were associated with greater overall survival when treated with nivolumab plus chemotherapy vs chemotherapy alone. @yjanjigianMD @KoheiShitara www.nature.com/articles/s41591-025-03575-0
-
Nature Medicine
@NatureMedicine
In two cohorts followed for 30 years, the associations of 8 different dietary patterns with healthy #aging - encompassing cognitive, physical and mental health - were studied, identifying food constituents linked to greater or lesser odds of healthy aging.
www.nature.com/articles/s41591-025-03570-5 -
Nature Medicine
@NatureMedicine
A transcriptomic atlas of the #endometrium of women with polycystic ovary syndrome uncovers both disease signatures and treatment responses. #pcos
www.nature.com/articles/s41591-025-03592-z -
Nature Medicine
@NatureMedicine
Analyses of pre-transplant omic data from different cohorts of African American recipients found that genetic polymorphisms at the LILRB3 gene are associated with kidney graft loss. #kidneytransplant
www.nature.com/articles/s41591-025-03568-z -
Nature Medicine
@NatureMedicine
Single and multiple intravenous infusions with an allogeneic #celltherapy is safe in patients with mild #alzheimer’s disease and may reduce the impact of cognitive decline and brain atrophy within 9 months of treatment.
www.nature.com/articles/s41591-025-03559-0 -
Nature Medicine
@NatureMedicine
An interim analysis of a phase 1/2 trial shows that a new mRNA influenza and SARS-CoV-2 combination #vaccine is safe and triggers an encouraging immune response. www.nature.com/articles/s41591-025-03591-0
-
Nature Medicine
@NatureMedicine
Post-hoc analysis of molecular residual disease (MRD) from the ADAURA trial of adjuvant osimertinib in resected EGFR-mutated stage IB–IIIA non-small cell #lungcancer shows that MRD detection predicts disease recurrence with adjuvant osimertinib treatment.
www.nature.com/articles/s41591-025-03577-y -
Nature Medicine
@NatureMedicine
Making #llms into reliable physician assistants:
In their News & Views article, Sílvia Mamede and Henk Schmidt argue that future research should harness our understanding of the cognitive processes underlying clinical reasoning to optimize LLM utility.
www.nature.com/articles/s41591-025-03606-w -
Nature Medicine
@NatureMedicine
Two trials of pig kidneys in humans will test their long-term safety and efficacy, offering hope to thousands of patients on dialysis.
Read the latest Clinical Pipeline, by @NatalieHealey #xenotransplantation
www.nature.com/articles/d41591-025-00020-0 -
Nature Medicine
@NatureMedicine
A randomized clinical trial shows the superiority of behavioral treatment plus phentermine to behavioral treatment plus placebo for weight loss, in those that previously had not responded to behavioral treatment.
www.nature.com/articles/s41591-025-03556-3 -
Nature Medicine
@NatureMedicine
The PREPARED case study app for deep reflection on research ethics challenges during crises. Correspondence from Doris Schroeder & Colleagues @PreparedEU
www.nature.com/articles/s41591-025-03549-2 -
Nature Medicine
@NatureMedicine
⭐Research highlight: #bacterialvaginosis is not just a woman’s problem; according to a new study, treating male partners resulted in significantly lower recurrence rates than treating women only. @NEJM
www.nature.com/articles/d41591-025-00019-7 -
Nature Medicine
@NatureMedicine
The updated analysis of the DYNAMIC biomarker-driven trial, including mature survival data at 5 years, supports a ctDNA-guided approach to adjuvant chemotherapy for stage II #coloncancer
@JeanneTie @PeterMacCC
www.nature.com/articles/s41591-025-03579-w -
Nature Medicine
@NatureMedicine
Geospatial modelling analyses in Malawi identified #hiv treatment deserts, clusters of communities with either very low or high levels of access to HIV treatment services, reflecting extreme geographic misalignment of healthcare resource allocation www.nature.com/articles/s41591-025-03561-6
-
Nature Medicine
@NatureMedicine
Spatial transcriptomics reveals distinct microglial mechanisms driving amyloid-β clearance in both passive and actively immunized #alzheimer’s disease patients @NUFeinbergMed
www.nature.com/articles/s41591-025-03574-1 -
Nature Medicine
@NatureMedicine
Nationwide implementation of stringent air #pollution prevention and monitoring policies in China was associated with reduced hospital admissions for cardiorespiratory and neuropsychiatric diseases over a period of 5 years. www.nature.com/articles/s41591-025-03515-y
-
Nature Medicine
@NatureMedicine
A study using #smartwatches to track and analyze cognitive health over 18 months in more than 23,000 US adults demonstrates the feasibility of remote cognitive health monitoring and uncovers potential methods for early detection of cognitive decline.
www.nature.com/articles/s41591-024-03475-9 -
Nature Medicine
@NatureMedicine
Cerebrospinal fluid circulating tumour DNA profiling had prognostic value in a cohort of 584 patients with lung cancer and CNS metastases, and could be used to personalize therapies
www.nature.com/articles/s41591-025-03538-5 -
Nature Medicine
@NatureMedicine
⚡Our March issue is live! This months' #futoreofmedicine theme is #diversity and diversifying health data; we have we have reviews, news & opionion and new research on #sleep, #malaria, #huntingtonsdisease, #parkinsonsdisease, #llms, #cartcells, & more.
www.nature.com/nm/volumes/31/issues/3 -
Nature Medicine
@NatureMedicine
Analyses from 5 cohorts show that individuals with social disadvantage, during both early and later life, have an increased risk of 56 age-related diseases mediated by 14 age-related proteins @MikaKivimaki
www.nature.com/articles/s41591-025-03563-4 -
Nature Medicine
@NatureMedicine
#h5n1 strain-specific antibodies are higher in older individuals and correlate more with birth year than with age, suggesting that younger individuals are potentially more likely to benefit from H5N1 #vaccination.
www.nature.com/articles/s41591-025-03599-6 -
Nature Medicine
@NatureMedicine
Multi-omic single-cell and spatial analyses of lung cancer brain metastases from multiple cohorts identify high levels of chromosomal instability and a neural-like profile in metastases compared to primary tumors
www.nature.com/articles/s41591-025-03530-z -
Nature Medicine
@NatureMedicine
Using longitudinal survey and neuroimaging data from more than 11,000 adolescents in the US, a machine learning model shows promising performance in identifying individuals at greater risk of transitioning to psychopathology.
www.nature.com/articles/s41591-025-03560-7 -
Nature Medicine
@NatureMedicine
In a large-scale, international multicenter phase 1/1b trial, treatment of patients with advanced solid tumors with the B7H3-targeting antibody-drug conjugate YL201 was safe and showed preliminary clinical efficacy.
www.nature.com/articles/s41591-025-03600-2 -
Nature Medicine
@NatureMedicine
MethyLYZR, an epigenetic classifier of brain tumors, provides clinically relevant cancer classification results within 15 minutes of sequencing, with potential applications for neurosurgical intraoperative use
www.nature.com/articles/s41591-024-03435-3 -
Nature Medicine
@NatureMedicine
A new algorithm combined with ultrasound imaging allows for the quantification of kidney quality before transplantation, potentially helping to alleviate global demand for #kidney #transplantation.
www.nature.com/articles/s41591-024-03417-5 -
Nature Medicine
@NatureMedicine
As part of Mobile WACh NEO, a parallel, randomized controlled trial at six health facilities across kenya, a text messaging communication intervention had no effect on neonatal mortality compared to standard of care.
www.nature.com/articles/s41591-025-03576-z -
Nature Medicine
@NatureMedicine
Secondary analyses of the phase 3 NRG GY018 trial show that in patients with advanced #endometrialcancer, firstline treatment with pembrolizumab and paclitaxel/carboplatin leads to prolonged progression free survival by blinded independent central review www.nature.com/articles/s41591-025-03566-1
-
Nature Medicine
@NatureMedicine
In acutely brain injured patients, well-formed sleep spindles on EEG were more likely present in patients with cognitive motor dissociation, were associated with a shorter time to recovery of consciousness and predicted recovery of independence.
www.nature.com/articles/s41591-025-03578-x -
Nature Medicine
@NatureMedicine
Women are twice as likely to develop #alzheimersdisease as men — but scientists do not know why.
Read our latest News Feature from @sofiamoutinhoBR
www.nature.com/articles/s41591-025-03564-3 -
Nature Medicine
@NatureMedicine
Clinics, communities and cities can act as real-world testbeds to understand the human #exposome and what drives healthspan, resilience and flourishing.
Comment from @TinaWoods David Furman & colleagues @BuckInstitute @NUSMedicine @KingsCollegeLon
www.nature.com/articles/s41591-025-03519-8 -
Nature Medicine
@NatureMedicine
A new study provides a cross-trait atlas of genetic and phenotypic associations across 42 female reproductive health diagnoses. @genomicstartu #reproductivehealth
www.nature.com/articles/s41591-025-03543-8 -
Nature Medicine
@NatureMedicine
The Rare Therapies Launchpad: a pilot program for individualized medicines in the UK. Correspondence from Daniel O’Connor, Julia Vitarello and colleagues
@GenomicsEngland @UniofOxford @BostonChildrens Mila’s Miracle Foundation
www.nature.com/articles/s41591-025-03547-4 -
Nature Medicine
@NatureMedicine
In a randomized phase 3 trial the combination of the the BET inhibitor pelabresib with the JAK inhibitor ruxolitinib resulted in a significantly higher spleen volume reduction from baseline versus placebo with ruxolitinib in patients with #myelofibrosis.
www.nature.com/articles/s41591-025-03572-3 -
Nature Medicine
@NatureMedicine
⭐Research highlight: The @LancetGH Commission on medical oxygen security highlights catastrophic failures of governments and other stakeholders to provide equitable access to this lifesaving resource, and sets out recommendations to close the gap.
www.nature.com/articles/d41591-025-00018-8 -
Nature Medicine
@NatureMedicine
Jordan eliminates leprosy disease and moves to post-elimination surveillance.
Correspondence from Vivek Lal, Feras Ibrahim Hawari & colleagues @WHO
www.nature.com/articles/s41591-024-03488-4 -
Nature Medicine
@NatureMedicine
A multinational randomized trial shows that task-sharing via nonspecialist providers and the use of telemedicine platforms are noninferior to specialists and in-person models for treating perinatal depression
www.nature.com/articles/s41591-024-03482-w -
Nature Medicine
@NatureMedicine
Analyses of pre-transplant omic data from different cohorts of African American recipients found that genetic polymorphisms at the LILRB3 gene are associated with kidney graft loss. #kidneytransplant
www.nature.com/articles/s41591-025-03568-z -
Nature Medicine
@NatureMedicine
Single and multiple intravenous infusions with an allogeneic #celltherapy is safe in patients with mild #alzheimer’s disease and may reduce the impact of cognitive decline and brain atrophy within 9 months of treatment.
www.nature.com/articles/s41591-025-03559-0 -
Nature Medicine
@NatureMedicine
The updated analysis of the DYNAMIC biomarker-driven trial, including mature survival data at 5 years, supports a ctDNA-guided approach to adjuvant chemotherapy for stage II #coloncancer
@JeanneTie @PeterMacCC
www.nature.com/articles/s41591-025-03579-w -
Nature Medicine
@NatureMedicine
A randomized clinical trial shows the superiority of behavioral treatment plus phentermine to behavioral treatment plus placebo for weight loss, in those that previously had not responded to behavioral treatment.
www.nature.com/articles/s41591-025-03556-3 -
Nature Medicine
@NatureMedicine
Leveraging #implementationscience in clinical trials of #vaccines in the global south.
Correspondence from @DrAAdamu @CharlesShey and Duduzile Ndwandwe @MRCza @WHOAFRO
www.nature.com/articles/s41591-025-03546-5 -
Nature Medicine
@NatureMedicine
⭐Research highlight: An N-of-1 study suggests that #prenatal therapy for spinal muscular atrophy — enabled by transplacental passage of #risdiplam from mother to fetus — could help prevent symptom onset before birth. @NEJM
www.nature.com/articles/d41591-025-00017-9 -
Nature Medicine
@NatureMedicine
Analyses of the phase 3 CheckMate649 trial show that in patients with gastroesophageal cancer, KRAS alterations were associated with greater overall survival when treated with nivolumab plus chemotherapy vs chemotherapy alone. @yjanjigianMD @KoheiShitara www.nature.com/articles/s41591-025-03575-0
-
Nature Medicine
@NatureMedicine
Advancing clinical genomics with Middle Eastern and South Asian pangenomes.
Comment from Mohammed Uddin, Alawi Alsheikh-Ali and colleagues @MBRUniversity @birminghamdubai
www.nature.com/articles/s41591-025-03544-7 -
Nature Medicine
@NatureMedicine
Global analyses of breast cancer incidence and mortality show that only 13 countries are currently meeting the targets of the WHO global breast cancer initiative in reducing breast cancer mortality
www.nature.com/articles/s41591-025-03502-3 -
Nature Medicine
@NatureMedicine
The unseen climate health risks of antimicrobial resistance in urban informal settlements.
Correspondence from Karin Leder and colleagues @MonashUni -
Nature Medicine
@NatureMedicine
⭐Research highlight: A machine learning framework — trained on B cell and T cell receptor sequences from thousands of people — can detect a range of infectious and autoimmune diseases. @ScienceMagazine
www.nature.com/articles/d41591-025-00016-w -
Nature Medicine
@NatureMedicine
Five ways to enhance the diversity and quality of health data.
Comment from @kamleshkhunti and colleagues at @HDR_UK @uniofleicester
www.nature.com/articles/s41591-025-03545-6 -
Nature Medicine
@NatureMedicine
A patient with newly diagnosed glioblastoma was safely treated with neoadjuvant agents prior to maximal resection, with no definitive evidence of recurrence at 17 months post-treatment @ProfGLongMIA @HelenRizos @Sydney_Uni @MelanomaAus @Macquarie_Uni
www.nature.com/articles/s41591-025-03512-1 -
Nature Medicine
@NatureMedicine
An analysis of a patient with multiple myeloma who developed peripheral T cell lymphoma after CAR-T treatment reveals that two mutated CAR+ CD8+ T cell clones are likely drivers of the neoplasm
www.nature.com/articles/s41591-025-03499-9 -
Nature Medicine
@NatureMedicine
Past migrations and environmental exposures have influenced human genomic #diversity; understanding and contextualizing this diversity is crucial to advancing #precisionmedicine & equitable healthcare.
Review from @mashaals @ccg_unam
www.nature.com/articles/s41591-025-03558-1 -
Nature Medicine
@NatureMedicine
A cluster randomised trial shows that telemedicine-based, village-doctor led delivery of integrated care reduced the occurrence of adverse cardiovascular events and hospitalisations in older adults with atrial fibrillation.
www.nature.com/articles/s41591-025-03511-2 -
Nature Medicine
@NatureMedicine
DNA sequencing offers opportunities for expanding #newbornscreening for treatable conditions affecting children; pilot studies will be critical to refining key parameters for scalability & optimal outcomes.
News & Views from @WendyKChung @BostonChildrens
www.nature.com/articles/s41591-025-03567-0 -
Nature Medicine
@NatureMedicine
Spatial transcriptomics reveals distinct microglial mechanisms driving amyloid-β clearance in both passive and actively immunized #alzheimer’s disease patients @NUFeinbergMed
www.nature.com/articles/s41591-025-03574-1 -
Nature Medicine
@NatureMedicine
Secondary analyses of the phase 3 NRG GY018 trial show that in patients with advanced #endometrialcancer, firstline treatment with pembrolizumab and paclitaxel/carboplatin leads to prolonged progression free survival by blinded independent central review www.nature.com/articles/s41591-025-03566-1
-
Nature Medicine
@NatureMedicine
Using longitudinal survey and neuroimaging data from more than 11,000 adolescents in the US, a machine learning model shows promising performance in identifying individuals at greater risk of transitioning to psychopathology.
www.nature.com/articles/s41591-025-03560-7 -
Nature Medicine
@NatureMedicine
Based on a systematic analysis of environmental exposures associated with aging and mortality in the UK Biobank, a study compares the relative contributions of such exposures and genetic risk for mortality and a range of age-related diseases
www.nature.com/articles/s41591-024-03483-9 -
Nature Medicine
@NatureMedicine
A study using #smartwatches to track and analyze cognitive health over 18 months in more than 23,000 US adults demonstrates the feasibility of remote cognitive health monitoring and uncovers potential methods for early detection of cognitive decline.
www.nature.com/articles/s41591-024-03475-9 -
Nature Medicine
@NatureMedicine
A new algorithm combined with ultrasound imaging allows for the quantification of kidney quality before transplantation, potentially helping to alleviate global demand for #kidney #transplantation.
www.nature.com/articles/s41591-024-03417-5 -
Nature Medicine
@NatureMedicine
In acutely brain injured patients, well-formed sleep spindles on EEG were more likely present in patients with cognitive motor dissociation, were associated with a shorter time to recovery of consciousness and predicted recovery of independence.
www.nature.com/articles/s41591-025-03578-x -
Nature Medicine
@NatureMedicine
A multinational randomized trial shows that task-sharing via nonspecialist providers and the use of telemedicine platforms are noninferior to specialists and in-person models for treating perinatal depression
www.nature.com/articles/s41591-024-03482-w -
Nature Medicine
@NatureMedicine
In a follow-up of a phase 1 trial of a first generation CAR-T cell therapy in patients with neuroblastoma, 1 patient has had a sustained clinical response for over 18 years without requiring any additional therapy @MDKevinCHLi, @CAGTHouston @bcmHouston
www.nature.com/articles/s41591-025-03513-0 -
Nature Medicine
@NatureMedicine
The case for investing in global genomic medicine.
World View from Mie Rizig @ucl
www.nature.com/articles/s41591-024-03461-1 -
Nature Medicine
@NatureMedicine
Multi-omic single-cell and spatial analyses of lung cancer brain metastases from multiple cohorts identify high levels of chromosomal instability and a neural-like profile in metastases compared to primary tumors
www.nature.com/articles/s41591-025-03530-z -
Nature Medicine
@NatureMedicine
MethyLYZR, an epigenetic classifier of brain tumors, provides clinically relevant cancer classification results within 15 minutes of sequencing, with potential applications for neurosurgical intraoperative use
www.nature.com/articles/s41591-024-03435-3 -
Nature Medicine
@NatureMedicine
Cerebrospinal fluid circulating tumour DNA profiling had prognostic value in a cohort of 584 patients with lung cancer and CNS metastases, and could be used to personalize therapies
www.nature.com/articles/s41591-025-03538-5 -
Nature Medicine
@NatureMedicine
A patient with newly diagnosed glioblastoma was safely treated with neoadjuvant agents prior to maximal resection, with no definitive evidence of recurrence at 17 months post-treatment @ProfGLongMIA @HelenRizos @Sydney_Uni @MelanomaAus @Macquarie_Uni
www.nature.com/articles/s41591-025-03512-1 -
Nature Medicine
@NatureMedicine
A report from the Australian Acute Care Genomics programme shows that the integration of rapid whole genome sequencing and multiomic analyses informs diagnoses and treatment decisions in a prospective cohort of 290 critically ill infants.
#rarediseaseday
www.nature.com/articles/s41591-023-02401-9 -
Nature Medicine
@NatureMedicine
In a randomized controlled trial in individuals with persistent atrial fibrillation, an individualized ablation procedure informed by AI led to improved efficacy for reducing arrhythmia recurrence
www.nature.com/articles/s41591-025-03517-w -
Nature Medicine
@NatureMedicine
Today is #rarediseaseday !
Check out this report on long-term and real-world safety and efficacy of gene therapy for adenosine deaminase deficiency www.nature.com/articles/s41591-023-02789-4 -
Nature Medicine
@NatureMedicine
Today is #rarediseaseday
Check out this report of the LUMINA trial testing an activin A monoclonal antibody for fibrodysplasia ossificans progressiva www.nature.com/articles/s41591-023-02561-8 -
Nature Medicine
@NatureMedicine
A personalized antisense oligonucleotide developed for a single patient was well tolerated and led to preliminary improvements in mobility and behavioural arrests in a girl with KIF1A-associated neurological disorder.
#rarediseaseday
www.nature.com/articles/s41591-024-03197-y -
Nature Medicine
@NatureMedicine
This study from the European Solve-Rare Diseases consortium presented a diagnostic framework including omics analyses coupled with expert panel review, leading to 500 new diagnoses in a cohort of 6000 families with suspected rare diseases. #rarediseaseday
www.nature.com/articles/s41591-024-03420-w -
Nature Medicine
@NatureMedicine
⭐Research highlight: In a phase 2 registrational trial, #bispecificantibody zenocutuzumab showed durable anti-tumor activity across several NRG1 fusion-positive #cancer types, providing a new treatment for patients with few alternative options. @NEJM
www.nature.com/articles/d41591-025-00015-x -
Nature Medicine
@NatureMedicine
By simulating the implementation of airport-based wastewater surveillance sites at global level, a modelling study shows how this early warning system would perform in identifying sources of pandemic outbreaks @stonge_g @alexvespi
www.nature.com/articles/s41591-025-03501-4 -
Nature Medicine
@NatureMedicine
Genomic and epidemiologic data suggest that the rapid spread of MPox Clade I in the Democratic Republic of the Congo has happened mostly through sexual contact within densely populated areas
www.nature.com/articles/s41591-025-03582-1 -
Nature Medicine
@NatureMedicine
Two novel phosphorylation sites, p-tau262 and p-tau356, detect the formation of pre-fibrillar tau aggregates and may serve as an early-stage plasma biomarker of tau pathology @tommykakari @PittPsychiatry @pedrorosaneto
www.nature.com/articles/s41591-024-03400-0 -
Nature Medicine
@NatureMedicine
Epigenetic editing of PCSK9 in the liver, designed to induce DNA methylation and silence gene expression, achieved long-lasting reductions in LDL-cholesterol levels in both transgenic mice expressing the human PCSK9 gene and cynomolgus monkeys
www.nature.com/articles/s41591-025-03508-x -
Nature Medicine
@NatureMedicine
A rare case of asymptomatic dominantly inherited Alzheimer's reveals confined tau pathology and unique proteomic features, highlighting potential resilience mechanisms decades beyond expected onset @WashUMedADRC @jorgellibre
www.nature.com/articles/s41591-025-03494-0 -
Nature Medicine
@NatureMedicine
In a large-scale analysis of ambulatory electrocardiographic recordings, a deep learning algorithm had a substantially higher sensitivity for detection of critical arrhythmias as compared to technicians
www.nature.com/articles/s41591-025-03516-x -
Nature Medicine
@NatureMedicine
Our genetics editor Anna Ranzoni will be at the #ksgenomeeng25 conference in Killarney next week - get in touch with her if you'd like to talk about publishing your work! keysym.us/KSGenomeEng25
-
Nature Medicine
@NatureMedicine
In a first-in-human phase 1 trial, HER2-specific CAR-macrophages were feasible to manufacture and well tolerated with no dose-limiting toxicities in patients with HER2-overexpressing solid tumors
www.nature.com/articles/s41591-025-03495-z -
Nature Medicine
@NatureMedicine
Using an electronic system for symptom monitoring of patient-reported outcomes during treatment led to sustained improvements in emergency visits, quality of life and delayed deterioration of physical function in patients with metastatic cancer
www.nature.com/articles/s41591-025-03507-y -
Nature Medicine
@NatureMedicine
A randomized controlled trial showed that a home-based, telemedicine supported lifestyle intervention reported improved glycemic control after 6 months in patients with coronary heart disease and type 2 diabetes compared to usual care
www.nature.com/articles/s41591-025-03498-w -
Nature Medicine
@NatureMedicine
Safe AI-enabled digital health technologies need built-in open feedback.
Comment from Stephen Gilbert and colleagues, TUD Dresden University of Technology.
www.nature.com/articles/s41591-024-03397-6 -
Nature Medicine
@NatureMedicine
Global analyses of breast cancer incidence and mortality show that only 13 countries are currently meeting the targets of the WHO global breast cancer initiative in reducing breast cancer mortality
www.nature.com/articles/s41591-025-03502-3 -
Nature Medicine
@NatureMedicine
Addressing maternal and infant health inequities requires improved birth record data collection.
Correspondence from Farah Kader and colleagues New York University Grossman School of Medicine.
www.nature.com/articles/s41591-024-03472-y -
Nature Medicine
@NatureMedicine
The medical crisis of war-injured children in Gaza and Lebanon.
Correspondence from Samar Al-Hajj and colleagues, American University of Beirut, Beirut, Lebanon.
www.nature.com/articles/s41591-024-03474-w -
Nature Medicine
@NatureMedicine
The case for investing in global genomic medicine.
World View from Mie Rizig @ucl
www.nature.com/articles/s41591-024-03461-1 -
Nature Medicine
@NatureMedicine
In the phase 3 CEPHEUS trial, patients with multiple myeloma were treated with subcutaneous daratumumab plus bortezomib, lenalidomide and dexamethasone, which led to a deeper and more durable increase in minimal residual disease responses @szusmani
www.nature.com/articles/s41591-024-03485-7 -
Nature Medicine
@NatureMedicine
Improved muscle function, strength and fatigue measures were observed electrical spinal cord stimulation in individuals with spinal muscular atrophy @scottensel @dona_sere @MCapogrosso, @ElviraPirondini
www.nature.com/articles/s41591-024-03484-8 -
Nature Medicine
@NatureMedicine
In a prospective study involving 92 physicians from multiple institutions, access to large language model assistance on top of conventional resources increased the quality of their reasoning in addressing patient care
www.nature.com/articles/s41591-024-03456-y -
Nature Medicine
@NatureMedicine
Pyrolysis gas chromatography-mass spectrometry reveals the presence of micro- and nanoplastics in human kidney, liver, and brain tissue samples from 2016 and 2024, with higher proportions found in the brain
www.nature.com/articles/s41591-024-03453-1 -
Nature Medicine
@NatureMedicine
The MI-CLAIM-GEN checklist for generative artificial intelligence in health.
Comment from Brenda Miao and colleagues, University of California, San Francisco.
www.nature.com/articles/s41591-024-03470-0 -
Nature Medicine
@NatureMedicine
New neurons are born in the adult human brain.
Turning Points from Rusty Gage, reflecting on his 1998 Nature Medicine paper, as part of our 30th anniverary series.
www.nature.com/articles/s41591-025-03497-x -
Nature Medicine
@NatureMedicine
US aid cuts are an opportunity to reimagine global health.
World View from Ntobeko Ntusi, South African Medical Research Council.
www.nature.com/articles/d41591-025-00009-9 -
Nature Medicine
@NatureMedicine
A new Review discusses the landscape of biomedical #hiv prevention technologies for women in Africa – who bear a disproportionate burden of new infections – and the cost-effectiveness, implementation & financing of these tools
@CeSHHAR @MaryamShJ @LSTMnews
www.nature.com/articles/s41591-025-03535-8 -
Nature Medicine
@NatureMedicine
⭐Research highlight: The CheckMate 8HW trial shows superior outcomes with nivolumab + ipilimumab (compared with nivolumab monotherapy) in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer. @TheLancet
www.nature.com/articles/d41591-025-00014-y -
Nature Medicine
@NatureMedicine
⭐Research highlight: Heart muscle grafts engineered from induced pluripotent #stemcells enhanced cardiac function in rhesus macaques with #heartfailure, while encouraging data from a single patient support ongoing clinical evaluation. @Nature
www.nature.com/articles/d41591-025-00013-z -
Nature Medicine
@NatureMedicine
An analysis of a patient with multiple myeloma who developed peripheral T cell lymphoma after CAR-T treatment reveals that two mutated CAR+ CD8+ T cell clones are likely drivers of the neoplasm
www.nature.com/articles/s41591-025-03499-9 -
Nature Medicine
@NatureMedicine
A cluster randomised trial shows that telemedicine-based, village-doctor led delivery of integrated care reduced the occurrence of adverse cardiovascular events and hospitalisations in older adults with atrial fibrillation.
www.nature.com/articles/s41591-025-03511-2 -
Nature Medicine
@NatureMedicine
⚡Our February issue is out! Our #futureofmedicine theme is the burden of #neurodegenerativediseases; we have reviews, news, opionion as well as new research on #neoadjuvant #immunotherapy, #raredisease #genomics, #baseediting, #xenotransplantation & more!
www.nature.com/nm/volumes/31/issues/2 -
Nature Medicine
@NatureMedicine
Based on a systematic analysis of environmental exposures associated with aging and mortality in the UK Biobank, a study compares the relative contributions of such exposures and genetic risk for mortality and a range of age-related diseases
www.nature.com/articles/s41591-024-03483-9 -
Nature Medicine
@NatureMedicine
One of our Deputy Editors, Liam Messin, will be attending the joint Obesity and MASH Keystone meetings in Banff from Feb 23 – 26 keysym.us/KSObesity25 + keysym.us/KSMASH25 #ksobesity25 + KSMASH25 (1/2)
Nature Medicine
@NatureMedicine
Please get in touch if you would like to discuss any work you think may be appropriate for Nature Medicine at the conference.
-
Nature Medicine
@NatureMedicine
Safe AI-enabled digital health technologies need built-in open feedback.
Comment from Stephen Gilbert and colleagues, TUD Dresden University of Technology.
www.nature.com/articles/s41591-024-03397-6 -
Nature Medicine
@NatureMedicine
In a follow-up of a phase 1 trial of a first generation CAR-T cell therapy in patients with neuroblastoma, 1 patient has had a sustained clinical response for over 18 years without requiring any additional therapy @MDKevinCHLi, @CAGTHouston @bcmHouston
www.nature.com/articles/s41591-025-03513-0 -
Nature Medicine
@NatureMedicine
Addressing maternal and infant health inequities requires improved birth record data collection.
Correspondence from Farah Kader and colleagues New York University Grossman School of Medicine.
www.nature.com/articles/s41591-024-03472-y -
Nature Medicine
@NatureMedicine
The medical crisis of war-injured children in Gaza and Lebanon.
Correspondence from Samar Al-Hajj and colleagues, American University of Beirut, Beirut, Lebanon.
www.nature.com/articles/s41591-024-03474-w -
Nature Medicine
@NatureMedicine
The case for investing in global genomic medicine.
World View from Mie Rizig @ucl
www.nature.com/articles/s41591-024-03461-1 -
Nature Medicine
@NatureMedicine
The MI-CLAIM-GEN checklist for generative artificial intelligence in health.
Comment from Brenda Miao and colleagues, University of California, San Francisco.
www.nature.com/articles/s41591-024-03470-0 -
Nature Medicine
@NatureMedicine
New neurons are born in the adult human brain.
Turning Points from Rusty Gage, reflecting on his 1998 Nature Medicine paper, as part of our 30th anniverary series.
www.nature.com/articles/s41591-025-03497-x -
Nature Medicine
@NatureMedicine
US aid cuts are an opportunity to reimagine global health.
World View from Ntobeko Ntusi, South African Medical Research Council.
www.nature.com/articles/d41591-025-00009-9 -
Nature Medicine
@NatureMedicine
In a randomized controlled trial in individuals with persistent atrial fibrillation, an individualized ablation procedure informed by AI led to improved efficacy for reducing arrhythmia recurrence
www.nature.com/articles/s41591-025-03517-w -
Nature Medicine
@NatureMedicine
A new Review discusses the landscape of biomedical #hiv prevention technologies for women in Africa – who bear a disproportionate burden of new infections – and the cost-effectiveness, implementation & financing of these tools
@CeSHHAR @MaryamShJ @LSTMnews
www.nature.com/articles/s41591-025-03535-8 -
Nature Medicine
@NatureMedicine
A large-scale, phenome-wide study enables a holistic view of the role of #sleep on human health, highlighting its potential as a modifiable risk factor for chronic disease. News & Views from Diego Mazzotti, Mason Manetta @KUMedCenter @BerkeleyBioE
www.nature.com/articles/s41591-025-03529-6 -
Nature Medicine
@NatureMedicine
A new study highlights the benefits of global aircraft-based wastewater surveillance, but the best early warning system will likely involve a combination of methods in an integrated bioinformatics pipeline.
News & Views from Raina MacIntyre @Globalbiosec
www.nature.com/articles/s41591-024-03460-2 -
Nature Medicine
@NatureMedicine
⭐Research highlight: A diet ‘restoration’ strategy that mimics non-industrialized dietary habits showed beneficial effects on the gut #microbiome that were predictive of cardiometabolic benefits. @CellCellPress
www.nature.com/articles/d41591-025-00010-2 -
Nature Medicine
@NatureMedicine
By simulating the implementation of airport-based wastewater surveillance sites at global level, a modelling study shows how this early warning system would perform in identifying sources of pandemic outbreaks @stonge_g @alexvespi
www.nature.com/articles/s41591-025-03501-4 -
Nature Medicine
@NatureMedicine
Genomic and epidemiologic data suggest that the rapid spread of MPox Clade I in the Democratic Republic of the Congo has happened mostly through sexual contact within densely populated areas
www.nature.com/articles/s41591-025-03582-1 -
Nature Medicine
@NatureMedicine
Two novel phosphorylation sites, p-tau262 and p-tau356, detect the formation of pre-fibrillar tau aggregates and may serve as an early-stage plasma biomarker of tau pathology @tommykakari @PittPsychiatry @pedrorosaneto
www.nature.com/articles/s41591-024-03400-0 -
Nature Medicine
@NatureMedicine
Epigenetic editing of PCSK9 in the liver, designed to induce DNA methylation and silence gene expression, achieved long-lasting reductions in LDL-cholesterol levels in both transgenic mice expressing the human PCSK9 gene and cynomolgus monkeys
www.nature.com/articles/s41591-025-03508-x -
Nature Medicine
@NatureMedicine
A rare case of asymptomatic dominantly inherited Alzheimer's reveals confined tau pathology and unique proteomic features, highlighting potential resilience mechanisms decades beyond expected onset @WashUMedADRC @jorgellibre
www.nature.com/articles/s41591-025-03494-0 -
Nature Medicine
@NatureMedicine
In a large-scale analysis of ambulatory electrocardiographic recordings, a deep learning algorithm had a substantially higher sensitivity for detection of critical arrhythmias as compared to technicians
www.nature.com/articles/s41591-025-03516-x -
Nature Medicine
@NatureMedicine
In a first-in-human phase 1 trial, HER2-specific CAR-macrophages were feasible to manufacture and well tolerated with no dose-limiting toxicities in patients with HER2-overexpressing solid tumors
www.nature.com/articles/s41591-025-03495-z -
Nature Medicine
@NatureMedicine
Using an electronic system for symptom monitoring of patient-reported outcomes during treatment led to sustained improvements in emergency visits, quality of life and delayed deterioration of physical function in patients with metastatic cancer
www.nature.com/articles/s41591-025-03507-y -
Nature Medicine
@NatureMedicine
A new study advances our understanding of how different #flood events affect direct and indirect causes of mortality — providing useful insights for disaster response and preparedness.
News & Views from Andrew Morse @LivUni
www.nature.com/articles/s41591-025-03491-3 -
Nature Medicine
@NatureMedicine
A randomized controlled trial showed that a home-based, telemedicine supported lifestyle intervention reported improved glycemic control after 6 months in patients with coronary heart disease and type 2 diabetes compared to usual care
www.nature.com/articles/s41591-025-03498-w -
Nature Medicine
@NatureMedicine
In the phase 3 CEPHEUS trial, patients with multiple myeloma were treated with subcutaneous daratumumab plus bortezomib, lenalidomide and dexamethasone, which led to a deeper and more durable increase in minimal residual disease responses @szusmani
www.nature.com/articles/s41591-024-03485-7 -
Nature Medicine
@NatureMedicine
The medical crisis of war-injured children in Gaza and Lebanon.
Correspondence from Samar Al-Hajj and colleagues, American University of Beirut, Beirut, Lebanon.
www.nature.com/articles/s41591-024-03474-w -
Nature Medicine
@NatureMedicine
Improved muscle function, strength and fatigue measures were observed electrical spinal cord stimulation in individuals with spinal muscular atrophy @scottensel @dona_sere @MCapogrosso, @ElviraPirondini
www.nature.com/articles/s41591-024-03484-8 -
Nature Medicine
@NatureMedicine
#parkinsonsdisease and other #synucleinopathies are undergoing a paradigm shift towards being defined and staged by biology, rather than symptoms; our latest Perspective offers context on progress, needs & opportunities
@McGovernMed @pddoc @Proteopathy_Lab
www.nature.com/articles/s41591-024-03469-7 -
Nature Medicine
@NatureMedicine
In a prospective study involving 92 physicians from multiple institutions, access to large language model assistance on top of conventional resources increased the quality of their reasoning in addressing patient care
www.nature.com/articles/s41591-024-03456-y -
Nature Medicine
@NatureMedicine
Pyrolysis gas chromatography-mass spectrometry reveals the presence of micro- and nanoplastics in human kidney, liver, and brain tissue samples from 2016 and 2024, with higher proportions found in the brain
www.nature.com/articles/s41591-024-03453-1 -
Nature Medicine
@NatureMedicine
Addressing maternal and infant health inequities requires improved birth record data collection.
Correspondence from Farah Kader and colleagues New York University Grossman School of Medicine.
www.nature.com/articles/s41591-024-03472-y -
Nature Medicine
@NatureMedicine
Safe AI-enabled digital health technologies need built-in open feedback.
Comment from Stephen Gilbert and colleagues, TUD Dresden University of Technology.
www.nature.com/articles/s41591-024-03397-6 -
Nature Medicine
@NatureMedicine
The MI-CLAIM-GEN checklist for generative artificial intelligence in health.
Comment from Brenda Miao and colleagues, University of California, San Francisco.
www.nature.com/articles/s41591-024-03470-0 -
Nature Medicine
@NatureMedicine
New neurons are born in the adult human brain.
Turning Points from Rusty Gage, reflecting on his 1998 Nature Medicine paper, as part of our 30th anniverary series.
www.nature.com/articles/s41591-025-03497-x -
Nature Medicine
@NatureMedicine
Gut R. gnavus may induce monoamine synthesis and neurotoxicity in some patients with #cirrhosis, causing #hepaticencephalopathy — revealing a possible therapeutic target for this understudied condition.
News & Views from @BloomPringle @MichiganLiver
www.nature.com/articles/s41591-024-03467-9 -
Nature Medicine
@NatureMedicine
US aid cuts are an opportunity to reimagine global health.
World View from Ntobeko Ntusi, South African Medical Research Council.
www.nature.com/articles/d41591-025-00009-9 -
Nature Medicine
@NatureMedicine
Imatinib and the dawn of precision cancer therapy
This Turning Points article from Brian Druker is part of our 30th anniversary 🎈 🍰 collection, where we ask past authors to share the impact of their Nature Medicine papers.
www.nature.com/articles/s41591-024-03436-2 -
Nature Medicine
@NatureMedicine
A small but in-depth study of allogeneic #cartcelltherapy in high-risk #neuroblastoma shows feasibility & potential efficacy, and reveals pathways to improved functionality in solid tumors
News & Views from Rozalyn Chok, @SRamakrishna_MD @StanfordMed
www.nature.com/articles/s41591-025-03510-3 -
Nature Medicine
@NatureMedicine
A phase 2 trial of autologous macrophage therapy fails to meet its primary endpoint, but it is too soon to dismiss this approach to treating liver #cirrhosis.
News & Views from Jacquelyn J. Maher @UCSFDOM
www.nature.com/articles/s41591-025-03490-4 -
Nature Medicine
@NatureMedicine
The CheckMate-7FL and KEYNOTE-756 trials provide robust evidence for the efficacy of neoadjuvant chemo-immunotherapy in high-risk, early-stage HR-positive breast cancer.
News & Views from Zahi Mitri, Karen Gelmon @UBCDoM
www.nature.com/articles/s41591-024-03441-5 -
Nature Medicine
@NatureMedicine
#organoid research is moving beyond developmental and disease biology, driving insights into current and emerging health threats and enabling personalized and regenerative medicine applications.
@GerliLab @paolodecoppi @ErasmusMC
www.nature.com/articles/s41591-024-03489-3 -
Nature Medicine
@NatureMedicine
How a medical mystery led to a cure for viral hepatitis
This Turning Points article from T. Jake Liang is part of our 30th anniversary 🎈 🍰 collection, where we ask past authors to share the impact of their Nature Medicine papers.
www.nature.com/articles/s41591-024-03368-x -
Nature Medicine
@NatureMedicine
Our Future Health: a unique global resource for discovery and translational research.
Comment from Michael B. Cook, Raghib Ali and colleagues @ukfuturehealth
www.nature.com/articles/s41591-024-03438-0 -
Nature Medicine
@NatureMedicine
Data sharing restrictions are hampering precision health in the European Union.
Comment from Cristina Legido-Quigley, Karolina Sulek and colleagues @Stenodiabetes
www.nature.com/articles/s41591-024-03437-1 -
Nature Medicine
@NatureMedicine
How patient advocates influence health policy.
World View from Elizabeth Kasimu Mutunga @AlzKenya
www.nature.com/articles/s41591-024-03444-2 -
Nature Medicine
@NatureMedicine
#parkinsonsdisease and other #synucleinopathies are undergoing a paradigm shift towards being defined and staged by biology, rather than symptoms; our latest Perspective offers context on progress, needs & opportunities
@McGovernMed @pddoc @Proteopathy_Lab
www.nature.com/articles/s41591-024-03469-7 -
Nature Medicine
@NatureMedicine
⭐Research highlight: A machine learning tool categorizes the degree of processing of over 50,000 food items in US stores — and guides consumers toward healthier choices through accessible data. @NatureFoodJnl
www.nature.com/articles/d41591-025-00007-x -
Nature Medicine
@NatureMedicine
📢 The Access to Dialysis in Low- and Middle-Income Countries Commission will explore Thailand’s experiences with changing its #dialysis coverage policy - offering lessons for other countries with universal health coverage #uhc systems. @HITAP_Thailand
www.nature.com/articles/s41591-024-03448-y -
Nature Medicine
@NatureMedicine
A trial in Malawian women with anaemia found a single dose of intravenous ferric carboxymaltose more effective than standard care (twice oral iron daily) in reducing anaemia rates before childbirth. #ferriccarboxymaltose #anaemia
www.nature.com/articles/s41591-024-03385-w -
Nature Medicine
@NatureMedicine
Imatinib and the dawn of precision cancer therapy
This Turning Points article from Brian Druker is part of our 30th anniversary 🎈 🍰 collection, where we ask past authors to share the impact of their Nature Medicine papers.
www.nature.com/articles/s41591-024-03436-2 -
Nature Medicine
@NatureMedicine
Global health engagement strengthens US security, prosperity and leadership.
Correspondence from Benjamin Mason Meier, Muhammad Jawad Noon, Xinshu She & Keith Martin @CUGHnews
www.nature.com/articles/d41591-025-00005-z -
Nature Medicine
@NatureMedicine
How a medical mystery led to a cure for viral hepatitis
This Turning Points article from T. Jake Liang is part of our 30th anniversary 🎈 🍰 collection, where we ask past authors to share the impact of their Nature Medicine papers.
www.nature.com/articles/s41591-024-03368-x -
Nature Medicine
@NatureMedicine
A large trial found that time-restricted eating at any time of day is a promising strategy for losing weight — but it does not reduce visceral adipose tissue.
News & Views from @CourtneyP_PhD and Olivia Altonji @NutritionUab
www.nature.com/articles/s41591-024-03468-8 -
Nature Medicine
@NatureMedicine
Our Future Health: a unique global resource for discovery and translational research.
Comment from Michael B. Cook, Raghib Ali and colleagues @ukfuturehealth
www.nature.com/articles/s41591-024-03438-0 -
Nature Medicine
@NatureMedicine
Data sharing restrictions are hampering precision health in the European Union.
Comment from Cristina Legido-Quigley, Karolina Sulek and colleagues @Stenodiabetes
www.nature.com/articles/s41591-024-03437-1 -
Nature Medicine
@NatureMedicine
How patient advocates influence health policy.
World View from Elizabeth Kasimu Mutunga @AlzKenya
www.nature.com/articles/s41591-024-03444-2 -
Nature Medicine
@NatureMedicine
RNA gene therapies offer hope for millions with high cholesterol.
Read the latest Clinical Pipeline, by @NatalieHealey
www.nature.com/articles/d41591-025-00002-2 -
Nature Medicine
@NatureMedicine
How citizen scientists and community engagement boost the impact of health research.
Q&A with the winners of the @NaturePortfolio Inclusive Health Research Awards @DrMark_Faghy @DrMonicaMalta and Kelsey Chapman.
www.nature.com/articles/d41591-025-00003-1 -
Nature Medicine
@NatureMedicine
In this phase 1 trial, patients with advanced tumors received mRNA Neoantigen-specific immunotherapy (iNeST) autogene cevumeran alone or with atezolizumab, showing long-lasting neoantigen-specific immune responses and preliminary clinical activity.
www.nature.com/articles/s41591-024-03334-7 -
Nature Medicine
@NatureMedicine
A comprehensive longitudinal analysis of individuals with preclinical #huntingtonsdisease identifies #biomarkers of #neurodegeneration and somatic expansion in blood DNA, detectable years before symptom onset. @DrMFarag @UCLHD @UCLIo
www.nature.com/articles/s41591-024-03424-6 -
Nature Medicine
@NatureMedicine
An ultra-sensitive and specific #ctdna assay provides novel pre-operative disease stratification in early-stage lung #adenocarcinoma. #biomarkers #lungcancer #tracerx
www.nature.com/articles/s41591-024-03216-y -
Nature Medicine
@NatureMedicine
The oral drug obeldesivir confers 80% survival when given after lethal Marburg virus exposure in cynomolgus macaques and also delays viral replication and disease onset, suggesting a potential treatment option for an infection with no approved therapies.
www.nature.com/articles/s41591-025-03496-y -
Nature Medicine
@NatureMedicine
A cohort study of over 15k U.S. adults found that 42% developed #dementia by age 95, with the highest risk in #apoe 𝜀4 carriers, women, and Black adults, and projected that around 1 million U.S. adults will develop dementia annually by 2060.
www.nature.com/articles/s41591-024-03340-9 -
Nature Medicine
@NatureMedicine
An in vivo #baseediting approach targeting the #prnp gene led to 52% increase in lifespan of mouse models inoculated with the most common sporadic and genetic types of pathogenic #prion isolate.
www.nature.com/articles/s41591-024-03466-w -
Nature Medicine
@NatureMedicine
National modelling estimates reported that 3 million children experience orphanhood and caregiver loss in the United States with drug overdose surpassing #covid19 as the leading cause of parental death by 2021.
www.nature.com/articles/s41591-024-03343-6 -
Nature Medicine
@NatureMedicine
An ultra-sensitive and specific ctDNA assay provides novel pre-operative disease stratification in early-stage lung adenocarcinoma.
www.nature.com/articles/s41591-024-03216-y -
Nature Medicine
@NatureMedicine
In the phase 3 COMPASSION-15 trial, patients with advanced gastric cancer treated with the anti-PD-L1/CTLA-4 bispecific Ab cadolinimab + chemotherapy show improved overall survival vs patients treated with placebo plus chemotherapy as first-line treatment.
www.nature.com/articles/s41591-024-03450-4 -
Nature Medicine
@NatureMedicine
In a case series of five pediatric patients with treatment-refractory #neuroblastoma, it was feasible to manufacture and administer donor-derived GD2-specific #car_tcells, and clinical responses were seen in four patients. @bambinogesu #immunotherapy
www.nature.com/articles/s41591-024-03449-x -
Nature Medicine
@NatureMedicine
In the CheckMate-7FL trial, neoadjuvant nivolumab and chemotherapy in patients with newly diagnosed, ER positive breast cancer increased pathological complete response rate compared with neoadjuvant chemotherapy alone @LoiSher
www.nature.com/articles/s41591-024-03414-8 -
Nature Medicine
@NatureMedicine
In a prespecified interim analysis of the KEYNOTE-756 phase 3 trial, pembrolizumab and chemotherapy treatment of patients with ER-positive and HER2-negative breast cancer improved pathological complete response rate compared with chemotherapy alone.
www.nature.com/articles/s41591-024-03415-7 -
Nature Medicine
@NatureMedicine
In an analysis of long term safety events in 783 patients treated with #tcell therapy in 38 trials, 2.3% of patients developed second primary malignancies, and vector integration analyses revealed no pathological insertions
www.nature.com/articles/s41591-024-03478-6 -
Nature Medicine
@NatureMedicine
A finger-based brain-computer interface was developed for a person with #tetraplegia to allow him to fly a virtual quadcopter, an innovation that can lead to improved social connectedness, recreation and a sense of enablement
www.nature.com/articles/s41591-024-03341-8 -
Nature Medicine
@NatureMedicine
In a ClinicalTrial, #heartfailure patients who did combined endurance and resistance training for a year showed no change in the modified Packer score vs. usual care but improved in oxygen consumption and #nyhaclass. #cardiachealth #resistancetraining
www.nature.com/articles/s41591-024-03342-7 -
Nature Medicine
@NatureMedicine
An atlas of associations between the use of #glp-1 receptor agonists (GLP1-RA) with 175 health outcomes reported the effectiveness and risks of GLP1-RA compared to other antihyperglycemic medications. @zalaly
www.nature.com/articles/s41591-024-03412-w -
Nature Medicine
@NatureMedicine
Imatinib and the dawn of precision cancer therapy
This Turning Points article from Brian Druker is part of our 30th anniversary 🎈 🍰 collection, where we ask past authors to share the impact of their Nature Medicine papers.
www.nature.com/articles/s41591-024-03436-2 -
Nature Medicine
@NatureMedicine
In a multicenter, open-label, randomized phase 2 trial, neoadjuvant chemoradiation with PD1 blockade elicited a superior pathological complete response rate than neoadjuvant chemoradiation alone in patients with locally advanced rectal cancer.
www.nature.com/articles/s41591-024-03360-5 -
Nature Medicine
@NatureMedicine
Multiomic profiling of the microbiome and host immunity of individuals treated with VE303 to prevent recurrent #clostridioidesdifficile infection in a phase 2 trial, show robust colonisation of VE303 and indicate potential biomarkers of response
www.nature.com/articles/s41591-024-03337-4 -
Nature Medicine
@NatureMedicine
Nature Medicine is 30! 🎈 🍰
To celebrate, past authors share the impact of their Nature Medicine papers.
We begin with 'How a medical mystery led to a cure for viral hepatitis' by T. Jake Liang, based on his 2005 paper.
www.nature.com/articles/s41591-024-03368-x -
Nature Medicine
@NatureMedicine
Global health engagement strengthens US security, prosperity and leadership.
Correspondence from Benjamin Mason Meier, Muhammad Jawad Noon, Xinshu She & Keith Martin @CUGHnews
www.nature.com/articles/d41591-025-00005-z -
Nature Medicine
@NatureMedicine
In a phase 2 trial of adults with #neurofibromatosis type 1 and inoperable plexiform neurofibromas, the #mek inhibitor #selumetinib shows an ORR of 63.6% and improved patient outcomes with additional biopsy data on drug activity.
www.nature.com/articles/s41591-024-03361-4 -
Nature Medicine
@NatureMedicine
Our latest Review explores the state-of-the-art applications of #ai in #drugdevelopment, from target identification, ADMET and drug synthesis up to trial design and conduct.
Part of our 30th Anniversary #futureofmedicine series
@KangZhangMD @WMU1958
www.nature.com/articles/s41591-024-03434-4 -
Nature Medicine
@NatureMedicine
⭐ Research highlight: A study detected hidden cancers in almost half of all pregnant people who were referred for #cancer screening following an abnormal or unreportable prenatal blood test result. #cfdna @NEJM
www.nature.com/articles/d41591-025-00006-y -
Nature Medicine
@NatureMedicine
⚡Our January issue is live!
🧵1/4 To celebrate our 30th Anniversary, we launch a year-long Series on the Future of Medicine and announce two Nature Medicine Commissions; not to mention a selection of brand new clinical research and reviews, news & opinion
www.nature.com/nm/volumes/31/issues/1Post not available here, view on X
Nature Medicine
@NatureMedicine
🧵3/4 Throughout the year, readers can keep track of the special content commissioned for the journal’s anniversary in a dedicated page on the Future of Medicine. Each month, will focus on a specific topic. First up is next-generation drug discovery.
www.nature.com/collections/jcdefebijj
Nature Medicine
@NatureMedicine
🧵4/4 Read a summary of all these developments in our latest editorial: www.nature.com/articles/s41591-024-03464-y
-
Nature Medicine
@NatureMedicine
Our Future Health: a unique global resource for discovery and translational research.
Comment from Michael B. Cook, Raghib Ali and colleagues @ukfuturehealth
www.nature.com/articles/s41591-024-03438-0 -
Nature Medicine
@NatureMedicine
Data sharing restrictions are hampering precision health in the European Union.
Comment from Cristina Legido-Quigley, Karolina Sulek and colleagues @Stenodiabetes
www.nature.com/articles/s41591-024-03437-1 -
Nature Medicine
@NatureMedicine
How patient advocates influence health policy.
World View from Elizabeth Kasimu Mutunga @AlzKenya
www.nature.com/articles/s41591-024-03444-2 -
Nature Medicine
@NatureMedicine
By simulating realistic patient-doctor conversations, a framework can be applied to LLMs to investigate shortcomings and bias in patient interactions, providing insight prior to actual clinical deployment. #medicalai #digitalhealth
www.nature.com/articles/s41591-024-03328-5 -
Nature Medicine
@NatureMedicine
Even a small dose of physical activity can be good medicine.
Comment from I-Min Lee and colleagues @HarvardChanSPH
www.nature.com/articles/s41591-024-03396-7 -
Nature Medicine
@NatureMedicine
Resurgence of malaria and artemisinin resistance in Africa requires a concerted response.
Correspondence from @JeanKaseya2 and colleagues @AfricaCDC
www.nature.com/articles/s41591-024-03439-z -
Nature Medicine
@NatureMedicine
Using a sex- and gender-informed lens to enhance care in Parkinson’s disease.
Comment from @AldreteCastro and colleagues @womensbrainpro
www.nature.com/articles/s41591-024-03363-2 -
Nature Medicine
@NatureMedicine
⭐Research highlight: The menstrual cycle may influence the breast cancer response to neoadjuvant chemotherapy — suggesting that treatment could be timed for optimal outcomes. @Nature
www.nature.com/articles/d41591-025-00004-0 -
Nature Medicine
@NatureMedicine
RNA gene therapies offer hope for millions with high cholesterol.
Read the latest Clinical Pipeline, by @NatalieHealey
www.nature.com/articles/d41591-025-00002-2 -
Nature Medicine
@NatureMedicine
#braincomputerinterfaces are expanding from functional to recreational applications, but their clinical utility is still uncertain.
News & Views from Nick Ramsey and Mariska Vansteensel @UMCU_Intl
www.nature.com/articles/s41591-024-03440-6 -
Nature Medicine
@NatureMedicine
Preparedness and priority research to tackle the mpox outbreak response.
Correspondence from Ali Azizi and colleagues @CEPIvaccines
www.nature.com/articles/s41591-024-03367-y -
Nature Medicine
@NatureMedicine
Singing for health: a participatory process to design a song-based intervention for hypertension.
Correspondence from Ifedola I. Olojo, Joe Tucker and colleagues @nimrnigeria @UNC
www.nature.com/articles/s41591-024-03377-w -
Nature Medicine
@NatureMedicine
Prioritizing infant mental health: a research-driven pathway for action.
Comment from Anusha Lachman and colleagues @StellenboschUni
www.nature.com/articles/s41591-024-03338-3 -
Nature Medicine
@NatureMedicine
In a single-arm phase 2b trial, glecirasib, an oral KRAS G12C inhibitor, had an overall response rate of 47.9% in patients with locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer.
www.nature.com/articles/s41591-024-03401-z -
Nature Medicine
@NatureMedicine
How citizen scientists and community engagement boost the impact of health research.
Q&A with the winners of the @NaturePortfolio Inclusive Health Research Awards @DrMark_Faghy @DrMonicaMalta and Kelsey Chapman.
www.nature.com/articles/d41591-025-00003-1 -
Nature Medicine
@NatureMedicine
Gene therapy targets the retina to treat eye disease.
Read the latest Clinical Pipeline, by @edbytes
www.nature.com/articles/s41591-024-03454-0 -
Nature Medicine
@NatureMedicine
Can quantum computing crack the biggest challenges in health?
News feature by @Marianne_Guenot
www.nature.com/articles/s41591-024-03369-w -
Nature Medicine
@NatureMedicine
CANAIRI: the Collaboration for Translational Artificial Intelligence Trials in healthcare.
Correspondence from Melissa D. McCradden and colleagues @SickKidsNews
www.nature.com/articles/s41591-024-03364-1 -
Nature Medicine
@NatureMedicine
#liver transplant is the only available treatment for end-stage liver disease. This study reports the safety and efficacy of autologous monocyte-derived macrophage therapy for #livercirrhosis in a phase 2 randomized controlled clinical trial #stemcells
www.nature.com/articles/s41591-024-03406-8 -
Nature Medicine
@NatureMedicine
In a large-scale prospective study run across 12 sites in Germany and involving 463,094 women and 119 radiologists, AI-supported screening increased breast cancer detection rates by a significant margin without affecting the recall rate.
www.nature.com/articles/s41591-024-03408-6 -
Nature Medicine
@NatureMedicine
Can quantum computing crack the biggest challenges in health?
News feature by @Marianne_Guenot
www.nature.com/articles/s41591-024-03369-w -
Nature Medicine
@NatureMedicine
In people of South Asia ancestry, specific genetic mechanisms may drive #diabetes development, offering insights into global diabetes heterogeneity and potential avenues toward #precisionmedicine.
News & Views from @miriam_udler @broadinstitute
www.nature.com/articles/s41591-024-03413-9 -
Nature Medicine
@NatureMedicine
Genomic analyses from the ongoing outbreak of #marburg virus disease in Rwanda point to a single #zoonotic origin of the outbreak @RBCRwanda @christian_happi
www.nature.com/articles/s41591-024-03459-9 -
Nature Medicine
@NatureMedicine
The spatial single-cell multiomic atlas of the first trimester human #placenta at molecular resolution provides a blueprint for future studies on early #placentaldevelopment and #pregnancy. #hca @insitubiology @JianShuLab @harvardmed
www.nature.com/articles/s41591-024-03073-9 -
Nature Medicine
@NatureMedicine
📢 Nature Medicine is hiring! 📢
We're looking for an editor to handle research on #metabolism, #endocrinology & #womenshealth, as part of our international team.
Closing date is December 1st. More details here:
springernature.wd3.myworkdayjobs.com/SpringerNatureCareer… -
Nature Medicine
@NatureMedicine
To celebrate 100+ years of the #warburgeffect, #cancer editors from @SpringerNature put together a collection of articles highlighting the breadth of #cancermetabolism research & its potential for the clinic. @BioMedCentral @NatResCancer @NaturePortfolio www.nature.com/collections/djjgbfahdf
-
Nature Medicine
@NatureMedicine
As medical #ai development gathers momentum, a new study reveals that much work still needs to be done before the public will willingly embrace AI-based technologies in healthcare.
News & Views from @RoxanaDaneshjou and colleagues @StanfordDBDS
www.nature.com/articles/s41591-024-03272-4 -
Nature Medicine
@NatureMedicine
Identifying a complex panel of bias dimensions to be evaluated, a framework is proposed to assess how prone large language models are to biased reasoning, with possible consequences on equity-related harms. www.nature.com/articles/s41591-024-03258-2
-
Nature Medicine
@NatureMedicine
Out now for #esmo24! In #bellini, pts with early-stage #tnbc received neoadjuvant #nivolumab w/ or w/o #ipilimumab, leading to ctDNA clearance & promising clinical response rates, esp. in preselected pts w/ high TIL levels @lab_kok @NKI_nl
www.nature.com/articles/s41591-024-03249-3 -
Nature Medicine
@NatureMedicine
Sequencing 88,005 nuclei from #breast tissues of healthy women of diverse genetic ancestry, a global breast single nuclei atlas was developed that identifies cell types & ancestry level differences that could shed light on subtypes & progression of disease www.nature.com/articles/s41591-024-03011-9
-
Nature Medicine
@NatureMedicine
Building #genomic capacity for precision health in Africa. Review from @christian_happi & colleagues focusing on challenges and opportunities around infrastructure, workforce & policy-making
Part of our Focus issue on #precisionhealth
@acegid @RedeemersUni
www.nature.com/articles/s41591-024-03081-9 -
Nature Medicine
@NatureMedicine
⚡️Our July issue is live! ⚡️
🧵1/4 This special Focus issue on #precisionhealth includes news, opinion, review and original research articles on critical areas and challenges that must be addressed to make precision health a global reality.
www.nature.com/nm/volumes/30/issues/7 -
Nature Medicine
@NatureMedicine
When tested across tasks, diseases and imaging modalities, performance of #ai models depends on encoding of demographic shortcuts and correcting for them decreases their ability to generalize in new populations. @MarzyehGhassemi @yang_yuzhe @MIT_CSAIL
www.nature.com/articles/s41591-024-03113-4 -
Nature Medicine
@NatureMedicine
In our latest Review, @christian_happi & colleagues call for #genomics capacity-building in Africa, delving into the challenges and opportunities — with an emphasis on infrastructure, workforce & policy-making.
@acegid @RedeemersUni #precisionhealth
www.nature.com/articles/s41591-024-03081-9 -
Nature Medicine
@NatureMedicine
A new framework for the diagnosis, staging and management of obesity in adults.
Comment from Luca Busetto and colleagues @EASOobesity
www.nature.com/articles/s41591-024-03095-3 -
Nature Medicine
@NatureMedicine
In our latest Review, @christian_happi & colleagues call for #genomics capacity-building in Africa, delving into the challenges and opportunities — with an emphasis on infrastructure, workforce & policy-making.
@acegid @RedeemersUni #precisionhealth
www.nature.com/articles/s41591-024-03081-9 -
Nature Medicine
@NatureMedicine
In a cohort of 281 children with diagnosed or suspected cancer presenting to the NHS, implementing routine whole genome sequencing provided clinical benefit in 29% of cases and led to change in management in 7% of patients @sangerinstitute
www.nature.com/articles/s41591-024-03056-w -
Nature Medicine
@NatureMedicine
When tested across tasks, diseases and imaging modalities, performance of #ai models depends on encoding of demographic shortcuts and correcting for them decreases their ability to generalize in new populations. @MarzyehGhassemi @yang_yuzhe @MIT_CSAIL
www.nature.com/articles/s41591-024-03113-4 -
Nature Medicine
@NatureMedicine
Navigating the health frontiers of Africa’s climate challenge.
New Turning Points article from @FortunArty, @CeSHHAR describing her career pivot from HIV research.
www.nature.com/articles/s41591-024-03061-z -
Nature Medicine
@NatureMedicine
Novel medical devices to address the opioid crisis.
Correspondence from Leonardo M. Angelone @NIDAnews and colleagues at @US_FDA
www.nature.com/articles/s41591-024-03028-0 -
Nature Medicine
@NatureMedicine
In our latest Review: Marlene Temmerman, Samuel Ojong & colleagues explore the intersectionality between women’s health & rights in the 21st century, outlining 5 essential priorities for sustainable advancement. #srhr #icpd @MamaDaktari @AKUGlobal @PMNCH
www.nature.com/articles/s41591-024-03036-0 -
Nature Medicine
@NatureMedicine
Mathematical modelling as a tool for precision health equity.
To relaunch our Turning Points series, Juliane Fonseca de Oliveira describes her role in the 100 Million Brazilians Cohort at @cidacs_fiocruz.
www.nature.com/articles/s41591-024-03062-y -
Nature Medicine
@NatureMedicine
To correct the market failures around pediatric #celltherapies and #genetherapies, Crystal Mackall & colleagues propose a new model to lead late-stage development and commercialize these outside of traditional routes in the US.
@MackallLab @StanfordMed
www.nature.com/articles/s41591-024-03035-1 -
Nature Medicine
@NatureMedicine
Meet the PrEP ambassadors who use social media to combat HIV.
News feature by @pauladepoju
www.nature.com/articles/s41591-024-03048-w -
Nature Medicine
@NatureMedicine
Our editor @LorenzoRighett7 will be attending #eular24 in Vienna next week! Please reach out if you would like to discuss current research and potential for consideration in our journal. Check out the recent rheumatology content too!
www.nature.com/articles/s41591-024-03009-3 -
Nature Medicine
@NatureMedicine
Now at #atc2024philly : A prospective observational study including 2,882 kidney allograft recipients from 14 centers in Europe and the US shows that cell-free DNA can be used to detect kidney allograft rejection @AlexandreLoupy @olivieraubert www.nature.com/articles/s41591-024-03087-3
-
Nature Medicine
@NatureMedicine
How medical schools can prepare students for new technologies.
World View from Chantal Mathieu @KU_Leuven
www.nature.com/articles/s41591-024-03041-3 -
Nature Medicine
@NatureMedicine
Next-generation #liquidbiopsy technologies could be a game-changer in early #cancer detection, but their adoption requires further clinical testing and consideration of harm - especially in young adult populations.
Read our latest editorial here: www.nature.com/articles/s41591-024-03046-y -
Nature Medicine
@NatureMedicine
New data from the #selecttrial mean that cardiologists & other clinicians will need to become familiar with prescribing #semaglutide and other #glp1ras, given their systemic effects
News & Views from Naveed Sattar and colleagues @UofGlasgow@UTSWMedCenter
www.nature.com/articles/s41591-024-03013-7 -
Nature Medicine
@NatureMedicine
Microbiome research in Africa must be based on equitable partnerships.
Comment from Ovokeraye H. Oduaran @V3ed @WitsUniversity and colleagues.
www.nature.com/articles/s41591-024-03026-2 -
Nature Medicine
@NatureMedicine
⚡Our May issue is out! Featuring #clinicaltrials of #cartcells, #immunotherapy, #genetherapy, and treatment for spinal cord injury, and studies on #xenografts, #heatwaves, #ai and much more - including reviews, news & opinion.
www.nature.com/nm/volumes/30/issues/5 -
Nature Medicine
@NatureMedicine
Adequate information about clinical trial results must be given to participants.
Comment from Rafael Dal-Ré and colleagues @UAM_Madrid
www.nature.com/articles/s41591-024-02948-1 -
Nature Medicine
@NatureMedicine
Findings from a multi-center study of 197,080 singleton live births in China report #maternal #hypertension as a mediator of the risks imposed by #heat exposure between conception and 20 weeks of gestation on preterm birth and its various clinical subtypes
www.nature.com/articles/s41591-024-03002-w -
Nature Medicine
@NatureMedicine
Our #oncology editor @UlrikeHarjes will be attending #esmobreast24, reach out to her if you would like to meet!
-
Nature Medicine
@NatureMedicine
The future of brain–computer interfaces in medicine.
Read our latest Clinical Pipeline column, by Paul Webster.
www.nature.com/articles/d41591-024-00031-3 -
Nature Medicine
@NatureMedicine
⭐Research highlight: Enzymes derived from gut bacteria switch A and B blood types to Group O (‘universal’), a strategy that could help solve blood donor shortages in the future. @NatureMicrobiol
www.nature.com/articles/d41591-024-00034-0 -
Nature Medicine
@NatureMedicine
#ai in #surgery: Our latest review outlines the ‘state of the art’ of AI in the preoperative, intraoperative & postoperative settings, and the potential for improving outcomes, education, & system efficiencies.
@EricTopol @ogrady_greg @ewenharrison
www.nature.com/articles/s41591-024-02970-3 -
Nature Medicine
@NatureMedicine
Climate change and health: understanding mechanisms will inform mitigation and prevention strategies.
Comment from Robbie M. Parks and colleagues @Columbia
www.nature.com/articles/s41591-024-02925-8 -
Nature Medicine
@NatureMedicine
An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution.
Comment from @lsubissi @mvankerkhove and colleagues @WHO
www.nature.com/articles/s41591-024-02949-0 -
Nature Medicine
@NatureMedicine
New data confirm that #apoe4 homozygosity is a major genetic cause of #alzheimersdisease, necessitating the development of specialized research strategies, treatments and clinical trials. News & Views from Yadong Huang and colleagues @GladstoneInst @UCSF
www.nature.com/articles/s41591-024-02923-w -
Nature Medicine
@NatureMedicine
The future of brain–computer interfaces in medicine.
Read our latest Clinical Pipeline column, by Paul Webster.
www.nature.com/articles/d41591-024-00031-3 -
Nature Medicine
@NatureMedicine
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites.
⚡NEW⚡ Correspondence from @djimdeab @fidocklab and colleagues published today for #worldmalariaday.
www.nature.com/articles/d41591-024-00028-y -
Nature Medicine
@NatureMedicine
‘Inverse vaccines’ could treat autoimmune disease — from multiple sclerosis to celiac disease.
Read our latest Clinical Pipeline column, by @edbites
www.nature.com/articles/d41591-024-00024-2 -
Nature Medicine
@NatureMedicine
Advances in bioengineering and organic chemistry have enabled targeting of the previously ‘undruggable’ #kras; our latest review from @EileenMOReilly & colleagues discusses the successes, challenges & future of KRAS therapeutics in #cancer
@MSKCancerCenter
www.nature.com/articles/s41591-024-02903-0 -
Nature Medicine
@NatureMedicine
‘Inverse vaccines’ could treat autoimmune disease — from multiple sclerosis to celiac disease.
Read our latest Clinical Pipeline column, by @edbites
www.nature.com/articles/d41591-024-00024-2 -
Nature Medicine
@NatureMedicine
An observational study of #functionalprecisionmedicine in #pediatriconcology showed that genomic profiling & ex vivo drug sensitivity testing enabled personalized treatment recommendations within 4 weeks. @ArletAcanda @Azzamlab @Diana_Azzam_PhD www.nature.com/articles/s41591-024-02848-4
-
Nature Medicine
@NatureMedicine
New data show that ex vivo drug screening of pediatric #cancer samples can identify effective therapies. If validated, this could herald a new approach to #precisiononcology
News & Views from Emmy Dolman, Paul Ekert @PeterMacCC @KidsCancerInst
www.nature.com/articles/s41591-024-02863-5 -
Nature Medicine
@NatureMedicine
📢 Looking for your next conference after #aacr24? Check out our upcoming @NatureConf on #cancer #immunotherapy! Planned w/ @NatRevImmunol @NatureCancer @NatImmunol
🗓️ Abstract & Early Registration Deadline = THIS Fri, April 12th
🎟️More details here: go.nature.com/CancerImm -
Nature Medicine
@NatureMedicine
At the #aacr24 #celltherapies in solid tumors session? Check out our 2 recent trials on #cartcells in patients with #glioblastoma!
Work led by Christine Brown @cityofhope: www.nature.com/articles/s41591-024-02875-1
Work led by @StephenBagleyMD @DrORourke2 @PennMedicine: www.nature.com/articles/s41591-024-02893-z -
Nature Medicine
@NatureMedicine
📢 ~ 2 weeks to go until abstracts are due for our upcoming @NatureConf on #cancer #immunotherapy!
🗓️ Deadline = Fri, April 12th
🎟️ More details here: go.nature.com/CancerImm
🌟 We have a great speaker line up, including Keynotes from Ira Mellman @genentech & @MackallLab! -
Nature Medicine
@NatureMedicine
New AI regulation in the EU seeks to reduce risk without assessing public benefit.
Comment from @BPrainsack and @nikolausf @univienna
www.nature.com/articles/s41591-024-02874-2 -
Nature Medicine
@NatureMedicine
⚡ Our March issue is live! Featuring several #biomarker and #immunotherapy studies in #crc, #pancreaticcancer, #hcc and others, studies on #tuberculosis, #cholera, #postnataldepression, foundation #ai, as well as News, Reviews, Opinion and more...
www.nature.com/nm/volumes/30/issues/3 -
Nature Medicine
@NatureMedicine
📢< 1 month until abstracts are due for our upcoming @NatureConf on #cancer #immunotherapy! This event is co-organized w/ @DanaFarber @NatureCancer @NatImmunol @NatRevImmunol
🗓️Deadline = April 12th
🎟️To register, submit an abstract & learn more, visit go.nature.com/CancerImm -
Nature Medicine
@NatureMedicine
Mpox (formerly monkeypox) continues to spread in Africa and threatens global health security.
Correspondence from Nicaise Ndembi and colleagues @AfricaCDC
www.nature.com/articles/s41591-024-02862-6 -
Nature Medicine
@NatureMedicine
Today, together with @NEJM_AI, we present a statement from the RAISE Consortium mapping immediate actions for healthcare leaders to support the responsible and ethical transition of healthcare to an AI-powered future. Read it now: www.nature.com/articles/s41591-024-02853-7 @HarvardDBMI @zakkohane
-
Nature Medicine
@NatureMedicine
A new inhibitor of Mycobacterium tuberculosis leucyl-tRNA synthetase is associated with bactericidal activity in humans and may be a candidate for combination therapy of #tuberculosis
www.nature.com/articles/s41591-024-02829-7 -
Nature Medicine
@NatureMedicine
In a prospective study across US states where abortion remains legal, telehealth medical abortion, provided primarily without tests, was effective, safe and comparable to previous large US studies investigating in-person medication abortion care. www.nature.com/articles/s41591-024-02834-w
-
Nature Medicine
@NatureMedicine
11 clinical trials that will shape medicine in 2024 - from base editing and a vaccine against HIV to AI tools for lung cancer and patient triage.
Part of our Year in Review, by Paul Webster and @edbites
www.nature.com/articles/s41591-023-02699-5 -
Nature Medicine
@NatureMedicine
GLP-1 receptor agonists such as semaglutide are promising but unproven treatments for alcohol and substance use disorders.
Comment from @Lorenzo__Leggio and colleagues @NIDAnews
www.nature.com/articles/s41591-023-02634-8 -
Nature Medicine
@NatureMedicine
#priscillabrastianos presenting results from this phase 2 trial of patients with untreated, recurrent and progressive #brainmetastases treated with an anti-PD-1 inhibitor at #sno2023 @MGHCancerCenter #brainmets #immunotherapy www.nature.com/articles/s41591-023-02392-7
-
Nature Medicine
@NatureMedicine
A risk score based on a 34 gene signature was developed and validated in large multi-institutional cohorts for discriminating post-op #menignioma outcomes. Results presented at #sno2023 by @WilliamCChen1 @LabRaleigh @StephenTMagill www.nature.com/articles/s41591-023-02586-z
-
Nature Medicine
@NatureMedicine
Five award-winning researchers share their tips for inclusive health research.
Q&A with Uma Palanisamy @kevinpottie @HaitanaTracy @RuthWellsSyd and @Research_Ambit, interviewed by @drbenjohnson
www.nature.com/articles/s41591-023-02683-z -
Nature Medicine
@NatureMedicine
In our latest Review: Chris Cunningham and Monica Mercury explore how research #coproduction with #indigenous peoples is evolving, and how it can be done in responsive and effective ways. @MasseyUni
www.nature.com/articles/s41591-023-02588-x -
Nature Medicine
@NatureMedicine
Modeling shows that antiretroviral treatment as pre-exposure prophylaxis (PrEP) can be highly effective in cisgender women at preventing #hiv-1 acquisition, but underscores the need to understand the barriers that limit PrEP adherence in women. www.nature.com/articles/s41591-023-02615-x
-
Nature Medicine
@NatureMedicine
#protacs reach clinical development in inflammatory skin disease, marking an important milestone for the safe application of this drug class beyond oncology.
Read the News and Views from @FleurMFerguson @UCSanDiego
#tpd #proteindegraders #protac
www.nature.com/articles/s41591-023-02622-y -
Nature Medicine
@NatureMedicine
Reporting standards for the use of large language model-linked chatbots for health advice.
Correspondence from @brighthuo and colleagues @McMasterU
www.nature.com/articles/s41591-023-02656-2 -
Nature Medicine
@NatureMedicine
Read our latest Review: Coproducing health research with #indigenous peoples.
Chris Cunningham and Monica Mercury explore how research #coproduction with Indigenous peoples is evolving, and how it can be done in responsive and effective ways. @MasseyUni
www.nature.com/articles/s41591-023-02588-x -
Nature Medicine
@NatureMedicine
A systematic review, combined with a stakeholder survey, presents an overview of current practices and recommendations for dataset curation in health, with specific focuses on data diversity and artificial intelligence -based applications @DrXiaoLiu #ai
www.nature.com/articles/s41591-023-02608-w -
Nature Medicine
@NatureMedicine
Targeted depletion of TRBV9+ T cells induces remission in a single ankylosing spondylitis patient, with significant improvements in functional and mobility metrics #immunotherapy #ankylosingspondylitis www.nature.com/articles/s41591-023-02613-z
-
Nature Medicine
@NatureMedicine
New for #esmo23: CLDN6-specific #cartcells +/- a CAR-T cell-amplifying RNA #vaccine were well-tolerated and exhibited encouraging clinical activity in patients with r/r CLDN6-positive solid tumors, particularly germ cell tumors @BioNTech_Group @HaanenJohn www.nature.com/articles/s41591-023-02612-0
-
Nature Medicine
@NatureMedicine
Out today for #esmo23: In a large multi-cancer cohort, a single liquid biopsy assay enables the detection of four epigenomic modifications, allowing the monitoring of expression of potential drug targets and resistance genes @SylvanBacaLab @DrChoueiri www.nature.com/articles/s41591-023-02605-z
-
Nature Medicine
@NatureMedicine
Biomarkers of aging remain elusive as researchers try to slow the biological clock.
News feature by @TechTyper, as part of our series Rethinking Evidence in Medicine.
www.nature.com/articles/s41591-023-02560-9 -
Nature Medicine
@NatureMedicine
⚡SAVE THE DATE!⚡ @NatureMedicine and @Nature are organizing jointly a @NatureConf on "Advancing Health with AI", hosted in Wenzhou next year (April 26-28 2024) - an incredible list of speakers is already up, abstract submissions are open!
conferences.nature.com/event/20f6abc4-5475-4071-b79c-c3c9… -
Nature Medicine
@NatureMedicine
Privilege and prejudice must be recognized for equitable research partnerships.
World View from Doris Schroeder @UCLan
www.nature.com/articles/s41591-023-02581-4 -
Nature Medicine
@NatureMedicine
A new Consensus Statement from the Precision Medicine in Diabetes Initiative outlines the milestones that must be achieved for broad clinical implementation of #precisionmedicine in #diabetes care.
#easd2023 @lunduniversity @harvardmed @novonordiskfond
www.nature.com/articles/s41591-023-02502-5 -
Nature Medicine
@NatureMedicine
How to modernize medical evidence for the misinformation era.
News feature from @clarewhatson, as part of our series on Rethinking Evidence in Medicine.
www.nature.com/articles/s41591-023-02537-8 -
Nature Medicine
@NatureMedicine
New Perspective: The current definition of myocardial infarction is applied inconsistently, with implications for patients. Nicholas Mills & Bertil Lindahl propose a new definition and call for further research & consensus.
#esc2023 @HighSTEACS @EdinUniCVS
www.nature.com/articles/s41591-023-02513-2 -
Nature Medicine
@NatureMedicine
A collaboration system helps to integrate decisions between human experts and #ai to optimize screening and triaging and to reduce clinicians' workload @GoogleDeepMind @GoogleAI @GoogleHealth @alan_karthi
www.nature.com/articles/s41591-023-02437-x -
Nature Medicine
@NatureMedicine
Why Wellcome is tackling the health impacts of climate change.
World View from @AlanDangour @wellcometrust, part of our focus on Building Healthy Populations.
www.nature.com/articles/s41591-023-02434-0 -
Nature Medicine
@NatureMedicine
Today is #worldhepatitisday! We join the call for raising awareness on need of prevention and treatment of a still widespread and devastating disease, with over 1 million related deaths per year globally
www.nature.com/articles/s41591-021-01513-4 -
Nature Medicine
@NatureMedicine
Engineered anti-mesothelin #tcells exhibit notable toxicities, but encouraging clinical responses, in patients with treatment-refractory #mesothelioma and #ovariancancer @theNCI @MDAndersonNews #immunotherapy
www.nature.com/articles/s41591-023-02452-y -
Nature Medicine
@NatureMedicine
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
Comment from @MKhasraw and colleagues, from the 27th Society of Neuro-Oncology annual meeting.
www.nature.com/articles/s41591-023-02464-8 -
Nature Medicine
@NatureMedicine
As the proportion of older adults increases globally, #digitalhealth innovations (particularly #wearables) could transform the future of healthy aging. Perspective from @JWangnano & colleagues @UCSanDiego, part of our focus on Building Healthy Populations
www.nature.com/articles/s41591-023-02391-8 -
Nature Medicine
@NatureMedicine
A risk score developed using biological, psychological, and social factor data from the @uk_biobank can predict different pain conditions and the prognosis of chronic pain up to 9-years later @evp82 @TanguaySabourin
www.nature.com/articles/s41591-023-02430-4 -
Nature Medicine
@NatureMedicine
The poorest and most vulnerable communities should be the first to be vaccinated.
World View from @GaviSeth, outgoing CEO of @Gavi, as part of our focus on Building Healthy Populations.
www.nature.com/articles/s41591-023-02389-2 -
Nature Medicine
@NatureMedicine
How to fight antibiotic resistance. #amr
Immersive news feature by @techtyper, part of our focus on Building Healthy Populations.
www.nature.com/immersive/d41591-023-00043-5/index.html -
Nature Medicine
@NatureMedicine
⚡️Our June issue is out!⚡️This month includes #clinicaltrials on oncolytic virotherapy in #glioblastoma , on antisense oligonucleotide for #alzheimers and a study on a polygenic risk score for #preeclampsia, as well as news, opinions and much more! www.nature.com/nm/volumes/29/issues/6
-
Nature Medicine
@NatureMedicine
A #single-cell atlas of the human #lungs, integrating data from 2.4 million cells from 486 individuals and including samples from healthy and diseased lungs, provides a roadmap for generating organ-scale cell atlases. @SikkemaLisa @MDLuecken @fabian_theis
www.nature.com/articles/s41591-023-02327-2 -
Nature Medicine
@NatureMedicine
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice.
Comment from Claus Garbe, Reinhard Dummer, @TeresaSAmaral, @ProfGLongMIA and colleagues. #asco23
www.nature.com/articles/s41591-023-02336-1 -
Nature Medicine
@NatureMedicine
Patients should be informed when artificial intelligence #ai systems are used in clinical trials.
Correspondence from @dbittermanmd and colleagues @BrighamWomens @DanaFarber
www.nature.com/articles/s41591-023-02367-8 -
Nature Medicine
@NatureMedicine
⚡️Our May issue is out!⚡️This month includes studies looking at #psychiatric comorbidity, #maternalhealth, resilience to #alzheimersdisease, #clinicaltrials for #neruoblastoma, rare #cancers, #prurigonodularis, as well as news, opinions, and much more! www.nature.com/nm/volumes/29/issues/5
-
Nature Medicine
@NatureMedicine
A phase 1 trial of the #oncolyticvirus DNX-2401 followed by intravenous anti-PD-1 #pembrolizumab in patients w/recurrent #glioblastoma shows an encouraging clinical benefit rate & 12 months overall survival. www.nature.com/articles/s41591-023-02347-y
@gelarehzadeh @FarshadNassiri -
Nature Medicine
@NatureMedicine
Rare-disease researchers pioneer a unique approach to clinical trials.
News feature from @TechTyper, part of our series Rethinking Evidence in Medicine.
www.nature.com/articles/s41591-023-02333-4 -
Nature Medicine
@NatureMedicine
Sexual and reproductive health and rights must be enshrined in universal healthcare.
World View from @Atayeshe, Executive Director @UNFPA
www.nature.com/articles/s41591-023-02267-x -
Nature Medicine
@NatureMedicine
In our latest Perspective: Steven Woloshin & colleagues outline practical considerations for designing and testing visual displays to communicate health information, with useful case examples.
@DartmouthInst @CarnegieMellon
www.nature.com/articles/s41591-023-02328-1 -
Nature Medicine
@NatureMedicine
First two patients receive CAR T cell therapy for HIV.
Read the latest column in The Clinical Pipeline, by @cyrilpedia
www.nature.com/articles/d41591-023-00042-6 -
Nature Medicine
@NatureMedicine
⚡️Our April issue is out!⚡️With two papers from the TRACERx #lungcancer study, clinical trials in #diabetes and #prostatecancer, studies on salt substitution for lowering #bloodpressure and on #ai for #braincancer diagnosis, news, opinions, and much more! www.nature.com/nm/volumes/29/issues/4
-
Nature Medicine
@NatureMedicine
Just in time for #aacr23 – the final results of the ROAR basket trial led by @VivekSubbiah @MDAndersonNews show that dabrafenib plus trametinib exhibited tumor-agnostic clinical activity in patients with rare BRAFV800E-mutated cancers.
www.nature.com/articles/s41591-023-02321-8 -
Nature Medicine
@NatureMedicine
Integrated analyses reveal that multiomics captured the heterogeneity of #metabolic states accompanying #obesity and changes in metabolic health in response to #lifestyle intervention which are not apparent in #bmi measurements. @nrappapo @isbsci
www.nature.com/articles/s41591-023-02248-0 -
Nature Medicine
@NatureMedicine
Check out the joint collection on Neuadjuvant #immunotherapy! This is a joint collection between Nature Medicine, @Nature and @NatureComms
www.nature.com/collections/ebagjdeiah -
Nature Medicine
@NatureMedicine
In a phase 2 trial, intratumoral injection of the #oncolyticvirus T-VEC during weekly paclitaxel followed by chemotherapy led to clinical benefit in patients with stage 2–3 triple-negative #breastcancer. #tnbc #nmedclinical @MoffittResearch
www.nature.com/articles/s41591-023-02210-0 -
Nature Medicine
@NatureMedicine
Caution with generative AI tools, such as chatGPT, in medicine.
World View from @biogerontology, CEO at Insilico Medicine.
www.nature.com/articles/d41591-023-00014-w -
Nature Medicine
@NatureMedicine
A participatory initiative to include LGBT+ voices in AI for mental health.
Correspondence from @kormilitzin @weballergy @empiricallykev and @dan_w_joyce, @UniofOxford and @DeepMind
www.nature.com/articles/s41591-022-02137-y -
Nature Medicine
@NatureMedicine
From today, primary research from authors from 70+ countries classified by the World Bank as low-income or lower-middle-income economies accepted for publication in @NatureMedicine or Nature research journals can be published Gold OA at no cost: group.springernature.com/gp/group/media/press-releases/na…
-
Nature Medicine
@NatureMedicine
2022 saw breakthroughs in several fields of #medicine. Check out the Year in Review for our selection of critical developments, including advances in #cartcells, #xenotransplantation, #digitalhealth, #nutrition, #mentalhealth and more:
www.nature.com/nm/articles?type=year-in-review -
Nature Medicine
@NatureMedicine
The impact of ending ‘zero COVID’ in China.
World View from @bencowling88, @HKUniversity
www.nature.com/articles/d41591-023-00001-1 -
Nature Medicine
@NatureMedicine
Analysis of data from California prisons shows that both the number of #covid19 vaccine doses received and prior #sarscov2 infection of index cases reduces the risk of virus transmission to close contacts @nathanlo3579 @UCSF www.nature.com/articles/s41591-022-02138-x
-
Nature Medicine
@NatureMedicine
As we start the new year, it's time for our notable advances of 2022.
We feature critical advances across medicine, from the impact of mental health, and the Mediterranean diet, to use of CAR T cells beyond cancer, and treatments for RSV.
www.nature.com/nm/reviews-and-analysis -
Nature Medicine
@NatureMedicine
11 trailblazing early-career researchers, shaping the future of #medicine, share what they are most excited about right now and where their research is going in the next 5 years - read now: go.nature.com/3C8xLYS
-
Nature Medicine
@NatureMedicine
In our December editorial we discuss the quest for better #biomarkers in #cancer #immunotherapy - go.nature.com/3jCk6D5
-
Nature Medicine
@NatureMedicine
Our last issue of the year is out, featuring our selection of research that moved medicine forward in 2022, top clinical trials to watch in 2023 and a word from 11 early-career researchers that are helping to shape the future of #medicine - read now: go.nature.com/3WV2D7j
-
Nature Medicine
@NatureMedicine
Preclinical data and results from a phase 1/2 trial demonstrate preliminary safety and efficacy of topically-administered #genetherapy for recessive dystrophic #epidermolysisbullosa @StanfordMed @KrystalBiotech @debraOfAmerica @EBResearch #ebawareness www.nature.com/articles/s41591-022-01737-y
-
Nature Medicine
@NatureMedicine
⏰There's still time to apply for our editor position! Deadline is Friday, Dec 23rd, details below...
Nature Medicine
@NatureMedicine
We're hiring! We're looking for an editor with expertise in any area of clinical and translational medicine. This position is open to candidates in any of our editorial office locations. Applications are due by Friday, Dec 23rd!
Full details here: careers.springernature.com/job-invite/47263/ -
Nature Medicine
@NatureMedicine
In patients with metastatic triple-negative #breastcancer, atezolizumab + anthracycline-based chemotherapy improves progression-free survival, including in PD-L1 negative disease #sabcs22 @andreashr @GroupKyte @AmundJon @Oslounivsykehus @UniOslo_MED #bcsm www.nature.com/articles/s41591-022-02126-1
-
Nature Medicine
@NatureMedicine
We're hiring! We're looking for an editor with expertise in any area of clinical and translational medicine. This position is open to candidates in any of our editorial office locations. Applications are due by Friday, Dec 23rd!
Full details here: careers.springernature.com/job-invite/47263/ -
Nature Medicine
@NatureMedicine
Carbon-containing particulates accumulate with age in a subset of #macrophages in human lung-associated lymph nodes, reduce macrophage phagocytic capacity and turnover and disrupt lymphoid tissue structure #immunology #pollution @DonnaFarber3 www.nature.com/articles/s41591-022-02073-x
-
Nature Medicine
@NatureMedicine
According to 2020 estimates from 185 countries, Asia and Africa have the most maternal #orphans due to #cancer, with #breastcancer and #cervicalcancer responsible for almost half of maternal cancers. #worldchildrensday @valmacsee @Flo_research @IARCWHO
www.nature.com/articles/s41591-022-02109-2 -
Nature Medicine
@NatureMedicine
⚡Our November issue is out! ⚡
Content includes large-scale studies on the role of #metabolomics in human health, reports on the effects of #diet on the #microbiome, clinical trials in #melanoma, #lungcancer, #hiv & #covid, and much, much more!
👉www.nature.com/nm/volumes/28/issues/11 -
Nature Medicine
@NatureMedicine
Merck bets on sotatercept in pulmonary arterial hypertension.
The latest column in the Clinical Pipeline, from @CyrilPedia
www.nature.com/articles/d41591-022-00109-w -
Nature Medicine
@NatureMedicine
Bivalent vaccines elicit broad immune responses that neutralize ancestral SARS-CoV-2 and variants of concern, and offer a customizable approach to protect from COVID-19 as new virus variants emerge. @msdiamondlab
www.nature.com/articles/s41591-022-02092-8 -
Nature Medicine
@NatureMedicine
In our latest Perspective, Christopher Murray @IHME_UW reflects on the past, present and future of the dynamic, expanding public health endeavor that is the #gbdstudy.
www.nature.com/articles/s41591-022-01990-1 -
Nature Medicine
@NatureMedicine
🧵1/5. Today in @NatureMedicine, a series of 'Burden of Proof' studies led by the @IHME_UW evaluates the strength of evidence of risk-outcome relationships to better inform effective clinical and policy recommendations. www.nature.com/collections/begeihaihj
-
Nature Medicine
@NatureMedicine
Africa must participate in finding a gene therapy cure for sickle-cell disease.
Correspondence from @juliemakani and colleagues @muhimbiliuniver
www.nature.com/articles/s41591-022-02033-5 -
Nature Medicine
@NatureMedicine
Our AI future is better than you think.
World View from @AaronNeinstein @UCSFMedicine
www.nature.com/articles/s41591-022-02021-9 -
Nature Medicine
@NatureMedicine
Sick as a dog: how understanding canine diseases will save human lives.
News feature from @edbites
www.nature.com/articles/s41591-022-02025-5 -
Nature Medicine
@NatureMedicine
Register for our free Nature Café on Advancing Health Equity Through Community Engagement.
Speakers include Folakemi Odedina @DrOdedina, Amitava Banerjee @amibanerjee1, Marcia Castro @marciacastrorj, Rafaela Alves Pachecho, and Andy Pattison @WHO
go.nature.com/3BCwFDQ -
Post not available here, view on X
Nature Medicine
@NatureMedicine
The conference, brought to you by Nature Medicine, is fully virtual and will take place form Oct 4th - 6th. Check out our speakers and register here (it's free!): conferences.nature.com/event/0b87c6fb-30cf-495a-9da0-88b2…
-
Nature Medicine
@NatureMedicine
On #worldcancerresearchday, don't forget our call for submission of innovative clinical research on the prevention, detection, diagnostic & treatment of #cancer - submit your paper any time! #oncology #nmedclinical
How to submit 👉go.nature.com/3LMQtY0 -
Nature Medicine
@NatureMedicine
⚡Our September issue is now live! ⚡ Lots on #microbiome dynamics in the context of FMT, as well as #genetherapy for #als, #cartcells, liquid biopsies, programmable antivirals, digital masks, and much more....
Check it out here: www.nature.com/nm/volumes/28/issues/9 -
Nature Medicine
@NatureMedicine
Why I pivoted from COVID-19 back to cancer research.
World view from @SamraTurajlic, @TheCrick
www.nature.com/articles/s41591-022-01994-x -
Nature Medicine
@NatureMedicine
An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials.
Comment from Sally Hopewell @OCTRUctu and colleagues from @EQUATORNetwork
www.nature.com/articles/s41591-022-01989-8 -
Nature Medicine
@NatureMedicine
Thinking of registering for our #digitalhealth conference #medinvirtualage22? (see link in comments)
@suchisaria will join as one of our keynote speakers; you may know her from these recent articles (which inspired our July cover):
www.nature.com/articles/s41591-022-01894-0
www.nature.com/articles/s41591-022-01895-z -
Nature Medicine
@NatureMedicine
Why I pivoted from COVID-19 back to cancer research.
World view from @SamraTurajlic, @TheCrick
www.nature.com/articles/s41591-022-01994-x -
Nature Medicine
@NatureMedicine
⭐ Research Highlight: A mouse study published in @NatureCancer
suggests that checkpoint inhibitors could negatively impact female fertility, highlighting a major clinical research gap in the cancer immunotherapy field.
www.nature.com/articles/d41591-022-00095-z -
Nature Medicine
@NatureMedicine
An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials.
Comment from Sally Hopewell @OCTRUctu and colleagues from @EQUATORNetwork
www.nature.com/articles/s41591-022-01989-8 -
Nature Medicine
@NatureMedicine
The unknown efficacy of the antiviral drug, tecovirimat, against monkeypox.
Read our new fortnightly column, The Clinical Pipeline, from @CyrilPedia.
www.nature.com/articles/d41591-022-00094-0 -
Nature Medicine
@NatureMedicine
News & Views: Assessment of TMB in blood could help identify who will benefit from #immunotherapy, but optimal cutoffs remain elusive. @pashtoonkasi discusses the BFAST study, and what's next for #liquidbiopsy and #tmb in solid cancers.
@WeillCornell
www.nature.com/articles/s41591-022-01999-6 -
Post not available here, view on X
Nature Medicine
@NatureMedicine
The conference is free to attend and fully virtual. Check out our speaker list and register here:
conferences.nature.com/event/0b87c6fb-30cf-495a-9da0-88b2… -
Nature Medicine
@NatureMedicine
How to correct the market for children’s cancer drugs
The development of pediatric cancer drugs is vastly underfunded compared with that for adults, but legislation can correct market failures.
#childhoodcancerawarenessmonth #cancertherapy
www.nature.com/articles/s41591-022-01747-w -
Nature Medicine
@NatureMedicine
A Phase 1/2a study shows that human neural progenitor cells modified to release GDNF are safely transplanted into the spinal cord of #als patients, w/ cell survival & GDNF production for >3 years. @CedarsSinaiMed, @CedarsSinai, @CliveSvendsen #nedclinical
www.nature.com/articles/s41591-022-01956-3 -
Nature Medicine
@NatureMedicine
mRNA vaccines boost CAR T cell therapy for @BioNTech_Group.
This is the first column in our new series, The Clinical Pipeline, which explores the latest translational and clinical research news.
Written by @CyrilPedia
www.nature.com/articles/d41591-022-00091-3 -
Nature Medicine
@NatureMedicine
Results from EMPOWER-Lung 3 demonstrate increased overall survival with #cemiplimab plus platinum-doublet #chemotherapy compared with cemiplimab as first-line treatment in patients with advanced non-small cell #lungcancer, irrespective of #pd-L1 expression
www.nature.com/articles/s41591-022-01977-y -
Nature Medicine
@NatureMedicine
Do you use art for your mental well-being or for healing? 🎨🖼️
We want to hear from you!
DM us now, starting your message with "art for health" and we will be in touch. -
Nature Medicine
@NatureMedicine
After smallpox, can other diseases be eradicated?
News feature from @anita_makri
www.nature.com/articles/s41591-022-01914-z -
Nature Medicine
@NatureMedicine
In a phase 2 trial, monitoring tumor resistance mutations in blood using liquid #biopsies allowed to rationally guide subsequent therapy with anti-EGFR antibodies in patients with #colorectalcancer. #egfr #biomarkers #cancer @Albert0Bardelli @BardelliLab
www.nature.com/articles/s41591-022-01886-0 -
Nature Medicine
@NatureMedicine
#springernature and #takeda will facilitate a panel entitled, “Achieving Health Equity Together – Forging the Path Forward” to incite dialogue around what it means to advance #healthequity globally. To register visit: conferences.nature.com/aK4dvv?sms=2
-
Nature Medicine
@NatureMedicine
Results from phase 2 SIGNAL study of #pepinemab #immunotherapy in early #huntingtonsdisease suggest a treatment-related reduction in caudate #brain atrophy and reversal of brain metabolic activity decline that is typical of #hd progression. #nmedclinical
www.nature.com/articles/s41591-022-01919-8 -
Nature Medicine
@NatureMedicine
📢 Less than 2 weeks till the abstract deadline! Submit by August 22nd to our digital health conference 'Medicine in a Virtual Age'. It's a fully virtual event and completely free to attend. 🎉
www.cvent.com/c/abstracts/858554f5-9204-40ec-9ac6-4229681…
#medinvirtualage22 #digitalhealth #ai -
Nature Medicine
@NatureMedicine
An engineered protein engages the efferocytosis pathway to induce beta-#amyloid engulfment, resulting in behavioral rescue in #alzheimers models without the increased inflammation or vascular pathology seen with conventional antibody therapy. @wonsukchung
www.nature.com/articles/s41591-022-01926-9 -
Nature Medicine
@NatureMedicine
As @WHO declares #monkeypox a public health emergency of international concern, we reflect on the missed opportunities to stop this outbreak and how the world is sleepwalking toward another pandemic.
A thread… (1 of 6)
www.nature.com/articles/s41591-022-01918-9 -
Nature Medicine
@NatureMedicine
The prospective evaluation of a #machinelearning based early warning system for #sepsis showed that interaction of health care providers with the system was associated with better patient outcomes, including reduced in-hospital mortality @suchisaria www.nature.com/articles/s41591-022-01894-0
-
Nature Medicine
@NatureMedicine
In our latest News & Views: A real-time early warning system for #sepsis detection shows promising adoption by providers and improvements in patient outcomes; David Bates and @AniaSyrowatka @harvardmed discuss the data.
@DBatesSafety @BrighamWomens #ai
www.nature.com/articles/s41591-022-01878-0 -
Nature Medicine
@NatureMedicine
In our latest News and Views: Charlotte Sumner and Thomas O. Crawford @HopkinsMedicine discuss implications of the phase 3 SPR1NT trial, in which pre-symptomatic #genetherapy demonstrated impressive outcomes in infants with spinal muscular atrophy #sma
www.nature.com/articles/s41591-022-01889-x -
Nature Medicine
@NatureMedicine
Virtual conferences democratize access to science.
World View from Deborah L. Johnson, President and CEO of @KeystoneSymp
www.nature.com/articles/s41591-022-01849-5 -
Nature Medicine
@NatureMedicine
Africa’s outbreak sentinels - how monitoring wildlife can prevent the next pandemic 🦇
Immersive news feature from @pauladepoju
www.nature.com/immersive/d41591-022-00064-6/index.html -
Nature Medicine
@NatureMedicine
Africa’s outbreak sentinels - how monitoring wildlife can prevent the next pandemic 🦇
Immersive news feature (our second ever!) from @pauladepoju
www.nature.com/immersive/d41591-022-00064-6/index.html -
Nature Medicine
@NatureMedicine
Delighted to announce that registration is open and FREE for @NatureMedicine's virtual conference on 'Medicine in a Virtual Age'.
Abstract submission also open... tell us about your research!
#medinvirtualage22 #digitalhealth #ai #wearables
Nature Conferences
@NatureConf
#medinvirtualage22 is now accepting registrations & abstracts for this fall!
This FREE virtual conference will discuss the recent advances in the development, application & implementation of strategies to deliver health care remotely.
🎟️👉conferences.nature.com/VirtualMedicine
@NatureMedicine -
Nature Medicine
@NatureMedicine
Strategies to record and use ethnicity information in routine health data, whilst engaging with patients and the public.
Comment from @AshRouten @kamleshkhunti and colleagues @uniofleicester
www.nature.com/articles/s41591-022-01842-y -
Nature Medicine
@NatureMedicine
Myths about diversity in clinical trials reduce return on investment for industry.
Correspondence from @SuhailBMT and colleagues @genentech
www.nature.com/articles/s41591-022-01858-4 -
Nature Medicine
@NatureMedicine
At the #asco22 Education session "Overcoming KRAS-mutant Lung Cancer"? Read about the phase 1 trial on tumor-infiltrating lymphocyte treatment for #pd-1 resistant #lungcancer led by speaker Eric Haura
www.nature.com/articles/s41591-021-01462-y -
Nature Medicine
@NatureMedicine
At the #asco22 Poster Session on genitourinary cancers? Read about the phase 1 trial on PSMA-targeting TGFβ-insensitive #cartcells for #prostatecancer led by presenter Naomi Haas www.nature.com/articles/s41591-022-01726-1
-
Nature Medicine
@NatureMedicine
At the #asco22 Poster Session on #melanoma? Read about the phase 1/2 trial on immune vaccine against IDO/PD-L1 plus #nivolumab for #melanoma led by presenter Inge Marie Svane www.nature.com/articles/s41591-021-01544-x
-
Nature Medicine
@NatureMedicine
Clinical outcome measures in patients with soft-tissue #sarcomas are better following #anti-PD-1 treatment in a cohort prospectively selected for the presence of intratumoral tertiary lymphoid structures. @AItalianoMD #nmedclinical #immunotherapy
www.nature.com/articles/s41591-022-01821-3 -
Nature Medicine
@NatureMedicine
Attending #asco22 this week?
Our call for submission of innovative research on the prevention, detection, diagnostic and treatment of #cancer is still open. Reach out to our #oncology editor @UlrikeHarjes to discuss your work!
How to submit 👉go.nature.com/3LMQtY0 -
Nature Medicine
@NatureMedicine
At the #asco22 Clinical Controversies session on #mesothelioma? Read about the phase II trial on durvalumab plus platinum-pemetrexed for unresectable mesothelioma led by speaker @FordePatrick www.nature.com/articles/s41591-021-01541-0
-
Nature Medicine
@NatureMedicine
At the #asco22 Plenary Session? Read about the phase II trial on #ctdna-guided treatment with #pertuzumab plus #trastuzumab for #her2-amplified metastatic colorectal cancer led by speaker Takayuki Yoshino www.nature.com/articles/s41591-021-01553-w
-
Nature Medicine
@NatureMedicine
At #asco22 #melanoma and skin cancer session?
Check out the results of the PRADO extension cohort of the OpACIN-neo trial on personalized treatment after neoadjuvant ipilimumab + nivolumab in melanoma, led by speaker @ProfCUBlankNKI
Published today 👉 www.nature.com/articles/s41591-022-01851-x -
Nature Medicine
@NatureMedicine
Attending #asco22 this week?
Our call for submission of innovative research on the prevention, detection, diagnostic and treatment of #cancer is still open. Reach out to our #oncology editor @UlrikeHarjes to discuss your work!
How to submit 👉go.nature.com/3LMQtY0 -
Nature Medicine
@NatureMedicine
At the #asco22 "Innovative approaches to the management of #aml session"? Read about the phase 1 #clinicaltrial on bispecific CAR T cells for refractory B cell malignancies by speaker @LoriMuffly www.nature.com/articles/s41591-021-01436-0
-
Nature Medicine
@NatureMedicine
At the #asco22 Genitourinary #cancer poster discussion? Read about the results and biomarker analysis of a #clinicaltrial on belzutifan in renal cell carcinoma by presenters @DrChoueiri and @EJonasch www.nature.com/articles/s41591-021-01324-7
-
Nature Medicine
@NatureMedicine
Attending #asco22 this week?
Our call for submission of innovative research on the prevention, detection, diagnostic and treatment of #cancer is still open. Reach out to our #oncology editor @UlrikeHarjes to discuss your work!
How to submit 👉go.nature.com/3LMQtY0 -
Nature Medicine
@NatureMedicine
At the #asco22 Gastrointestinal cancer poster discussion? Read a recent report of the interim results of a phase 1 trial on Claudin18.2-specific CAR T cells in gastrointestinal cancers led my presented Changsong Qi www.nature.com/articles/s41591-022-01800-8
-
Nature Medicine
@NatureMedicine
In case you missed the #asco22 session on The Microbiome As an Emerging Target in Gastroesophageal, Pancreatic, and Hepatobiliary Cancers this morning - check out this Review from @JenWargoMD & colleagues on recent advances in microbial targeting:
www.nature.com/articles/s41591-022-01779-2 -
Nature Medicine
@NatureMedicine
At the #asco22 "Bringing #immunotherapy into the clinical setting" session? Read about the NEOSTAR phase 2 #clinicaltrial in non-small cell lung cancer led by presented Tina Cascone www.nature.com/articles/s41591-020-01224-2
-
Nature Medicine
@NatureMedicine
At #asco22 Symposium on targeted therapy in GI cancer?
Check out the results & biomarker analysis of the phase 2 PRINCE trial on a CD40 agonist, nivolumab and chemotherapy in #pancreaticcancer, led by speaker @laceykitch @parkerici
Published today 👉 www.nature.com/articles/s41591-022-01829-9 -
Nature Medicine
@NatureMedicine
At the #asco22 session on Global Challenges in Access to and Implementation of Precision Oncology? Check out this Perspective from Emile Voest & colleagues
@quimmateo @LotteSteuten @VHIO @NKI_nl
www.nature.com/articles/s41591-022-01717-2 -
Nature Medicine
@NatureMedicine
At the #asco22 Genitourinary Cancer session? Read about the phase 3 #clinicaltrial of atezolizumab with enzalutamide in metastatic castration-resistant #prostatecancer led by speaker @tompowles1 www.nature.com/articles/s41591-021-01600-6
-
Nature Medicine
@NatureMedicine
At the #asco22 Head and Neck Cancer session? Read about the phase 3 #clinicaltrial on Toripalimab plus chemotherapy for #nasopharyngeal carcinoma led by speaker Hai-Qiang Mai www.nature.com/articles/s41591-021-01444-0
-
Nature Medicine
@NatureMedicine
At the #asco22 Cancer Groundshot session? Check out this Perspective from CS Pramesh & colleagues on challenges & priorities for cancer research in low- and middle-income countries 🌍
www.nature.com/articles/s41591-022-01738-x
@cspramesh @TataMemorial @doctorsoumya @WHO @IARCWHO @NCIGlobalHealth -
Nature Medicine
@NatureMedicine
1/6 Attending #asco22 or #ada2022 and haven’t had the opportunity to speak to one of editors in person? You can still submit your research to @NatureMedicine. Here’s a quick how-to guide on our scope and submission guidelines. @UlrikeHarjes @JenLSargent #oncologytwitter #diabetes
-
Nature Medicine
@NatureMedicine
JOB ALERT: We're seeking a talented individual to join our team as Associate or Senior Editor handling research in #ai, digital medicine & health informatics - applications close on July 1 👉 go.nature.com/3GIFspB
-
Nature Medicine
@NatureMedicine
Strategies to record and use ethnicity information in routine health data.
Comment from @AshRouten @kamleshkhunti and colleagues @uniofleicester
www.nature.com/articles/s41591-022-01842-y -
Nature Medicine
@NatureMedicine
#machinelearning applied on #electronichealthrecords can predict #mentalhealth crises 28 days in advance and become a clinically valuable tool for managing caseloads and mitigating the risk of crisis. #ai @ollieharrison @plusjavi_ @amat1c @KoaHealth
www.nature.com/articles/s41591-022-01811-5 -
Nature Medicine
@NatureMedicine
Our call for submission of innovative research on the prevention, detection, diagnostic and treatment of #cancer is still open. Reach out to our #oncology editor, @UlrikeHarjes, at #asco22 next week, to discuss your work! How to submit 👉go.nature.com/3LMQtY0
-
Nature Medicine
@NatureMedicine
A new population-based study reveals that promising #alzheimersdisease plasma #biomarkers, #p-tau181 and #p-tau217, are increased in individuals without #ad but who have other co-morbidities, affecting their normal reference ranges and cut-points.
www.nature.com/articles/s41591-022-01822-2 -
Nature Medicine
@NatureMedicine
Solving medicine’s data bottleneck: Nightingale Open Science.
Comment from @m_sendhil @oziadias @UCBerkeley @NightingaleOS
www.nature.com/articles/s41591-022-01804-4 -
Nature Medicine
@NatureMedicine
#coronavac protects young children from severe #covid19 during a #sarscov2 #omicron surge, supporting the effectiveness and importance of vaccinating this #pediatric population. #vaccine
www.nature.com/articles/s41591-022-01874-4 -
Nature Medicine
@NatureMedicine
Why preprints are good for patients.
Worldview from @PeterHorby @PSIOxford @UniofOxford
www.nature.com/articles/s41591-022-01812-4 -
Nature Medicine
@NatureMedicine
A joint international collaboration to address the inevitable mental health crisis in Ukraine.
Correspondence from Wei Bai, Hong Cai, Sha Sha and colleagues @UM_1981 @WPA_Psychiatry @PRCPconference
www.nature.com/articles/s41591-022-01828-w -
Nature Medicine
@NatureMedicine
In our latest News and Views: John Buse and Klara Klein @UNC_SOM discuss the DAWN and SEED trials, which demonstrate the potential of glucokinase activators for treatment of type 2 #diabetes - but how will they fit in the treatment landscape?
www.nature.com/articles/s41591-022-01783-6 -
Nature Medicine
@NatureMedicine
Analysis of individual-level patient records from #brazil reveals that the extensive shocks in #covid19 mortality rates are associated with pre-pandemic geographic #inequities, as well as shortages in healthcare capacity during the #pandemic
www.nature.com/articles/s41591-022-01807-1 -
Nature Medicine
@NatureMedicine
Read our latest News and Views: Amit Bar-Or and colleagues discuss recent data that provide some of the most convincing evidence yet linking Epstein–Barr virus to multiple sclerosis.
#ebv #ms @PennMedicine @TheWistar
www.nature.com/articles/s41591-022-01823-1 -
Nature Medicine
@NatureMedicine
Our #genetics and #genetherapy editor @AnnaRanzoni is virtually attending the Keystone Precision Genome Engineering meeting this week 🧬
Get in touch if you'd like to chat and learn more about @NatureMedicine!
#ksprecisiongene22
👉keysym.us/22Q5Nature -
Nature Medicine
@NatureMedicine
Results from a phase 1 clinical trial show that a broadly neutralizing, HIV-specific antibody is durably expressed in vivo from a viral vector, highlighting an alternate approach for the delivery of antibodies in humans @NIAIDNews #hiv #nmedclinical www.nature.com/articles/s41591-022-01762-x
-
Nature Medicine
@NatureMedicine
A decentralized, privacy-preserving machine learning framework used to train a clinically relevant #ai system identifies actionable molecular alterations in #colorectalcancer patients from histopathology slides collected in real-world settings @jnkath www.nature.com/articles/s41591-022-01768-5
-
Nature Medicine
@NatureMedicine
Could microbial targeting become a pillar of personalized cancer care? In their Review, @JenWargoMD & colleagues discuss recent advances and future directions that could make this a reality.
@mchelvanambi @GustaveRoussy @MDAndersonNews @NatResCancer
www.nature.com/articles/s41591-022-01779-2 -
Nature Medicine
@NatureMedicine
📰Learn more about the development and implications of this new study on infant B cell #leukemia in our recent Research Briefing! @Muzz_Haniffa @sbomken @Dr_JB @HaniffaLab @UniofNewcastle @sangerinstitute @NatResCancer www.nature.com/articles/s41591-022-01719-0
-
Nature Medicine
@NatureMedicine
How to correct the market for children’s cancer drugs.
World View from patient advocate @NancyFGoodman @KIDSvCANCER. @NatResCancer
www.nature.com/articles/s41591-022-01747-w -
Nature Medicine
@NatureMedicine
Theranostics aim to both diagnose and treat cancer - and could be big business in precision oncology.
News Feature from @edbites. @NatResCancer
www.nature.com/articles/s41591-022-01759-6 -
Nature Medicine
@NatureMedicine
A golden era of cancer clinical trials: from antibody drug conjugates and proteolysis-targeting chimeras to liquid biopsy for early detection.
News feature from Paul Webster. @NatResCancer
www.nature.com/articles/s41591-022-01760-z -
Nature Medicine
@NatureMedicine
Gut microbiome composition correlated with clinical response to anti-CD19 #cartcells & prior antibiotic treatment was associated with ⬇️ survival & ⬆️neurotoxicity @MelodySmithMD @MarcoRuella @DrMvandenBrink @MSKCancerCenter @PennMedicine Image: G. Sotillo www.nature.com/articles/s41591-022-01702-9
-
Nature Medicine
@NatureMedicine
Cancer treatments should benefit patients: a common sense revolution in oncology. Comment from @oncology_bg and Christopher Booth @QueensuPHS @queensu
@NatResCancer
www.nature.com/articles/s41591-021-01662-6 -
Nature Medicine
@NatureMedicine
New Review: CS Pramesh and colleagues from around the 🌍 discuss challenges and priorities for cancer research in low- and middle-income countries
#closethecaregap
@cspramesh @TataMemorial @doctorsoumya @WHO @IARCWHO @NCIGlobalHealth @NatResCancer
www.nature.com/articles/s41591-022-01738-x -
Nature Medicine
@NatureMedicine
Nature Medicine, in partnership with @NatureComms and @CommsMedicine, is excited to announce a call for submission of clinical cancer research papers. Learn how to submit your clinical trial > go.nature.com/3OmiIiC #cancerresearch #oncology #clinicaltrials
-
Nature Medicine
@NatureMedicine
⚡Our April issue is live! ⚡
🧵1/4 In this Focus issue dedicated to The Future of Cancer Research, we take stock of progress and explore ways to deliver research and care that is innovative, sustainable, and patient-focused.
@NatResCancer 🦀
www.nature.com/nm/volumes/28/issues/4Post not available here, view on X
Nature Medicine
@NatureMedicine
🧵4/4 With @CommsMedicine and @NatureComms we are issuing a call for papers that describe innovative approaches to cancer prevention, detection and treatment — both clinical trials and population-based studies with global implications.
#nmedclinical
www.nature.com/nm/clinicalresearch/callforpapers2022 -
Nature Medicine
@NatureMedicine
The BF1RST trial assessing the utility of blood tumor mutational burden to predict benefit from atezolizumab in #lungcancer did not meet its 1ry objective, underscoring the need to further investigate the significance of the biomarker for patient selection www.nature.com/articles/s41591-022-01754-x
-
Nature Medicine
@NatureMedicine
It's the last day of #aacr2022 and we want to know what are your top 3 highlights from this year's meeting? Keep following @NatureMedicine and watch out for our special focus on The Future of Cancer Research going live on April 19! @AACR #cancerresearch
-
Nature Medicine
@NatureMedicine
Six places where drones are delivering medicines - from the islands of Scotland and Vanuatu to the Congolese jungle.
News feature from @ElizabethType1
www.nature.com/articles/d41591-022-00053-9 -
Nature Medicine
@NatureMedicine
At the #aacr22 Minisymposium on Adoptive Cell Therapy? Check out this phase 1 trial led by #aacr22 speaker @MackallLab and #davidmiklos @StanfordCancer on bispecific CD19- and CD22-specific CAR T cells in patients with B-cell #lymphoma and B-cell #leukemia www.nature.com/articles/s41591-021-01436-0
-
Nature Medicine
@NatureMedicine
#aacr22 attendees, interested in submitting clinical trials & observational studies to @NatureMedicine?
✔️Our clinical research submission guidelines go.nature.com/3sidex5
📧Email us with any ❓s ! nature.com/nm/editors
🔍Find our 2019-2021 clinical papers with #nmedclinical -
Nature Medicine
@NatureMedicine
At the #aacr22 Biomarkers of Cancer Evolution session? Check out this phase 2 clinical trial led by speaker #priscillabrastianos @MGHCancerCenter showing that anti-PD-1 was safe & associated with a 3 month OS of 60% in patients with leptomeningeal disease www.nature.com/articles/s41591-020-0918-0
-
Nature Medicine
@NatureMedicine
Check out this phase 1 trial of PSMA-specific, TGF-Beta signaling resistant #cartcells in patients with #prostatecancer led by #aacr22 speaker @carlhjune, @NaomiHaas5 & #josephfraietta @PennMedicine www.nature.com/articles/s41591-022-01726-1
-
Nature Medicine
@NatureMedicine
At the #aacr22 plenary session on Precision Medicine for Immuno-Oncology? Check out this work led by @thommen_ds and speaker #tonschumacher @NKI_nl on an ex vivo platform of patient-derived #tumor fragments to assess responses to #immunotherapy www.nature.com/articles/s41591-021-01398-3
-
Nature Medicine
@NatureMedicine
An analysis of brain metastasis models and cohorts of patient samples identifies a targetable mechanism underlying the resistance to whole-brain #radiotherapy that can inform patient selection for personalized radiotherapy @valientelab @CNIOStopCancer
www.nature.com/articles/s41591-022-01749-8 -
Nature Medicine
@NatureMedicine
At the #aacr22 Biomarkers Minisymposium? Read about this biomarker analysis of the phase 3 JAVELIN Bladder 100 trial, which may identify patients with urothelial carcinoma who will benefit from avelumab #bladdercancer @tompowles1 @QMBCI @PfizerOncMed www.nature.com/articles/s41591-021-01600-6
-
Nature Medicine
@NatureMedicine
At the #aacr22 Understanding Microbe-Tumor Interactions in Health & Disease session? Read work led by speaker @JenWargoMD & Laurence Zitvogel @GustaveRoussy on the association between clinical responses to #immunotherapy and commensal bacteria in #melanoma www.nature.com/articles/s41591-021-01406-6
-
Nature Medicine
@NatureMedicine
At the #aacr22 CAR T cells for Solid Tumors session? Read about interim results from the phase 1 BrainChild-01 trial evaluating intracranial infusions of HER2-specific #cartcells in patients with #cnstumors @VitanzaNick @seattlechildren @SCTherapeutics www.nature.com/articles/s41591-021-01404-8
-
Nature Medicine
@NatureMedicine
At the #aacr22 Neoadjuvant & Perioperative Immunotherapy Clinical Trials session? Check out the NEOSTAR phase 2 clinical trial led by speaker #tinacascone @MDAndersonNews, showing that neoadjuvant #immunotherapy could be beneficial in #lungcancer www.nature.com/articles/s41591-020-01224-2
-
Nature Medicine
@NatureMedicine
At the #aacr22 Clinical Trials Plenary Session on Cellular Immunotherapies? Read about a #transcriptomics analysis of axi-cel #cartcells infusion products that identified associations with response and toxicity @GreenLymphoLab @IamLinghua @Lymphoma_Doc www.nature.com/articles/s41591-020-1061-7
-
Nature Medicine
@NatureMedicine
At the #aacr22 session on Artificial Intelligence in Cancer Research and Care? Read this #ai study on a model that can predict follow-up recommendations to improve early detection & reduce screening costs in #breastcancer @YalaTweets @AIHealthMIT www.nature.com/articles/s41591-021-01599-w
-
Nature Medicine
@NatureMedicine
Attending the #aacr22 Opening Plenary Session? Check out this paper led by @KarunaMDPhD, speaker @CharlesSawyers and @JoshSmithMDPhD on a rectal cancer organoid platform that retains the pathological features of matched patient tumors www.nature.com/articles/s41591-019-0584-2
-
Nature Medicine
@NatureMedicine
At the #aacr22 Opening Plenary Session on Precancer Discovery Science? Check out this study led by speaker @RFitzgerald_lab and @markowetzlab on a deep learning system that streamlines the workflow of pathologists for Barrett’s esophagus detection www.nature.com/articles/s41591-021-01287-9
-
Nature Medicine
@NatureMedicine
At the #aacr22 educational session on neoadjuvant #immunotherapy? Read about long-term outcomes and biomarker analyses of 2 neoadjuvant immunotherapy clinical trials in patients with #melanoma led by speaker @ProfCUBlankNKI @NKI_nl www.nature.com/articles/s41591-020-01211-7
-
Nature Medicine
@NatureMedicine
In a phase 1b/2 trial, intravitreal administration of sepofarsen in patients with #lebercongenitalamaurosis achieved a manageable safety profile, adverse events being dose-dependent,and improvements of visual function @uiowaeye @uzgent @PennMedicine @ProQR www.nature.com/articles/s41591-022-01755-w
-
Nature Medicine
@NatureMedicine
In our latest Review, @Sander_vdLinden takes a deep dive into the psychology of misinformation — from susceptibility to spread and interventions to boost psychological immunity.
@Cambridge_Uni @CambPsych
www.nature.com/articles/s41591-022-01713-6 -
Nature Medicine
@NatureMedicine
News and Views just out: Kathryn Edwards and @kathleen_neuzil discuss data from the first human challenge study with SARS-CoV-2, and consider the implications for future research.
@VanderbiltU @UMmedschool
www.nature.com/articles/s41591-022-01778-3 -
Nature Medicine
@NatureMedicine
In the phase 2 ZUMA-12 trial, first-line treatment with axi-cel #cartcells exhibited a high complete response rate and a manageable safety profile in adults with high-risk large B cell lymphoma @MDAndersonNews @MoffittNews @NatResCancer #tcellrx #lymsm www.nature.com/articles/s41591-022-01731-4
-
Nature Medicine
@NatureMedicine
Innovative approaches from recent conflicts can aid the health crisis in Ukraine.
World view from Debarati Guha-Sapir @CREDUCL @UCLouvain_be @JohnsHopkins
www.nature.com/articles/d41591-022-00045-9
-
Nature Medicine
@NatureMedicine
Preclinical data and results from a phase 1/2 trial demonstrate preliminary safety and efficacy of topically-administered #genetherapy for recessive dystrophic #epidermolysisbullosa @StanfordMed @KrystalBiotech @debraOfAmerica @EBResearch #ebawareness www.nature.com/articles/s41591-022-01737-y
-
Nature Medicine
@NatureMedicine
A global analysis across 62 studies reveals an increased risk of death by #suicide in #cancer patients and underscores the need for comprehensive psycho-oncologic therapy during clinical routine to improve the quality of life of patients. #mentalhealth
www.nature.com/articles/s41591-022-01745-y -
Nature Medicine
@NatureMedicine
Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery.
Comment from Thomas Marron, @MiriamMerad and colleagues @IcahnMountSinai
www.nature.com/articles/s41591-022-01681-x -
Nature Medicine
@NatureMedicine
⏰1 week left to apply for our locum editor position! This 6 month job will be based out of our NYC 🏙️or London🎡offices. Applicants should be interested in 👉#editorlife
👉#immunology, #immunotherapy, #machinelearning or #digitalmedicine!
Apply here! 👇career5.successfactors.eu/sfcareer/jobreqcareer?jobId=41346 -
Nature Medicine
@NatureMedicine
⏰There's still time to register for our #covid19 conference! go.nature.com/3JgPFcY #futurecovid2022 #sarscov2
With sessions on:
💉immune responses
💊therapeutics
🦠COVID19 risk factors & sequelae
🌐Challenges to pandemic responses
🔮Applying advances for future pandemics -
Nature Medicine
@NatureMedicine
Innovative approaches used in recent armed conflicts, such as remote medicine, can aid the health crisis in #ukraine.
World view from Debarati Guha-Sapir @CREDUCL @UCLouvain_be @JohnsHopkins
www.nature.com/articles/d41591-022-00045-9
-
Nature Medicine
@NatureMedicine
Therapeutic antibodies, and sera from immunocompromised individuals prophylactically treated with therapeutic antibodies, differ in neutralizing activity against the #sarscov2 #omicron BA.1 and BA.2 sublineages #covid19 @Timothee_B @Virus_Immunity www.nature.com/articles/s41591-022-01792-5
-
Nature Medicine
@NatureMedicine
In our latest News and Views: Christina Vandenbroucke-Grauls and Jan Kluytmans discuss new data highlighting the importance of a ‘One Health’ approach to tackling the huge problem of antimicrobial resistance
@AarhusUni #amr
www.nature.com/articles/s41591-022-01752-z -
Nature Medicine
@NatureMedicine
Establishment of an open biomedical database for commercial spaceflight 🚀
Correspondence from @EUrquietaMD, Jimmy Wu, James Hury and @DoritDSpaceHlth @bcmhouston @BCMSpaceHealth
www.nature.com/articles/s41591-022-01761-y -
Nature Medicine
@NatureMedicine
In the phase 2 ZUMA-12 trial, first-line treatment with axi-cel #cartcells exhibited a high complete response rate and a manageable safety profile in adults with high-risk large B cell lymphoma @MDAndersonNews @MoffittNews @NatResCancer #tcellrx #lymsm www.nature.com/articles/s41591-022-01731-4
-
Nature Medicine
@NatureMedicine
Deep learning applied to endomyocardial biopsy images can detect rejection of transplanted hearts and determine the subtype and grade of rejection, with potential for reducing inter-observer variability www.nature.com/articles/s41591-022-01709-2
-
Nature Medicine
@NatureMedicine
Preimplantation genetic testing of human embryos is a rapidly advancing field, but scientists and ethicists are calling for caution.
We present 3 articles highlighting new research and expert commentary on this controversial topic.
THREAD 🧵 -
Nature Medicine
@NatureMedicine
📢We're hiring a locum editor! This 6 month position will be based out of our NYC 🏙️or London 🎡offices. If you're interested in #immunology, #cancer #immunotherapy, #machinelearning or #digitalmedicine, apply by April 1st! Please RT & reach out with❓s! www.linkedin.com/jobs/view/2964185169
-
Nature Medicine
@NatureMedicine
Russian COVID-19 vaccine in jeopardy after Ukraine invasion.
News from Paul Webster.
www.nature.com/articles/d41591-022-00042-y -
Nature Medicine
@NatureMedicine
Africa prepares for endemic COVID-19.
News feature from @pauladepoju
www.nature.com/articles/d41591-022-00040-0 -
Nature Medicine
@NatureMedicine
⏰ Last call for abstracts for our conference on "Understanding COVID-19 to prepare for the next pandemic"! 🦠💉 #futurecovid2022
🗓️ Abstracts are due by this upcoming Monday, March 14th!
📒 Program go.nature.com/3vys3gs
⭐️ Register here! go.nature.com/3JgPFcY -
Nature Medicine
@NatureMedicine
Our #genetics editor @AnnaRanzoni is going to attend the "Single Cell Biology: Pushing New frontiers in the Life Sciences" symposium - 5-9 April 2022 @KeystoneSymp #kssinglecell22
Get in touch if you'd like to chat and learn more about @NatureMedicine
👉 keysym.us/22T9Nature -
Nature Medicine
@NatureMedicine
📢 Abstracts due by Monday, March 14th for our conference on "Understanding COVID-19 to prepare for the next pandemic"! 🦠💉 See some of our fabulous speakers below! #futurecovid2022
⭐️ Registration is FREE for students! go.nature.com/3JgPFcY
📒 Program go.nature.com/3vys3gs -
Nature Medicine
@NatureMedicine
Characterization of myelodysplastic syndromes reveals compensatory survival mechanisms underpinning the failure of hypomethylating agents, and uncovers biomarkers that predict clinical response to venetoclax-based therapy www.nature.com/articles/s41591-022-01696-4
-
Nature Medicine
@NatureMedicine
Healthcare is increasingly provided in a patient’s home, but this raises unique liability issues.
Comment on the hospital-at-home from @david__simon, @CohenProf, Celynne Balatbat & @anaeze_offodile, @PetrieFlom @Harvard_Law @theNASEM
www.nature.com/articles/s41591-022-01697-3 -
Nature Medicine
@NatureMedicine
In a recent News and Views, @HeidiRehm discusses the impact of the UK’s 100,000 Genomes Project and how to further advance #raredisease diagnosis for all.
#genomes100k @broadinstitute #rarediseaseday
www.nature.com/articles/s41591-021-01657-3 -
Nature Medicine
@NatureMedicine
Today is #rarediseaseday, a day dedicated to raising awareness and generating change for the 300 million people living worldwide with a #raredisease. To mark this day, here is a selection of recent content on #rarediseases we published @NatureMedicine www.rarediseaseday.org
-
Nature Medicine
@NatureMedicine
1/
A regulatory loophole that allows a number #invitrodiagnostic tests to enter the market without any independent regulatory oversight poses a significant risk to the public. Our Feb editorial calls for policy makers to address this #publichealth concern www.nature.com/articles/s41591-022-01729-y -
Nature Medicine
@NatureMedicine
A multi-scale model using population-level transmission and individual-level vaccination data suggests that vaccine dose fractionation could be a cost-effective strategy for mitigating the #covid19 pandemic in India @bencowling88 www.nature.com/articles/s41591-022-01736-z
-
Nature Medicine
@NatureMedicine
Healthcare is increasingly provided in a patient’s home, but this raises unique liability issues.
Comment on the hospital-at-home from @david__simon, @CohenProf, Celynne Balatbat & @anaeze_offodile, @PetrieFlom @Harvard_Law @theNASEM
www.nature.com/articles/s41591-022-01697-3 -
Nature Medicine
@NatureMedicine
To celebrate #blackhistorymonth , we're highlighting pieces by & about fantastic Black researchers in the US. A call to action from @Dr_Ighodaro, Erica Littlejohn, @AdeAkhMD & Richard Benson on giving voice to Black women in science and medicine www.nature.com/articles/s41591-021-01438-y
-
Nature Medicine
@NatureMedicine
📆 Deadline extended to February 28th 📆
📣We are hiring a senior or deputy editor! If you have prior editorial experience in #cancer or #oncology research, consider applying! Please retweet and reach out to us if you have any questions. More details 👇
career5.successfactors.eu/sfcareer/jobreqcareer?jobId=408… -
Nature Medicine
@NatureMedicine
Multi-omic profiling of patients with coronary artery disease reveals links between alterations in the serum #metabolome with genetics, diet and the #microbiome @segal_eran www.nature.com/articles/s41591-022-01686-6
-
Nature Medicine
@NatureMedicine
To celebrate #blackhistorymonth , we're highlighting pieces by and about fantastic Black researchers in the United States. Kizzmekia Corbett @KizzyPhD talks about the importance of mentorship and the need for representation in underserved communities www.nature.com/articles/s41591-020-1122-y
-
Nature Medicine
@NatureMedicine
Mark your 🗓️! Our #immunology editor @SaheliSadanand, along with @krknrm from @NatureCancer and @SafiaDanovi from @NatureGenet, will be participating in a @BlackinCancer Pipeline Series discussion about #editorlife next Tuesday, Feb 22 at 1 PM EST/6 PM GMT. More details 👇
BlackinCancer
@BlackinCancer
The Pipeline Series is BACK and we're bringing back the Nature editorial team!🥳📃
Interested in an #editorialcareer or have questions about #academicpublishing? Come along and join the conversation next week ➡️www.eventbrite.co.uk/e/the-pipeline-series-a-chat-with-na…
#published #bicpp #cancerresearch #scicomm -
Nature Medicine
@NatureMedicine
The medicalization of freedom: how anti-science movements use the language of personal liberty and how we can address it.
Correspondence from Jerel Ezell @AfricanaCU @Cornell
www.nature.com/articles/s41591-021-01640-y -
Nature Medicine
@NatureMedicine
To celebrate #blackhistorymonth , we're highlighting pieces by & about fantastic Black researchers in the US. @rpocisv chats with the founders of @BlackinNeuro, @BlackinCancer, @BlackinCardio & @BlackinPhysio.
@clintoria @siggs28 @Juststanss @kss_phd www.nature.com/articles/s41591-021-01315-8 -
Nature Medicine
@NatureMedicine
⏰ 10 days until applications close for this #cancer editor position in our @NatureMedicine team! #oncology @NatResCancer 👇
Nature Medicine
@NatureMedicine
📢 We are hiring a senior or deputy editor! If you have prior editorial experience in #cancer or #oncology research, consider applying! The deadline to apply is February 21st. Please retweet and reach out to us with ❓s! More details 👇 @NatResCancer
career5.successfactors.eu/sfcareer/jobreqcareer?jobId=408… -
Nature Medicine
@NatureMedicine
First-in-human combined intrathalamic and intrathecal gene therapy in two patients with Tay-Sachs disease provides early evidence on the safety and feasibility of the approach www.nature.com/articles/s41591-021-01664-4
-
Nature Medicine
@NatureMedicine
To celebrate #blackhistorymonth , we're highlighting pieces by and about fantastic Black researchers in the United States. Erica Warner @MonganInstitute @MGH_RI @MassGeneralNews and colleagues describe the MGH COVID Corps Research Internship www.nature.com/articles/s41591-020-1134-7
-
Nature Medicine
@NatureMedicine
Mars mission 🚀 could bring health benefits on Earth 🌍 - from research on radiation and microgravity, to advances in remote medicine and telehealth.
News feature from @MarionRenault
www.nature.com/articles/s41591-021-01665-3 -
Nature Medicine
@NatureMedicine
Registration & abstract submission are now open! Join us and our amazing speakers to discuss what it will take for the world to be better prepared for future pandemics. Please RT! #sarscov2 #covid19 #futurecovid2022 go.nature.com/3JgPFcY
-
Nature Medicine
@NatureMedicine
To celebrate #blackhistorymonth , we're highlighting pieces by and about fantastic Black researchers in the United States. Folakemi Odedina @MayoClinic & @MarianaStern @USC discuss how funders' diversity, equity and inclusion goals can be met www.nature.com/articles/s41591-021-01555-8
-
Nature Medicine
@NatureMedicine
Read our latest News and Views: @HeidiRehm discusses the impact of the UK’s 100,000 Genomes Project and how to further advance #raredisease diagnosis for all
#genomes100k @broadinstitute
www.nature.com/articles/s41591-021-01657-3 -
Nature Medicine
@NatureMedicine
Implantation of a multielectrode paddle that allows personalized electrical stimulation to all regions of the spinal cord involved in leg and trunk movements rapidly restores motor function in spinal cord injury patients with complete paralysis www.nature.com/articles/s41591-021-01663-5
-
Nature Medicine
@NatureMedicine
We @NatureMedicine are privileged to work with talented cancer researchers every day, publishing #translational and #clinical studies to help improve the lives of patients. In honor of #worldcancerday, here's a selection of our 2021 #cancer papers! #closethecaregap @NatResCancer
Post not available here, view on X
Nature Medicine
@NatureMedicine
The benefits of patient-reported outcomes (PROs) in early-phase clinical trials, including #oncology trials: from preliminary evidence on benefits and risks, to support for regulatory review @CPROR_UoB @drmelcalvert #worldcancerday #closethecaregap www.nature.com/articles/s41591-021-01648-4
-
Nature Medicine
@NatureMedicine
📢 We are hiring a senior or deputy editor! If you have prior editorial experience in #cancer or #oncology research, consider applying! The deadline to apply is February 21st. Please retweet and reach out to us with ❓s! More details 👇 @NatResCancer
career5.successfactors.eu/sfcareer/jobreqcareer?jobId=408… -
Nature Medicine
@NatureMedicine
To celebrate #blackhistorymonth , we're highlighting pieces by and about fantastic Black researchers in the United States. First up: @FutureDrDukes, the founder of @BlackInNeuro, shares ways you can better support Black trainees in the biomedical sciences www.nature.com/articles/s41591-020-1101-3
-
Nature Medicine
@NatureMedicine
1/ 🌏🆘
The threat of #climatechange to the future and wellbeing of humanity has never been more acute. Our January editorial calls for an urgent health-centered approach to climate action across all sectors.
www.nature.com/articles/s41591-021-01658-2 -
Nature Medicine
@NatureMedicine
⚡ Our January issue is live! ⚡ Read our latest content on pediatric #covid19, #genetherapy, therapeutic #sirna, #aso therapy, #ai and #spaceflight, as well as phase 3 clinical trial data on #prostatecancer, and much more!
www.nature.com/nm/volumes/28/issues/1 -
Nature Medicine
@NatureMedicine
In the IMbassador250 phase 3 trial, there was no improvement in overall survival following a checkpoint #immunotherapy combo + enzalutamide vs enzalutamide alone in mCRPC, but genomic & immune biomarkers may identify patients who derive benefit.
www.nature.com/articles/s41591-021-01600-6 -
Nature Medicine
@NatureMedicine
COVID-19 has revealed a pandemic of inequality in the Americas, which must be tackled.
World View from Carissa Etienne @DirOPSPAHO, Director of @pahowho @opsoms
www.nature.com/articles/s41591-021-01596-z -
Nature Medicine
@NatureMedicine
Read our latest News and Views: Nehmat Houssami & Karla Kerlikowske discuss new data on the use of of #ai in risk-based screening for #breastcancer
@CCNewSouthWales @Sydney_Uni @UCSF
www.nature.com/articles/s41591-021-01649-3 -
Nature Medicine
@NatureMedicine
Peripheral ancestral #sarscov2 spike-specific CD4+ and CD8+ #tcells induced by #bnt162b2 vaccination cross-react to the #omicron variant at higher levels than those induced by prior SARS-CoV-2 infection #covid19 #vaccines @marcus_buggert @karolinskainst
www.nature.com/articles/d41591-022-00017-z -
Nature Medicine
@NatureMedicine
HLA-independent #tcell receptors, in which the heavy and light chains of a CAR scFv are incorporated into the endogenous TCR locus, are more effective than #cd28-based #cars at targeting #tumors with low antigen expression. #leukemia #aml @sloan_kettering
www.nature.com/articles/s41591-021-01621-1 -
Nature Medicine
@NatureMedicine
COVID-19 in #pregnancy in Scotland study reveals substantially lower #vaccine uptake in pregnant women than in the general female population and not being vaccinated is associated with increased risk of severe complications of #covid19 in pregnancy.
www.nature.com/articles/s41591-021-01666-2 -
Nature Medicine
@NatureMedicine
The French health pass, or passe sanitaire, holds lessons for mandatory COVID-19 vaccination.
Correspondence from @JeremyK_Ward @INSERM and colleagues.
www.nature.com/articles/s41591-021-01661-7 -
Nature Medicine
@NatureMedicine
Parents give consent for their children’s health data to be used in research, but what happens when the children reach adulthood?
World View from @HastingsJ123, Independent Chair of the Participant Panel at @GenomicsEngland
www.nature.com/articles/s41591-021-01561-w -
Nature Medicine
@NatureMedicine
Hypermutation and microsatellite burden determine responses & long-term survival following PD-1 blockade in children and young adults with refractory cancers resulting from germline DNA replication repair deficiency @Uri_Tabori #immunotherapy #glioblastoma
www.nature.com/articles/s41591-021-01581-6 -
Nature Medicine
@NatureMedicine
In an interim analysis of the pivotal phase 2 ELARA trial, anti-CD19 #cartcells produced a high rate of complete responses with a manageable safety profile in adults with r/r #follicularlymphoma #lymsm #immunotherapy @DrNathanFowler @NovartisCancer www.nature.com/articles/s41591-021-01622-0
-
Nature Medicine
@NatureMedicine
#ai algorithms trained using chest X-rays consistently underdiagnose pulmonary abnormalities in historically under-served patient populations, raising ethical concerns regarding the clinical use of such algorithms @MarzyehGhassemi @Laleh77025150 @UofT
www.nature.com/articles/s41591-021-01595-0 -
Nature Medicine
@NatureMedicine
The risk of intensive care unit admission among children with #covid-19 or its sequelae is affected by age, ethnicity,and comorbidities. Understanding these modifiers may help identify at-risk children and guide interventions @_joe_ward @UCLchildhealth www.nature.com/articles/s41591-021-01627-9
-
Nature Medicine
@NatureMedicine
11 clinical trials that will shape medicine in 2022.
We ask leading researchers to name their most anticipated clinical trial for 2022, from CRISPR and psilocybin to oncolytic viruses.
News feature from @edbites
www.nature.com/articles/s41591-021-01601-5 -
Nature Medicine
@NatureMedicine
⚡️Our December issue is out⚡️Read our latest content on #covid19 vaccines, mRNA vaccine for #hiv, the effect of #school closures during the pandemic, biases in healthcare #ai, #clinicaltrial data in #mastocytosis, and much much more! www.nature.com/nm/volumes/27/issues/12
-
Nature Medicine
@NatureMedicine
As data emerge that boosters may help protect against Omicron, the supply of vaccines to Africa is further squeezed.
But fears of the COVID-19 variant may increase uptake, which is worryingly low in some countries - @pauladepoju reports.
www.nature.com/articles/d41591-021-00073-x -
Nature Medicine
@NatureMedicine
Our Year in Review is out now! We look back on another turbulent year of COVID-19, as well as notable advances across medicine, and what to expect from 2022.
healthcommunity.nature.com/posts/nature-medicine-s-year-i… -
Nature Medicine
@NatureMedicine
#ai algorithms trained using chest X-rays consistently underdiagnose pulmonary abnormalities in historically under-served patient populations, raising ethical concerns regarding the clinical use of such algorithms @MarzyehGhassemi @Laleh77025150 @UofT
www.nature.com/articles/s41591-021-01595-0 -
Nature Medicine
@NatureMedicine
Just announced! Understanding #covid-19 to prepare for the next #pandemic, April 4-5, 2022. We hope to see you there! Registration opens soon. Join the waitlist👉go.nature.com/3oEPnFx #natconf
-
Nature Medicine
@NatureMedicine
We are seeking an individual with strong interest in immunology, cancer or immunotherapy to join our team for a fixed 6mo term next year > check it out and spread the word. Applications close on Dec 23.👉 www.linkedin.com/jobs/senior-associate-editor-jobs
-
Nature Medicine
@NatureMedicine
How four transgender researchers are improving the health of their communities.
Q&A with @aydenisaac, @blackqueersci, @EKaleEdmiston & @TransHealthUK @Clini_Q, written by @Tara_Santora
Part of our series on DEI in medical research.
www.nature.com/articles/s41591-021-01597-y -
Nature Medicine
@NatureMedicine
⚡ Read our latest editorial ⚡
As part of our series on diversity, equity and inclusion, we commit to increase our diversity of commissioned content, and share reviewer demographics for geographical location, self-identified gender and career stage.
www.nature.com/articles/s41591-021-01582-5 -
Nature Medicine
@NatureMedicine
⚡November issue now live⚡ This month we launch a Series on Diversity, Equity and Inclusion in medical research. Our new content also includes #clinicaltrial data on colorectal and breast #cancer, #covid-19 vaccines, drug resistance in #ibd and much more. www.nature.com/nm/volumes/27/issues/11
-
Nature Medicine
@NatureMedicine
Patient-reported outcomes (PROs) in the regulatory approval of medical devices.
Correspondence from @samsamcr @drmelcalvert and colleagues @CPROR_UoB @unibirmingham
www.nature.com/articles/s41591-021-01546-9 -
Nature Medicine
@NatureMedicine
Funders’ goals for diversity, equity and inclusion will only be successful if they prioritize health disparities research and address biases in the funding application process.
Comment from @DrOdedina @MayoClinic and @MarianaStern @USC for our DEI series.
www.nature.com/articles/s41591-021-01555-8 -
Nature Medicine
@NatureMedicine
PRS scores are moving closer to widespread clinical use.
In our latest Perspective, a panel of experts in genetics, law, and ethics discuss recent advances and potential benefits, risks, and gaps.
@ICDAbio @cristenw @minouye271 @umichCVC @Cambridge_Uni
www.nature.com/articles/s41591-021-01549-6 -
Nature Medicine
@NatureMedicine
Read our News and Views by @RyanTedfordMD and colleagues @MUSChealth for an insightful discussion into SGLT-2 inhibitors for treatment of #heartfailure with preserved ejection fraction.
www.nature.com/articles/s41591-021-01565-6 -
Nature Medicine
@NatureMedicine
Our #immunotherapy editor @SaheliSadanand is virtually attending #sitc21! Please contact her if you'd like to chat about your work and learn more about the journal!
Saheli Sadanand
@SaheliSadanand
Excited for the next few days of #sitc21! Please reach out if you want to discuss your work and learn more about @NatureMedicine! #immunotherapy #immunology @sitcancer
-
Nature Medicine
@NatureMedicine
Today we publish 4 comments and an editorial that launch a new series: #dei in medical research.
Diversity, equity and inclusion are critically important if medical research is to deliver on its goal to improve human health.
A thread...
(1 of 6)
www.nature.com/collections/hbifidcdbe -
Nature Medicine
@NatureMedicine
A single dose of a broadly neutralizing, HIV-specific antibody transiently reduces viral load in plasma, and in some individuals is associated with durable virus suppression in the absence of antiretroviral therapy @BarouchLab @RagonInstitute www.nature.com/articles/s41591-021-01509-0
-
Nature Medicine
@NatureMedicine
School closures in municipalities in Japan at the start of the #covid19 pandemic showed no significant reduction in cases compared with case counts in municipalities with open #schools #sarscov2 @000fukumoto @cmcclean www.nature.com/articles/s41591-021-01571-8
-
Nature Medicine
@NatureMedicine
Results from a nationwide cohort study in the United States indicate that #schools can re-open for in-person learning without substantially increasing community case rates of #sarscov2 #covid19 www.nature.com/articles/s41591-021-01563-8
-
Nature Medicine
@NatureMedicine
In an observational cohort of pregnant women in Israel, the BNT162b2 #covid19 #vaccine was found to have effectiveness similar to that seen in the general population #sarscov2 #pregnancy @RanBalicer @dagan_noa @ClalitHealth www.nature.com/articles/s41591-021-01490-8
-
Nature Medicine
@NatureMedicine
🌟 NEW Consensus Statement on advancing the global public health agenda for #nafld in @NatRevGastroHep! @NatureMedicine is proud to be one of the many @NaturePortfolio journals endorsing this statement. 🧵 below, including a link to the accompanying editorial in @NatRevGastroHep
Nature Reviews Gastroenterology & Hepatology
@NatRevGastroHep
📢Out now! This new Consensus Statement on Advancing the global public health agenda for #nafld
FREE www.nature.com/articles/s41575-021-00523-4
Led by @JVLazarus & an international list of experts, the article aims to put NAFLD in the NCD spotlight @EASL_ilf
#fattyliver #mafld -
Nature Medicine
@NatureMedicine
During the COVID-19 pandemic, the public have turned to scientists and doctors for vital information. But science communication is a skill in itself, so we asked the experts to share their tips.
Feature from @polkajunction
www.nature.com/articles/s41591-021-01528-x -
Nature Medicine
@NatureMedicine
Clinical and genetic phenotyping of consanguineous family cases of neonatal syndromic diabetes and type 2 diabetes reveals a role for #genetic variants of ONECUT1 in monogenic and multifactorial #diabetes @KlegerLab @InstitutCochin @uni_ulm #stemcells www.nature.com/articles/s41591-021-01502-7
-
Nature Medicine
@NatureMedicine
Genomic analyses in the UK Biobank show that clonal hematopoiesis of indeterminate potential in the lymphoid lineage is associated with a higher risk of developing lymphoid malignancies #cancer @broadinstitute www.nature.com/articles/s41591-021-01521-4
-
Nature Medicine
@NatureMedicine
⭐ Research Highlight: Fatal police violence in the US is a major public health issue. A new study in @TheLancet reveals the extent to which this is systematically under-reported in government databases.
www.nature.com/articles/d41591-021-00063-z -
Nature Medicine
@NatureMedicine
⚡Our October issue is now live! ⚡ Read our latest content on #covidvaccines, #clonalhematopoiesis, new #clinicaltrial data on #hiv, #nash, #nafld, #melanoma, #all, neuromodulation for #depression, #prosthetics and much, much more.
www.nature.com/nm/volumes/27/issues/10 -
Nature Medicine
@NatureMedicine
#hepatitisb continues to exact a heavy public-health toll.
In our latest News and Views, Jake T. Liang @NIDDKgov discusses new approaches using #aso technology to treat the infection.
#hepb #antisense
www.nature.com/articles/s41591-021-01512-5 -
Nature Medicine
@NatureMedicine
The vast burden of #anemia in women within low- and middle-income countries requires immediate action.
Read our latest News and Views on this topic from @ParulChristian @JohnsHopkinsSPH
www.nature.com/articles/s41591-021-01514-3 -
Nature Medicine
@NatureMedicine
⭐ Research Highlight: People conceived as 'identical' twins have a distinct epigenetic signature that lasts into adulthood, according to a study published in @NatureComms
www.nature.com/articles/d41591-021-00062-0 -
Nature Medicine
@NatureMedicine
Protein structures predicted by Alphafold @DeepMind will aid medical research, but the greatest benefit will come if clinical data can be similarly used for #ai.
Comment from Janet Thornton @emblebi and colleagues
www.nature.com/articles/s41591-021-01533-0 -
Nature Medicine
@NatureMedicine
A phase 2b study, inhibition of hepatic stearoyl-CoA desaturase in patients with nonalcoholic #steatohepatitis was safe and tolerated; although reductions in liver fat were not significant, changes in liver enzymes and histology were observed. #scd1 #nash
www.nature.com/articles/s41591-021-01495-3 -
Nature Medicine
@NatureMedicine
Studies in mature human #adipocytes demonstrate that #obesity and #hyperinsulinemia can induce reentry into the cell cycle and induce #sensecence. #diabetes #insulin @SpaldingLab @karolinskainst
www.nature.com/articles/s41591-021-01501-8 -
Nature Medicine
@NatureMedicine
Case report describes a #biomarker driven closed-loop therapy for depression using implanted electrodes to continually sense brain activity and automatically trigger direct brain electrical stimulation in high #depression states. @scangos @ChangLabUcsf
www.nature.com/articles/s41591-021-01480-w -
Nature Medicine
@NatureMedicine
Psychedelics show great promise in treating mental-health conditions, but legal obstacles limit their use.
@MasonMarksMD and @CohenProf present a roadmap for wider acceptance and use of psychedelic therapy in the USA
@PetrieFlom @UNHLaw @Harvard_Law
www.nature.com/articles/s41591-021-01530-3 -
Nature Medicine
@NatureMedicine
⚡Read our latest editorial ⚡
With the end of the #covid19 pandemic nowhere in sight, a return to safe, in-person schooling must be prioritized now to avoid lifelong setbacks.
www.nature.com/articles/s41591-021-01543-y -
Nature Medicine
@NatureMedicine
⚡If you'd like to hear the latest discoveries in the fields of #genetherapy, #celltherapy and #tissueengineering, don't miss the #natconftissue21 virtual conference, organized by @SanRaffaeleMI and @NatureComms, 16-18 November 2021
Register at: conferences.nature.com/TissueTherapies -
Nature Medicine
@NatureMedicine
Neutralizing #antibodies, but not virus-specific #tcells, increased in most patients with solid tumors after a 3rd BNT162b2 #vaccine dose
#covid19 #sarscov2 #cancer @rachnatshroff @bonnie_lafleur @deeptabhattacha @uazcancer
www.nature.com/articles/s41591-021-01542-z -
Nature Medicine
@NatureMedicine
Health data from millions of people has been used to develop drugs and vaccines against COVID-19. But will researchers continue to access your data after the pandemic?
@MarionRenault investigates.
www.nature.com/articles/s41591-021-01493-5 -
Nature Medicine
@NatureMedicine
⚡ Read our latest Editorial ⚡ "It’s time to send children back to school"
With the end of the #covid19 pandemic nowhere in sight, a return to safe, in-person schooling must be prioritized now to avoid lifelong setbacks
www.nature.com/articles/s41591-021-01543-y -
Nature Medicine
@NatureMedicine
A government-led effort to identify correlates of protection for COVID-19 vaccines.
Correspondence from Richard Koup @NIH and colleagues
www.nature.com/articles/s41591-021-01484-6 -
Nature Medicine
@NatureMedicine
In a randomized trial, the angiotensin receptor blocker valsartan improves cardiac structure and function in patients with early-stage hypertrophic #cardiomyopathy, a condition lacking effective therapies to modify disease progression www.nature.com/articles/s41591-021-01505-4 #nmedclinical
-
Nature Medicine
@NatureMedicine
Flaws in ivermectin data suggest that COVID-19 meta-analyses need rethinking
Correspondence from Jack Lawrence @GidMK @K_Sheldrick and colleagues
www.nature.com/articles/s41591-021-01535-y -
Nature Medicine
@NatureMedicine
Young people must be involved in setting the global health agenda.
Worldview from @ishukataria3, Senior Public Health Researcher @RTI_Intl
www.nature.com/articles/s41591-021-01474-8 -
Nature Medicine
@NatureMedicine
Malaria: a problem to be solved and a time to be bold.
Comment from @PAlonsoMalaria, Director Global Malaria Programme @WHO
www.nature.com/articles/s41591-021-01492-6 -
Nature Medicine
@NatureMedicine
With another @SpaceX flight today 🌎🚀 it is increasingly important that health data from astronauts and space tourists is stored in a single database, to understand the effects on the human body 🌌
⚡Our latest editorial⚡
www.nature.com/articles/s41591-021-01508-1 -
Nature Medicine
@NatureMedicine
COVID-19 research has relied on access to the health data of millions of people. This massive trove could be used to understand other diseases, but not everyone is convinced.
News feature from @MarionRenault
www.nature.com/articles/s41591-021-01493-5 -
Nature Medicine
@NatureMedicine
Preliminary and exploratory analyses show that a third dose of the #covid19 vaccine mRNA-1273 or variant-modified #boosters can boost levels of neutralizing antibodies against #sarscov2 variants #vaccines #nmedclinical @moderna_tx www.nature.com/articles/s41591-021-01527-y
-
Nature Medicine
@NatureMedicine
📣Our team is growing and we are looking for an editor to join us in our London or New York offices.
If you want to pursue a career in #scientificpublishing and enjoy being exposed to a braod range of areas in medicine, consider applying. Deadline Oct-4th career5.successfactors.eu/sfcareer/jobreqcareer?jobId=387… -
Nature Medicine
@NatureMedicine
A study by Dr. Noa Dagan, @RanBalicer and colleagues on an observational cohort of pregnant women in Israel, shows the BNT162b2 mRNA #covid-19 vaccine has effectiveness similar to that seen in the general population. www.nature.com/articles/s41591-021-01490-8
-
Nature Medicine
@NatureMedicine
Mandates and incentives are being considered to increase uptake of vaccines against COVID-19, but payment for vaccination may be the fairest approach.
Comment from @juliansavulescu, Jonathan Pugh and Dominic Wilkinson @ethicsinthenews @UniofOxford
www.nature.com/articles/s41591-021-01466-8 -
Nature Medicine
@NatureMedicine
In today's News and Views, Randy Cron and colleagues discuss the latest data on cytokine blockade treatment for #covid19 #cytokinestorm
@UABSOM @templemedschool
www.nature.com/articles/s41591-021-01500-9 -
Nature Medicine
@NatureMedicine
The association between certain #mitochondrialdna variants and increased risk of late-onset diseases in humans could be explained by a direct role of mitochondrial DNA in the regulation of cellular proteostasis @caina89 @nicolesoranzo @OliverStegle
www.nature.com/articles/s41591-021-01441-3 -
Nature Medicine
@NatureMedicine
News and Views just out: Hildegard Büning and Axel Schambach discuss a recent study in @NEJM which sets the stage for in vivo gene editing
#genetherapy #crispr
www.nature.com/articles/s41591-021-01476-6 -
Nature Medicine
@NatureMedicine
COVID-19 boosters in rich nations will delay vaccines for all.
Correspondence from @paimadhu and @zchagla
www.nature.com/articles/s41591-021-01494-4 -
Nature Medicine
@NatureMedicine
The @US_FDA approval of aducanumab for Alzheimer's disease was controversial.
Joel Perlmutter and Jeffrey Cummings present alternative opinions on what this approval means for Alzheimer's research.
Perlmutter: www.nature.com/articles/s41591-021-01477-5
Cummings: www.nature.com/articles/s41591-021-01478-4 -
Nature Medicine
@NatureMedicine
A new cluster randomized trial in 13 American states shows that a #socialmedia campaign with videos of healthcare professionals to encourage users to stay at home over the holidays was effective in reducing travel and subsequent spread of #covid19 @MITEcon www.nature.com/articles/s41591-021-01487-3
-
Nature Medicine
@NatureMedicine
Lack of rigor in approving #aducamumab for Alzheimer's disease may lead to serious harm.
Worldview from Joel Perlmutter @WUSTLmed who resigned from the FDA Expert Advisory Committee. A separate Worldview by Jeffrey Cummings presents an alternative opinion.
www.nature.com/articles/s41591-021-01477-5 -
Nature Medicine
@NatureMedicine
A randomised crossover #clinicaltrial testing rapid-acting insulin aspart delivered in a closed-loop system vs. standard care demonstrates increased time in range in patients with type 2 #diabetes who require dialysis. #nmedclinical @ckboughton @MRL_Cam www.nature.com/articles/s41591-021-01453-z
-
Nature Medicine
@NatureMedicine
⚡Read our new editorial⚡
"Gene therapies should be for all" #genetherapy #equity www.nature.com/articles/s41591-021-01481-9 -
Nature Medicine
@NatureMedicine
How to implement translational medicine in the clinic - a pilot from Academia Europaea @acad_euro, @pte1367 and @semmelweishu.
Correspondence from Péter Hegyi and colleagues.
www.nature.com/articles/s41591-021-01458-8 -
Nature Medicine
@NatureMedicine
How to implement translational medicine in the clinic - a pilot from Academia Europaea @acad_euro, @pte1367 and @semmelweishu.
Correspondence from Péter Hegyi and colleagues.
www.nature.com/articles/s41591-021-01458-8 -
Nature Medicine
@NatureMedicine
In our latest Review, Carmella Evans-Molina and colleagues reflect on the past, present and future of insulin therapy for #diabetes
@cevansmo #100yearsofinsulin
www.nature.com/articles/s41591-021-01418-2 -
Nature Medicine
@NatureMedicine
⭐ Research Highlight: An implant that delivers nerve stimulation could offer a new treatment option for chronic #clusterheadache, according to a clinical study published in @TheLancetNeuro
www.nature.com/articles/d41591-021-00044-2 -
Nature Medicine
@NatureMedicine
Mix-and-match vaccination with the AstraZeneca ChAdOx-1 nCoV-19 vaccine followed by the Pfizer BNT162b2 mRNA #vaccine elicited stronger immune responses, including against variants of concern, than two doses of the AstraZeneca vaccine #covid19 #sarscov2 go.nature.com/3BbEVcX
-
Nature Medicine
@NatureMedicine
Misinformation about COVID-19 vaccines often starts life in Europe or the United States but has found fertile ground in Africa, which poses a challenge for local health leaders.
News feature from @pauladepoju
www.nature.com/articles/s41591-021-01426-2 -
Nature Medicine
@NatureMedicine
In our latest News and Views: @florian_krammer discusses recent progress towards establishing a correlate of protection for #sarscov2 #vaccines
www.nature.com/articles/s41591-021-01432-4 -
Nature Medicine
@NatureMedicine
⭐ New Research Highlight: Engineered face masks with integrated #crispr technology can detect #covid19, according to a study in @NatureBiotech
www.nature.com/articles/d41591-021-00043-3 -
Nature Medicine
@NatureMedicine
The Tuberculosis Drug Accelerator, an experiment designed to facilitate collaboration in drug discovery, has reached a 10-year landmark.
Carl Nathan @WeillCornell and colleagues review the consortium’s achievements, advantages and limitations. #tb
www.nature.com/articles/s41591-021-01442-2 -
Nature Medicine
@NatureMedicine
Results from a phase 2 randomized controlled trial demonstrate improved #insulin sensitivity in patients with severe #obesity and #metabolicsyndrome following single-dose microbial transplantation and daily supplementation with low fiber for 6 weeks. #fmt
www.nature.com/articles/s41591-021-01399-2 -
Nature Medicine
@NatureMedicine
Misinformation about COVID-19 vaccines often starts life in Europe or the United States but has found fertile ground in Africa, which poses a challenge for local health leaders.
News feature from @pauladepoju
www.nature.com/articles/s41591-021-01426-2 -
Nature Medicine
@NatureMedicine
The emergence of measles during the COVID-19 pandemic threatens Pakistan’s children and the wider region.
Correspondence from Muhammad Suleman Rana and colleagues @NIH_Pakistan
www.nature.com/articles/s41591-021-01430-6 -
Nature Medicine
@NatureMedicine
Black people living in Africa must be involved in setting the priorities for global health research, policies and programs that affect their daily lives.
Correspondence from Bolajoko O. Olusanya and colleagues.
www.nature.com/articles/s41591-021-01422-6 -
Nature Medicine
@NatureMedicine
New estimates of life expectancy at birth and at age 65 years in Brazil reveal substantial declines as result of #covid19, bringing mortality back to levels observed 20 or more years ago #sarscov2 www.nature.com/articles/s41591-021-01437-z
-
Nature Medicine
@NatureMedicine
⭐ New Research Highlight: Novel mRNA vaccine designs could provide protection against many coronaviruses in a single formulation, according to a new study published in @ScienceMagazine
www.nature.com/articles/d41591-021-00042-4 -
Nature Medicine
@NatureMedicine
Dysregulated immune features in a patient with a homozygous loss-of-function mutation in PDCD1 suggest that IL-6, IL-23, STAT3 and RORγT might be potential targets for treatment of PD-1 blockade-induced #autoimmunity @casanova_lab @RockefellerUniv go.nature.com/360Z078
-
Nature Medicine
@NatureMedicine
In our latest News and Views: Cathryn Nagler and @mark_mimee @UChicago discuss how engineered yeast can 'tune down' gut inflammation in models of inflammatory bowel disease.
#ibd #ulcerativecolitis
www.nature.com/articles/s41591-021-01420-8 -
Nature Medicine
@NatureMedicine
"Asian healthcare workers have experienced racism during the COVID-19 pandemic, including from the medical community, with potentially long-term consequences for those affected." - Jo-Hsuan Wu, physician-scientist at the @ShileyEye @UCSanDiego - Read now: go.nature.com/3diUl4A
-
Nature Medicine
@NatureMedicine
Analysis of antibody responses in recipients of the #dengue #vaccine Dengvaxia supports their utility as a predictor of protection against disease, and reveals that Dengvaxia efficacy declines three years after complete vaccination @hsalje www.nature.com/articles/s41591-021-01392-9
-
Nature Medicine
@NatureMedicine
"Black people living in Africa must be involved in setting the priorities for global health research, policies and programs that affect their daily lives, in order to move away from a funding culture that fosters colonialism, racism and white supremacy" > go.nature.com/3wSYnsk
-
Nature Medicine
@NatureMedicine
Analysis of a prospectively enrolled cohort of patients with #sarscov2 infections reveals a high proportion who experienced #longcovid symptoms at 6 months, despite being relatively young and having only mild to moderate acute #covid19 symptoms www.nature.com/articles/s41591-021-01433-3
-
Nature Medicine
@NatureMedicine
Results from the Phase II/III #dian-TU #alzheimersdisease prevention trial reveals no beneficial effect on cognitive measures despite a significant reduction in #amyloid plaques and other key #biomarkers in those treated with #gantenerumab. @WUSTLmed
www.nature.com/articles/s41591-021-01369-8 -
Nature Medicine
@NatureMedicine
⭐ Research Highlight: Certain types of immune cells that patrol the central nervous system are sourced locally from the bone marrow, not the blood, according to two studies in @ScienceMagazine
www.nature.com/articles/d41591-021-00040-6 -
Nature Medicine
@NatureMedicine
Results from a phase 1 trial testing a novel oral GLP-1 receptor agonist danuglipron in patients with type 2 #diabetes demonstrate acceptable safety, tolerability and pharmacokinetic profiles of the drug #nmedclinical go.nature.com/3grzih2
-
Nature Medicine
@NatureMedicine
In our latest News and Views: Michael Nauck and colleagues @ruhrunibochum discuss the latest clinical milestone in the development of GLP-1-based therapy for #diabetes.
www.nature.com/articles/s41591-021-01394-7 -
Nature Medicine
@NatureMedicine
At early timepoints after vaccination with 1 or 2 doses of the BNT162b2 mRNA #covid19 #vaccine, breakthrough #sarscov2 infections can be disproportionately caused by B.1.1.7 or B.1.351 variants of concern @SacklerMed @TelAvivUni @ClalitHealth go.nature.com/3iEaKnG
-
Nature Medicine
@NatureMedicine
Strengthened health systems are needed to tackle COVID-19 in Africa.
A call to action from @alobosifuma at @AASciences.
www.nature.com/articles/s41591-021-01395-6 -
Nature Medicine
@NatureMedicine
⭐ Research Highlight: A new technique allows for enhanced data security and confidentiality in clinical #ai, according to a study published in @Nature
www.nature.com/articles/d41591-021-00039-z -
Nature Medicine
@NatureMedicine
Calling all science writers around the globe! We’re expanding and diversifying our roster of freelance news contributors. If you’re reporting on medicine, science & society, DM us introducing yourself, interests and sharing a couple of bylines by July 5. #scicomm
-
Nature Medicine
@NatureMedicine
⭐ Research Highlight: A study published in @TheLancet finds that critically ill patients with #covid19 in Africa are at higher risk of death than those elsewhere, and seeks to identify the factors associated with this outcome.
www.nature.com/articles/d41591-021-00037-1 -
Nature Medicine
@NatureMedicine
Our #infectiousdiseases editor Alison Farrell is attending the virtual #vkshivpath21 and #vkshivvax21 meetings this week! Get in touch if you'd like to chat and learn more about @NatureMedicine! @BayAreaBioEd @KeystoneSymp
-
Nature Medicine
@NatureMedicine
⭐Research Highlight: A brain implant in a paralyzed person allows them to communicate by translating neural activity into text, according to a new study published in @Nature
#bci #neuroscience
www.nature.com/articles/d41591-021-00036-2 -
Nature Medicine
@NatureMedicine
Editorial: To curb COVID-19, global health must go local⚡️go.nature.com/3oPMekH 🇧🇷🇮🇳
#covidindia #covidvaccine #covid19 #globalhealth -
Nature Medicine
@NatureMedicine
Data from #wearable sensors, including heart rate, body temperature, electrodermal activity and movement, can predict clinical laboratory measurements.
www.nature.com/articles/s41591-021-01339-0 #healthtech #precisionmedicine @SnyderShot @StanfordMed -
Nature Medicine
@NatureMedicine
‘N of 1’ therapies need a better model.
Oligonucleotides offer therapeutic potential for patients that carry unique genetic mutations, but developing individualized therapies is not supported by the current process for drug development, argues @oligogirl
www.nature.com/articles/s41591-021-01380-z -
Nature Medicine
@NatureMedicine
Injection of a light-activated #genetherapy vector combined with the wearing of light-stimulating goggles achieves partial vision restoration in a blind patient with retinitis pigmentosa.
www.nature.com/articles/s41591-021-01351-4 #optogenetics #raredisease @IOB_Roska @InstVisionParis -
Nature Medicine
@NatureMedicine
Have you had your personal genome sequenced?
Increasing data are collected by companies that provide personal genomic tests, yet health legislation is inadequate to protect users, according to Joseph S. Ross and colleagues at @YaleMed @YaleSPH
www.nature.com/articles/s41591-021-01368-9 -
Nature Medicine
@NatureMedicine
Urbanization, armed conflict, and deforestation in African countries have increased the risk of zoonotic infections, which requires a One Health approach that includes animal health.
Comment from Akan Otu and colleagues @Unical1975 @UniversityLeeds
www.nature.com/articles/s41591-021-01375-w -
Nature Medicine
@NatureMedicine
What is the future of the hospital?
Tian and colleagues describe a 5G smart hospital in Guangdong, China, which has embedded 5G technology, combined with AI, from the ambulance to the operating room.
www.nature.com/articles/s41591-021-01376-9 -
Nature Medicine
@NatureMedicine
#onehealth approaches are needed to assess risks from the human-animal-environment interface. Two comments on this important topic, coinciding with a new @UN panel, from Rwanda and Nigeria:
@ughe_org Rwanda
www.nature.com/articles/s41591-021-01350-5
@Unical1975 Nigeria
www.nature.com/articles/s41591-021-01375-w -
Nature Medicine
@NatureMedicine
A systematic evaluation of an #ai decision support system in skin cancer diagnosis demonstrates the superiority of human–computer collaboration for automated diagnostic medicine.
www.nature.com/articles/s41591-020-0942-0 #melanomaawarenessmonth #artificialintelligence -
Nature Medicine
@NatureMedicine
A study of hospitalized patients with liquid or solid #cancer who were infected with #sarscov2 suggests that hematologic malignancy is an independent risk factor for mortality and that CD8+ T cells might limit infection irrespective of humoral #immunity. www.nature.com/articles/s41591-021-01386-7
-
Nature Medicine
@NatureMedicine
An analysis of #covid19 vaccine allocation frameworks in the US reveals that some jurisdictions have adopted disadvantage indices to reduce health disparities, and highlights the importance of #vaccine prioritization based on health and place.
www.nature.com/articles/s41591-021-01379-6 #policy -
Nature Medicine
@NatureMedicine
Molecular profiling of multiple serial tumor biopsies from a #melanoma patient treated with immune checkpoint inhibitors, uncovers changes in the tumor microenvironment occurring during treatment resistance.
www.nature.com/articles/s41591-021-01331-8 #melanomaawarenessmonth @gmboland @dliu_ccb -
Nature Medicine
@NatureMedicine
🌟 New Correspondence: Klaus Marhold and Jan Fell discuss the importance of developing compatible #covid19 Electronic Vaccination Certificates across different countries @wu_vienna
www.nature.com/articles/s41591-021-01286-w -
Nature Medicine
@NatureMedicine
Longitudinal single-cell analysis of #multiplemyeloma patients in a prospective clinical trial uncovers new pathways of drug resistance and identifies potential actionable targets #nmedclinical @IdoAmitLab @WeizmannScience @NatResCancer go.nature.com/3dAyeHI
-
Nature Medicine
@NatureMedicine
🌟 New Review Article out now from Ilio Vitale, @deadoc80 and colleagues, discussing the sources and impact of intratumoral heterogeneity in #cancer progression and treatment. @ShemaEfrat @LoiSher. #epigenetics #intratumoralheterogeneity @WCM_MeyerCancer
www.nature.com/articles/s41591-021-01233-9 -
Nature Medicine
@NatureMedicine
Interrogation of SARS-CoV-2 variant sequences isolated in South Africa during the first 6 months of the #covid19 pandemic reveals three major monophyletic lineages responsible for more than half of the infections in the country @Tuliodna @krisp_news @uwdgh go.nature.com/3at9Vs1
-
Nature Medicine
@NatureMedicine
Looking beyond #covid19 #vaccine phase 3 trials: Jerome Kim, Florian Marks and John Clemens discuss the next steps needed to achieve successful #vaccination of the global population - Read now: go.nature.com/3p2GcfU @IVIHeadquarters @drjeromekim1
-
Nature Medicine
@NatureMedicine
Clustering of patients with prediabetes using simple clinical features reveals six distinct groups with differing risk of developing type 2 #diabetes and its associated complications.@HelmholtzMunich @uktuebingen @DiabResearch @wagrob
go.nature.com/3b3N6gJ -
Nature Medicine
@NatureMedicine
In our last issue of the year, we've asked experts to reflect on what is to come. 2021: research and medical trends in a post-pandemic world. www.nature.com/articles/s41591-020-01146-z
-
Nature Medicine
@NatureMedicine
Do you work in biomedical sciences and have been using art as a way to cope with the pandemic? DM us today starting your messages with: "pandemic-art", we want to hear from you!
-
Nature Medicine
@NatureMedicine
On #worldaidsday read about national HIV-prevention strategies in African countries through PrEP rollout in this Perspective from Elizabeth M. Irungu & Jared M. Baeten
@DiscoverJKUAT @uwdgh go.nature.com/3lxbiJH -
Nature Medicine
@NatureMedicine
The randomized-controlled trial ADVICE4U demonstrates non-inferiority of an automated #ai-based decision support system compared with advice from expert physicians for optimal insulin dosing in youths with type 1 #diabetes. @Moshe_Phillip @TelAvivUni
go.nature.com/3m5sN5A -
Nature Medicine
@NatureMedicine
In recovered #covid19 patients, virus spike-specific #antibodies were consistently elicited, but neutralizing activity was variable and inversely correlated with the proportion of CCR6+CXCR3- spike-specific circulating T follicular helper cells. @unimelb go.nature.com/2ATrwf4
-
Nature Medicine
@NatureMedicine
Nature Medicine summarizes all the research you need to know this week on the #covid19 pandemic. This week, read about the GWAS study study suggesting increased risk of severe #covid19 in people with blood group A and reduced risk with blood group O.
go.nature.com/3hICrJ0 -
Nature Medicine
@NatureMedicine
An IgG-cleaving endopeptidase can degrade circulating anti-adeno-associated virus antibodies in mice and nonhuman primates in vivo, as well as in human plasma in vitro, offering a potential solution for a major hurdle in gene therapy. #aav #immunogenicity go.nature.com/3cmSHvz
-
Nature Medicine
@NatureMedicine
Check here the results from the exploratory NICHE study by @MyriamChalabi & colleagues, evaluating neoadjuvant #immunotherapy combination in early-stage colon #cancer―Striking clinical responses in MMR-proficient and MMR-deficient patients www.nature.com/articles/s41591-020-0805-8
#asco20 -
Nature Medicine
@NatureMedicine
Characterization of 200 antibodies that bind a #malaria parasite protein provides insights that could enable better #vaccine design. @HWardemann @jphilippejulien @e_levashina @mpiib_berlin @DKFZ @SickKidsNews go.nature.com/36uZqSV
-
Nature Medicine
@NatureMedicine
"Our analyses clearly show that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus." -> read now: go.nature.com/3d9UhlQ #covid19 @K_G_Andersen
-
Nature Medicine
@NatureMedicine
On March 4, #worldobesityday, we at Nature Medicine and all journals @nresearchnews pledge to work together to help ending the #stigma of #obesity > go.nature.com/2IdGEEh #openaccess @WorldObesity @FRubinoMD @KingsCollegeLon
-
Nature Medicine
@NatureMedicine
Prenatal androgen exposure causes transgenerational increases in offspring susceptibility to polycystic ovary syndrome in adulthood | go.nature.com/2YCDH7n| #pcos @ElisabetStener
-
Nature Medicine
@NatureMedicine
A sardonic professor once told @LoiSher, “If you want a good next life, come back as a phase I or II trial as they are all positive.”
Read her heartfelt account of the moments that led her to research the #cancer #genome in #breastcancer: go.nature.com/33laDTg -
Nature Medicine
@NatureMedicine
New Perspective outlining a way forward to understanding mechanisms of #neuropsychiatric disease by investigating high-penetrance risk factors for rare genetic disorders from @Winkytheelf and coauthors
nature.com/articles/s41591-019-0581-5 -
Nature Medicine
@NatureMedicine
This systematic comparison of ctDNA vs tissue sequencing by Ryan Corcoran, Gad Getz & cols. shows the superiority of liquid biopsy for capturing clinically relevant alterations mediating therapy resistance in #cancer patients www.nature.com/articles/s41591-019-0561-9 #precisionmedicine #genomics
-
Nature Medicine
@NatureMedicine
In the age of #bigdata, how is your medical data protected? Find out about potential #ethics and privacy challenges in this Perspective from @CohenProf @WNicholsonPrice
go.nature.com/30Tcde2 -
Nature Medicine
@NatureMedicine
In mouse models of stress-induced #depression, molecular and chemogenetic stimulation of the entorhinal cortex induces the production of adult-born hippocampal neurons and generates antidepressive-like effects: go.nature.com/2F3CScg
-
Nature Medicine
@NatureMedicine
Sorafenib treatment has the potential to contribute to an immune-mediated cure of a mutant acute myeloid #leukemia relapse, an otherwise fatal complication after allogeneic hematopoietic cell transplantation: go.nature.com/2G7Z3z8
-
Nature Medicine
@NatureMedicine
A full night of sleep deprivation causes attenuated & delayed neuronal responses that correlate w/impaired cognition go.nature.com/2yB77cm
-
Nature Medicine
@NatureMedicine
A first in the US, scientists used #crispr to edit disease-causing genes in the DNA of human embryos: go.nature.com/2v2VhVq #nmednewsbeat
-
Nature Medicine
@NatureMedicine
Join us in Seattle in September for the Human Immune Profiling meeting! More details here: go.nature.com/2pZrbzf
-
Nature Medicine
@NatureMedicine
Proteins have long been drug targets, but scientists believe new targets can now be found in RNA. More in our story: go.nature.com/2pXUwKo
-
Nature Medicine
@NatureMedicine
Differentiation status of the cell of origin is a primary determinant of tumors' genomic landscapes: go.nature.com/2pqj3Z4 #breastcancer
-
Nature Medicine
@NatureMedicine
Stress-induced pathological gene activation in the heart involving an epigenetic checkpoint: go.nature.com/2ddENBP
-
Nature Medicine
@NatureMedicine
News coverage of our recent paper (here: rdcu.be/jmnv) on #placebo response & #immunity: www.wsj.com/articles/why-placebos-really-work-the-latest-… #nmedinthenews
-
Nature Medicine
@NatureMedicine
A gut-vascular barrier walls off bacteria from entering the circulation: www.sciencemag.org/content/350/6262/830.full #nmedhighlight
























































































































































































































